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2Abstract
Tissue-specific genes have been found to be epigenetically marked in embryonic stem cells
by different combination of histone modifications. These marks are believed to prime genes for
activation at later stages of development. Previous work has revealed the presence of one such
signature on one enhancer of the mouse 5-VpreB1 locus, which is expressed at the pro- and
pre-B cell stage of B lymphocyte development. This element, which has been called Early-
Transcriptional Competence Mark (ETCM), is characterised by the presence of tightly localised
peaks of histone H3K4 methylation and H3K9 acetylation. However, the ETCM lacks the
trimethylation of H3K27 that defines bivalent domains at many tissue-specific genes in ES cells.
The results described in this thesis show that that two ES cell transcription factors, Sox2 and
Foxd3, bind to the 5-VpreB1 ETCM in ES cells. Analysis of factor binding to the 5-VpreB1
locus at the proB cell stage of B-cell development showed that the same sequences are occupied
by the B-cell specific factors Sox4 and Foxp1.
Chromatin immunoprecipitation and microarray analysis (ChIP-on-Chip) showed that
Sox2 and Foxd3 are bound to a number of ETCM-like elements in ES cells, as well as bivalent
domains, suggesting that they are involved in the establishment and maintenance of these
epigenetic marks in ES cells. Knockdown of Sox2 by siRNA confirmed its involvement in the
methylation of H3K4 on these DNA regions. Based on these data, I propose a factor-relay
model in which embryonic stem cell transcription factors generate epigenetic signatures at key
regulatory elements of tissue-specific genes. During differentiation these proteins are replaced
by related factors, which share their DNA-binding profile, and play an important role in
activating tissue-specific transcription.
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1  Introduction
The genome is the repository of the information that regulates the life of every organism
and the gene is one of its functional units. The concept of the gene has evolved over the last
century; it was first used in 1909 by Wilhelm Johannsen to indicate the discrete units of heredity
that enable specific somatic traits to be passed to the offspring (Johannsen, 1909), a
phenomenon that was first described by Gregor Mendel in 1866 (Mendel, 1886). The latest
definition of the gene reflects the progress in biology of the past decades. Nowadays a gene is
defined as a genomic sequence, of DNA or RNA, directly encoding functional product
molecules, either RNAs or proteins (Gerstein et al., 2007). Considering the importance of genes,
a surprising finding emerged when the sequencing of the human genome showed that they
occupy only a small fraction (10 to 20%) of the genome (Lander et al., 2001; Venter et al.,
2001), with most of the genome made up of non-coding sequences. The non-coding regions
have attracted more and more attention over the past two decades, due to their fundamental role
in controlling gene transcription.
Transcription is the process that produces RNA from a DNA template. This is the first step
into the production of proteins or functional RNAs. Each cell is characterised by the genes that
it transcribes and by the levels of this transcription, therefore the precise regulation of the
process is essential for cellular identity and homeostasis. Some cells have the ability to
differentiate and, in particular, the embryonic stem (ES) cells derived from mouse blastocyst
are capable of both self-renewing and producing all the cell types present in every tissue of an
adult mouse. From a transcriptional point of view, it means that an ES cell is able to radically
change its transcriptional pattern and levels to a state that is characteristic of each of the many
cells of a mouse.
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1.1  Gene regulation
The control of transcription is achieved at multiple levels by different mechanisms, which
control chromatin organisation, histone modifications, histone variants and nucleotide
modifications. These mechanisms are called epigenetic because they influence gene expression,
without affecting the DNA sequence, and are heritable through the cell cycle. Non epigenetic
mechanisms regulating gene expression include binding of proteins to regulatory DNA
elements and finally transcription itself. In additions, each level of regulation – epigenetic or
not – is influenced by changes in the others, creating a complex system that allows a cell to
precisely control which genes are expressed and to what extent.
1.1.1  Chromatin organisation
Chromatin is the structure formed by DNA and its associated proteins in eukaryotic cells.
One of the main contributions of chromatin is to compact the approximately two meter long
DNA molecule to fit into the nucleus, preventing knots and tangles and protecting the genome
from physical damage. The main proteins that contribute to the chromatin structure are the
histones. Of these, four core histones (H2A, H2B, H3 and H4) are part of the nucleosome, while
the linker histone (H1) is bound to DNA sequences between nucleosomes.
The nucleosome consists of 147bp of DNA wrapped around a histone octamer, which is
composed by two dimers of H2A-H2B and two dimers of H3-H4. This arrangement means that
the DNA is folded around the histone octamer around 1.65 turns, severely distorting its path
and providing a level of compaction of about 7-fold (Luger et al., 1997). There are more than
116 direct and 358 water-bridged interactions between the histone octamer and the DNA, which
act to stabilise the structure of the nucleosome (Davey et al., 2002; Luger and Richmond, 1998).
Subsequent regions of DNA folded around nucleosomes form the 10nm fiber, which has a
structure described as “beads on a string”. The secondary configuration of chromatin has a
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diameter of 30nm and requires the presence of the linker histone, but its actual structure is still
unresolved (Tremethick, 2007) and there is not direct evidence of it in vivo (Horowitz-Scherer
and Woodcock, 2006). Chromatin can be further compacted into tertiary structures and this
process has been shown to be dependent on the activity of several cofactors, including H1
(Edmondson et al., 1996; Georgel et al., 2003; Grigoryev, 2001; Hecht et al., 1995; Taddei et
al., 1999) (Figure 1.1.1).
In each cell different chromatin regions have different degrees of compactions. This
phenomenon was first observed almost a century ago when it was noted that some nuclear
regions remained stained (condensed) through the cell cycle, while other underwent cycles of
condensation-decondensation. The first structure was called heterochromatin, to contrast the
second, which was thought to be the “true” chromatin (euchromatin) (Heitz, 1928). Heitz also
Figure 1.1.1 Schematic illustration of chromatin organisation and different levels of condensation.
Reprinted, with permission, from the Annual Review of Biophysics and Biomolecular Structure, Volume 31  ©
2002 by Annual Reviews  www.annualreviews.org
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formulated the hypothesis that euchromatin is active and contains genes, while heterochromatin
is inactive and mainly without genes (Heitz, 1929). Although it has been proved not to be
entirely valid, this idea has been a central concept in chromatin research for several decades.
Table 1.1.1 highlights the main differences between euchromatin and heterochromatin.
Euchromatin has a more decondensed structure and is more sensitive to enzymatic digestions.
A peculiar distinction between the two types of chromatin includes differences in the time of
replication of different genomic areas, with euchromatic regions replicating earlier than regions
that are heterochromatic (Schubeler et al., 2002).
Heterochromatin has a number of physical properties: it can spread, has a highly condensed
structure, tends to cluster to form nuclear compartments and, when present in large amounts, is
cytologically visible. Improvements in staining methods and the development of electron
microscopy revealed that heterochromatin can be further subdivided into two categories,
constitutive and facultative heterochromatin (Brown, 1966). Constitutive heterochromatin is
generally associated with pericentromeric regions. These are formed by repetitive sequences
(satellite repeats), whose lengths vary in different species. Telomeres also exhibit many of the
properties of constitutive heterochromatin. In addition, genomic regions of constitutive
heterochromatin tend to colocalise at the periphery of interphase nuclei (Weierich et al., 2003).
Despite the condensed chromatin state, transcription at constitutive heterochromatic regions is
possible and in certain instances even required for its establishment, since it generates the
Lightly staining Darkly staining
Decondensed, open Condensed, closed
DNase sensitive Less sensitive
Transcriptionally poised or active Mostly silent
Loosely positioned nucleosomes Ordered, regularly spaced nucleosomes
Acetylated H3 and H4 histones Hypoacetylated histones
Early replicating Late replicating
General features of euchromatin and heterochromatin.
Table 1.1.1
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silencing RNA (siRNA) molecules that help to induce heterochromatin formation (see Section
1.1.2.1) (Grewal and Elgin, 2007; Smith et al., 2007).
Facultative heterochromatin is transcriptionally silent and it is formed from previously
euchromatic regions. Facultative heterochromatin can cover an entire chromosome (e.g. the
inactive X chromosome of female mammalian organisms), can span large genomic distances
(e.g. the homeotic gene clusters), or can be restricted to defined regulatory regions of genes (e.g.
promoters of silenced genes). It can therefore adopt a wide range of chromatin condensation
states, including local compaction of the 10nm fiber (for instance at promoters of inactive
genes) or more complex higher-order structures. Facultative heterochromatin also has the
potential to reconvert to euchromatin in order to allow transcription in response to specific
stimuli (Trojer and Reinberg, 2007).
1.1.2  Histone modifications and histone variants
As mentioned above, five main histones are found in eukaryotic cells; four core histones
and one linker histone.
The nucleosome core is an octamer formed by two molecules of each core histone (Figure
1.1.2). The core histones are small highly basic proteins, ranging between 11 and 16 kDa. They
represent some of the most conserved proteins in eukaryotes, highlighting the importance of
their role in organizing DNA folding. Structural studies have shown that core histones are
comprised of two distinct domains. The histone fold domain, formed by three a-helices
connected by two loops, is involved in histone-histone and histone-DNA interactions, while the
N-terminal tail domain, which is composed of about 15–30 highly basic amino acids, protrude
out of the nucleosome surface (Arents et al., 1991; Luger et al., 1997).
The assembly of the nucleosome is a two step process that starts with deposition of a
tetramer of two H3-H4 dimers on the DNA. A H2A-H2B dimer then binds to each side of this
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tetramer to form the final octamer (Kleinschmidt et al., 1990; Smith and Stillman, 1991). The
assembly is dependent on several proteins, called histone chaperones, that bind histones and
promote histone polymerisation and deposition on the DNA during replication (see Section
1.1.2.5).
Histone H1 has a central globular domain, flanked by a relatively short N- and a long
C-terminal domain; the globular domain is the most conserved part of the protein. Lower
organisms possess only one H1 isoform, while mammalian cells have up to six different
subtypes of H1, all encoded by different genes. The different H1 isoforms have developmental
and tissue specificity (Khochbin, 2001). The globular domain of H1 is located close to the
entry-exit sites of linker DNA on the nucleosome and protects 20 extra base pairs from nuclease
digestion, in addition to the 147bp protected by the nucleosomal structure (Allan et al., 1980;
Simpson, 1978). Moreover, the linker histone plays a role in chromatin organization by
promoting coiling or folding of the chromatin fiber for example by shielding the negative
charge of linker DNA between adjacent nucleosomes (Ramakrishnan, 1997).
Histones can undergo post-translational modification, especially at the N-terminal tails of
the core histones (Figure 1.1.3). These changes influence transcription of the affected loci as
well as chromatin conformation and compaction. Further levels of regulation are achieved by
the presence of histone variants. All of these aspects have been studied extensively in recent
Figure 1.1.2 Nucleosome structure. (A) A 2.8 Å model of the nucleosome. (B) A schematic representation of the
octamer core with the DNA (black line) wrapped around it to form the nucleosome. Reproduced, with permission,
from Allis et al., 2007b. © 2007 by Cold Spring Harbour Laboratory Press.
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years and will be discussed in the sections below. In the treatment of the enzymes that are
involved in modifying histones, the nomenclature proposed by Allis and colleagues (Allis et al.,
2007a) will be used to name lysine methyltransferases, lysine demethylases and lysine
acetyltransferases; the conventional names will be used for all of the other enzymes.
Methylation is the most complex covalent modification that is found on the histones. It can
occur on either lysine or arginine residues and each residue can be poly-methylated (up to three
methyl-group for lysines, two for arginines). Given that there are at least 24 identified sites of
methylation among the core histones, the number of possible nucleosomal methylation states is
significant.
Arginine methylation was first identified in vitro as a product of the activity of the enzyme
CARM1 (Chen et al., 1999) before being detected in vivo. Several methyl-arginine residues
have been associated with transcription activation (H4R3, H3R2, H3R17, H3R26) (Bauer et al.,
2002; Strahl et al., 2001; Wang et al., 2004b) while some have been found important for the
repression of numerous genes (H4R3 and H3R8) (Fabbrizio et al., 2002; Pal et al., 2003).
Figure 1.1.3 Sites of covalent histone modifications. Reproduced, with permission, from Allis et al., 2007b. ©
2007 by Cold Spring Harbour Laboratory Press
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Histone H4R3 has been detected at both active and repressed genes; the effects of this
modification are thought to depend on the enzyme involved in its establishment and its
cofactors. Several studies on the activation of the estrogen-regulated gene pS2 have
demonstrated that arginine methylation can be very dynamic, being set up soon after the
binding of the estrogen receptor and coinciding with the arrival of activated RNA polymerase
II (PolII) at the promoter. The modification and the presence of PolII become then rapidly
undetectable (Cuthbert et al., 2004; Metivier et al., 2003; Wang et al., 2004b). No methyl-
arginine specific demethylase has been isolated. Instead it has been shown that the imine group
is removed from the amino acid, along with the bound methyl; this deimination converts an
arginine into a citrulline. PADI4 (peptidylarginine deiminase-4) has been identified as the
enzyme responsible for this activity and analysis of estrogen-regulated promoters showed that
the gene shut-off coincides with the appearance of citrullines on histones (Cuthbert et al., 2004;
Wang et al., 2004b).
Lysine methylation is set up by a series of enzyme all but one of which share a SET domain.
Methylated histones are recognised by a series of protein that are characterised by one of these
three domains: chromo, tudor or PHD (plant homeodomain). Histone H3K4 methylation is
associated with euchromatin and with active genes (Noma et al., 2001). The three possible
H3K4 methyl-states have been linked to different regulatory elements. While H3K4me3 is
found predominantly around promoter regions, H3K4me1 has been shown to be associated
with regulatory elements, such as enhancers; the intermediate state (H3K4me2) has been found
both at promoters and enhancers (Heintzman et al., 2007). One mechanism for the
establishment of H3K4me3 was identified in yeast and involves PolII phosphorylated on
serine-5, an isoforms of PolII that is normally associated with promoters (Boehm et al., 2003;
Espinosa et al., 2003; Spilianakis et al., 2003). PolII can directly recruit KMT2 (lysine methyl
transferase-2; previously Set1), which induces trimethylation around the promoter, before PolII
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escape (Ng et al., 2003). A second system that is involved in H3K4 methylation is the
anti-repressor Trithorax (Trx) protein complex (Klymenko and Muller, 2004), which is
recruited to regulatory elements and promoters by several transcription factors. Trx proteins
have been implicated in chromatin remodelling (see Section 1.1.3) and different subunits show
lysine methyltransferase activity that is specific for H3K4 (Beisel et al., 2002).
An additional lysine methylation that is associated with active transcription is H3K36,
which has been found necessary for efficient elongation by PolII and is particularly enriched at
coding regions, in contrast to the 5′ localisation of H3K4me3. PolII has also been found to play
an important role in setting up also this mark, since PolII that is phosphorylated on serine-2, the
elongating form of the enzyme (Phatnani and Greenleaf, 2006) can recruit KMT3 (Set2), the
enzyme responsible for H3K36 methylation (Li et al., 2003; Li et al., 2002).
H3K79 is the remaining lysine methylation mark that is associated with active transcription.
It is an unusual modification because it involves a residue that is located in the globular part of
the histone, rather than the tail region. The second peculiarity is that it is established by the only
lysine methyltransferases that lacks the Set domain (KMT4 or Dot1). This histone modification
has been also associated with DNA repair mechanisms, since it induces the recruitment to the
DNA of 53BP1, a checkpoint protein involved in the recognition of double strand breaks
(Huyen et al., 2004).
H3K9 methylation, a histone modification that is associated with silencing, has been
extensively studied since the enzyme catalysing this modification, KMT1 (Su(var)3-9) was the
first histone methyltransferase to be isolated (Rea et al., 2000). Mammals have four related
enzymes catalysing H3K9 methylation, KMT1A-D. The Drosophila homolog is a known
modifier of Position-effect variegation (PEV), a silencing mechanism that involves the
spreading of heterochromatin into adjacent euchromatic genes. H3K9 methylation has also
been found implicated in the formation of pericentromeric heterochromatin. KMT1-dependent
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H3K9 methylation creates a binding platform for HP1 (heterochromatin protein-1). Once HP1
is bound, it can spread into nearby nucleosomes by its association with other HP1 molecules
and with KMT1, which further catalyse H3K9 methylation (Nakayama et al., 2001; Noma et
al., 2001).
The first step in heterochromatic formation involves the transcription of dsRNA (double-
stranded RNA) from the pericentromeric repeats. The dsRNA are processed by the enzyme
Dicer into siRNA, which interacts with a multi-protein complex called RIST (RNA-induced
transcriptional silencing). The interaction with RIST targets further nascent dsRNA synthesis
from the repeats. The RIST complex is thought to recruit KMT1 to the repeats, thereby
initiating H3K9 methylation and HP1 binding (Noma et al., 2004). In addition, one of the RIST
subunits (Chp1) has a chromo-domain that recognises methylated H3K9 and promotes
recruitment of further siRNA/RIST to the nascent heterochromatin (Hall et al., 2002; Volpe et
al., 2002).
Repression of normally euchromatic genes also involves binding of HP1 to methyl H3K9,
which can lead to the formation of facultative heterochromatin regions. Recruitment of KMT1
in these circumstances is mediated by transcriptional repressors and, in contrast to
pericentromeric heterochromatin formation, HP1 binding is localised and does not spread
across broad regions (Nielsen et al., 2001; Tachibana et al., 2002; Tachibana et al., 2005).
H4K20me2 and H4K20me3 are also associated with pericentromeric heterochromatin.
There is some evidence that methylation of H3K9 is necessary for recruitment of KMT5B or C,
the enzymes responsible for H4K20 methylation (Schotta et al., 2004). H4K20me1 has been
instead associated with control of mitosis, since lack of the related enzyme, KMT5A, induces
cell-cycle arrest in Drosophila (Karachentsev et al., 2005).
H3K27 methylation is another repressive mark, which is found at silenced euchromatic
genes, pericentromeric heterochromatin and on the inactive X chromosome in mammals.
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KMT6 (EZH2 or enhancer of zeste -E(Z)- in Drosophila) catalyse this methylation and is a
component of the Polycomb repressive complexes (PRC). In Drosophila PRCs are recruited to
the DNA by specific Polycomb response elements (PRE). Similar elements have not been
identified so far in mammals. Two distinct PRC complexes exist; PRC2 contains KMT6 and
mediates H3K27 methylation, while PCR1 includes Pc (polycomb), which binds the
methylated H3K27 through its chromo-domain. PRC1 induces silencing by interacting with
neighbouring histones and creating a compacted chromatin, which blocks transcription factors
and their cofactors from gaining access to the DNA (Francis et al., 2004; Shao et al., 1999).
For many years a major issue in the histone methylation field was whether the methyl mark
is actively removed in vivo. The question was resolved by the identification of the first lysine
demethylase, KDM1 (LSD1) (Shi et al., 2004). This enzyme specifically remove mono- and
dimethyl group from H3K4 and is associated to a number of repressive complexes (Lee et al.,
2005; Shi et al., 2005). The association of KDM1 with the androgen receptor changes the
specificity of its demethylation activity from H3K4 to H3K9, thus inducing activation rather
than silencing (Metzger et al., 2005). A different class of lysine demethylases, containing a
novel catalytic domain called Jumonji (Jmj – KDM2-6), was recently discovered (Tsukada et
al., 2006). Several proteins presenting the Jmj domain have been identified so far, which target
all histone methyl-lysines with the exception of H3K79 and H4K20 (Agger et al., 2007; Cloos
et al., 2006; Fodor et al., 2006; Klose et al., 2006; Tsukada et al., 2006; Whetstine et al., 2006;
Yamane et al., 2006). An important difference between the Jmj demethylases and KDM1, is
their ability to remove all three methyl groups from lysines, while KDM1 only targets mono-
and dimethyl groups.
The analysis of acetylated histones by chromatin immunoprecipitation (ChIP) within the
transcribed -globin locus in chicken erythrocytes, showed for the first time the correlation
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between this histone modification and transcriptionally active chromatin regions (Hebbes et al.,
1994). Histone hypo-acetylation was instead found on a silenced region of the yeast genome
(Braunstein et al., 1993). Further details on the correlation between transcription and histone
acetylation and between silencing and hypo-acetylation came from the isolation of histone
lysine acetyltransferases (KAT or HAT according to the old nomenclature) and histone
deacetylases (HDAC). The first identified enzyme with KAT activity was KAT2 (Gcn5), a
protein already known for interacting with transcriptional activators (Brownell et al., 1996),
while the first HDAC was identified as a known transcriptional cofactor, Rpd3 (Taunton et al.,
1996). These results identified a correlation between enzymes regulating the acetylation of
histones and the transcription machinery. Over the years many co-activators or co-repressors
were shown to possess KAT or HDAC activity or to associate with such enzymes. These
discoveries suggested a model that involves the recruitment of KATs by DNA-bound
transcriptional activators, while repressors recruit HDACs (see Figure 1.1.4).
Figure 1.1.4 Recruitment of histone acetyltransferases (KAT) or deacetylases (HDAC) to regulatory
elements has opposing effects on gene transcription. Activators recruit HATs to upstream activating sequences
(UAS). The enzyme then acetylates neighbouring nucleosomes, which favours gene transcription. HDACs are
recruited by repressors to upstream regulatory sequences (URS) where they deacetylate local histones. This
contributes to gene repression. Reproduced, with permission, from Kouzarides and Berger, 2007. © 2007 by Cold
Spring Harbour Laboratory Press
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Several mechanisms favour transcription when lysines are acetylated. First the acetyl group
neutralises the positive charge of lysines, reducing the strength of the binding between the basic
histone tails and the negatively charged DNA chain, thus decompacting the chromatin structure
and exposing DNA binding sites (Shogren-Knaak et al., 2006; Vettese-Dadey et al., 1996).
Then the acetyl-group form a docking platform for the association of protein characterised by
bromodomains (Dhalluin et al., 1999), a structure found in many chromatin-associated proteins.
Among the protein that posses bromodomain are members of the remodelling complex Swi/Snf
(see Section 1.1.3) (Hassan et al., 2002) and members of the TFIID complex, such as Taf1 and
Bdf1 (see Section 1.1.5). Binding of such proteins helps to modify further the chromatin
structure or are essential for the correct activation of transcription.
Different classes of KATs have been identified, each characterised by different substrate
specificities. KAT2 (Gcn5) predominantly targets histone H3, KAT5 (MYST or Tip60 in
mammals) has a preference for histone H4, while KAT3A (CBP) and KAT3B (p300) are more
promiscuous. Histone acetyltransferases, like most histone modifying enzymes, are part of
multi-protein complexes. One of the first to be identified was the KAT2-containing SAGA
(Spt-Ada-Gcn5-Acetylatransferase), which targets primarily H3 but also H2A and is associated
with several gene-activation complexes (Grant et al., 1997). KAT5 is the catalytic subunit of
the highly conserved acetyltransferases complex NuA4 (nucleosome acetyltransferase of
histone H4) (Doyon et al., 2004), which is a co-activator of many transcription factors
including nuclear hormone receptors, such as the androgen receptor (Brady et al., 1999), NF-kB
(Baek et al., 2002) and c-Myc (Frank et al., 2003). KAT3A and KAT3B are paralogous proteins
that interact with several general transcription factors, PolII (Neish et al., 1998; Yuan et al.,
1996) and other transcription factors, allowing the transcriptional machinery to interact with its
regulators (reviewed in Chan and La Thangue, 2001), as well as acetylating nearby histones.
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Different types of HDACs also exist. Two of such groups (Type I and II) do not need
cofactors for their catalytic activity (Finnin et al., 1999), while Type III (sirtuin deacetylases)
require NAD+ for their function (Braunstein et al., 1993; Imai et al., 2000; Landry et al., 2000).
Type I and II HDACs are generally part of large multi-protein complexes, such as Sin3 (Ayer
et al., 1995; Schreiber-Agus et al., 1995), NuRD (nucleosome remodelling and deacetylating)
(Xue et al., 1998) and CoREST (corepressor of REST) (You et al., 2001). These complexes are
recruited to gene loci that have to be repressed by DNA-binding transcriptional repressors. For
example Sin3 and CoREST complexes are known to bind, among the others, REST (RE1
silencing transcription factor) (Andres et al., 1999; Roopra et al., 2000) while NuRD has been
associated with the Hox gene silencing mediated by Hunchback and PRCs (Kehle et al., 1998).
Sirtuin deacetylases are also recruited by sequence-specific DNA-binding proteins, such as
CTIP2 (Senawong et al., 2003); these enzymes have been associated with different processes,
including heterochromatin formation at telomeres (Maillet et al., 1996) and silencing of
ribosomal RNAs (Shou et al., 1999; Straight et al., 1999). Sirtuins have substrate other than
histones and some of their transcriptional functions are mediated by the deacetylation of these
proteins; for example, they have been associated with muscle development via MyoD (Fulco et
al., 2003) and stress response via Foxo3 (Brunet et al., 2004).
All of the core histone, their variants and the linker histone are subject to phosphorylation.
The first evidence of a link between histone phosphorylation and gene activation arose from the
temporal correlation of induction of immediate-early genes and increase in this histone
modification (Mahadevan et al., 1991). Under the same kind of stimuli phosphorylation also
correlates with hyper acetylation of histones (Barratt et al., 1994), suggesting that these two
modifications are linked during gene activation. In particular, activation of c-Jun and c-Fos
(two immediate-early genes) correlates with H3S10 phosphorylation and H3K14 acetylation
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(Clayton et al., 2000), although the pathways that induce these marks do not always converge
during gene activation (Thomson et al., 2001). The presence of H3S10 phosphorylation inhibits
methylation of H3K9, a mark of silent chromatin (see Section 1.1.2.1) (Rea et al., 2000)
confirming the opposite roles of these modifications in transcriptional regulation.
Histone phosphorylation also plays a role in chromosome condensation and segregation
during mitosis and meiosis (Gurley et al., 1978). Two H3 residues, S28 and T11, are
specifically phosphorylated during these processes (Goto et al., 1999; Preuss et al., 2003),
along with H3S10. The Aurora-B kinase is the enzyme that sets up these marks during the
transition from G2 to M phase. Aurora-B also interacts with other factors that regulate
chromosome condensation and formation of the mitotic spindle (Giet and Glover, 2001). The
importance of correct levels of histone phosphorylation during mitosis is highlighted by the
activity of specific H3 phosphatases during DNA replication (Hsu et al., 2000).
A new role for the aurora-mediated H3S10 phosphorylation was recently highlighted in
terminally differentiated cells. Nucleosome of silenced genes, which are marked by H3K9me3
and bind HP1, become phosphorylated at H3S10. This induces displacement of HP1 and has
the potential to modulate silencing in latest stages of differentiation (Sabbattini et al., 2007).
Ubiquitin is a 76 amino-acid long polypeptide; this means that covalent binding of ubiquitin
considerably increases the size of histones. Poly-ubiquitination is generally associated with
protein degradation via the proteasome, whereas mono-ubiquitination functions as a tag that
marks the target substrate for a particular function. Histone mono-ubiquitination has been found
to be associated with gene activation as well as with silencing, depending on the targeted
residues. Ubiquitination has been detected on the core histones, including variants, and on the
linker histone. H2B was the first histone to be identified as target for mono-ubiquitination on
lysine 120, a reaction that requires Rad6 and the E3 ubiquitin ligase Bre1 in yeast (Robzyk et
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al., 2000) or their homologues in other species. This mark has been associated with gene
activation and it can be necessary for the subsequent methylation of H3K4 (Kao et al., 2004;
Shahbazian et al., 2005). In some contexts, for a correct gene transcription, H2BK120
ubiquitination has to be actively removed. A subunit of the acetyltransferase SAGA complex is
required for this function (Henry et al., 2003), suggesting that the large ubiquitin tag could
induce chromatin opening to allow access of other proteins.
H2A mono-ubiquitination on K119 has been instead associated with silencing. The reaction
is mediated by Ring1A, a subunit of PRC1. H2A ubiquitination has indeed been found at
polycomb repressed genes (Wang et al., 2004a) and this histone mark appears downstream of
the PRC2-mediated H3K27 methylation (see Section 1.1.2.1). The presence of H2A
ubiquitination inhibits the methylation of H3K4 at promoters, thus repressing transcription
initiation, while a H2A-specific ubiquitin protease (USP21) reverses this repression (Nakagawa
et al., 2008b). A new H2A ubiquitin ligase (2A-HUB) has been recently discovered and its
activity specifically represses RNA elongation at a series of chemokine genes (Zhou et al., 2008).
SUMO is a polypeptide tag similar to ubiquitin. Histones H4, H2A and H2B have been
found to be SUMOylated (Nathan et al., 2006). It has been shown that targeting of
SUMOylation to histones mediates gene repression (Shiio and Eisenman, 2003), for example
by antagonising histone acetylation (Nathan et al., 2006).
The core histones H3 and H2A are present in different variants, which have been shown to
be involved in different functions (see Table 1.1.2). The canonical histones are transcribed and
deposited on the DNA in a replication-dependent (RD) process that requires CAF1 (chromatin-
assembly factor-1) and ASF1 (anti-silencing factor-1), part of a complex called RCAF
(replication-coupling assembly factor). Histone chaperones work in coordination with
chromatin remodelling complexes (see Section 1.1.3) to precisely position nucleosomes on the
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DNA template. In contrast to this replication-dependent incorporation, histone variants are
generally incorporated into nucleosomes by replication-independent (RI) mechanisms that
operate throughout the cell cycle.
H3.1 and H3.2 are the replication-dependent isoforms of histone 3 and their sequence differ
only by one amino acid. CENP-A, the centromeric variant, was identified for its tendency to
co-purify with other core histones (Palmer et al., 1987). The CENP-A C-terminal fold domain
shares high similarities with the canonical H3, while the N-terminal tail is more diverse. This
histone variant has been found associated only with centromeres and its function is essential.
CENP-A knock-out induces embryonic lethality, as it has been found required for kinetochore
assembly during mitosis and meiosis (Howman et al., 2000). From a structural point of view,
the central domain is highly conserved between H3.1 and CENP-A; however this domain is
fundamental for the correct targeting of CENP-A to centromeres (Sullivan et al., 1994).
H3.3, the second RI histone 3 variant, is almost identical to the RD H3s. H3.1 and H3.3
differ at only four amino-acids, but these variant residues are essential for the distinctive
replication-independent deposition of H3.3 (Ahmad and Henikoff, 2002). Indeed H3.3 is the
predominant H3 variant in terminally differentiated non-dividing cells, which also confirms its
H3.1, H3.2 and H4 Canonical core histones encoded by replication-coupled genes
CENP-A Centromere-specific histone 3 variant
H3.3 Replacement histone 3 variant found in active chromatin
H2A, H2B Canonical core histones encoded by replication-coupled genes
H2A.X H2A form with a C-terminal motif that becomes serine phosphorylated at sites of
double-strand breaks double-strand breaks
H2A.Z Diverged form of H2A; enriched around gene promoters
MacroH2A Vertebrate specific H2A variant associated with silent chromatin that has an
additional globular domain
H2ABbd Vertebrate-specific H2A variant associated with active chromatin
Sperm histones Variants that have evolved to tightly package sperm or pollen
Core histone variants and their major functions.
Table 1.1.2
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non cell-cycle dependent incorporation (Pina and Suau, 1987; Urban and Zweidler, 1983). H3.3
is enriched at DNA regions that are actively transcribed (Hendzel and Davie, 1990) and it is,
accordingly, enriched for post-translational modifications that mark active chromatin regions
(McKittrick et al., 2004). A fundamental component of the RI H3.3 deposition is the histone
chaperone HIRA (histone regulator A), which specifically binds H3.3, while H3 associates only
with CAF-1.Both HIRA and CAF-1 containing complexes interact with H4 and its chaperone
ASF1 (Tagami et al., 2004).
There are four variant of histone H2A. H2A.Z is essential in animals (Faast et al., 2001) but
not in yeast, which has been therefore extensively used for studying its functional role. H2A.Z
has been found enriched at euchromatic regions, where it functions as an anti-silencer by
inhibiting the spreading of heterochromatin (Meneghini et al., 2003). In addition, H2A.Z was
detected at the 5′ end of both transcribed and non­transcribed genes, on the nucleosomes that
flank the nucleosome-free region that characterises promoters (Raisner et al., 2005). In
mammals it has also been found in heterochromatic regions and associated with HP1
(Rangasamy et al., 2003), as well as in active regions (Farris et al., 2005). Therefore it is still
difficult to reach a final conclusion for the role of H2A.Z. SWR1, a component of the SWI/SNF
family of ATP-dependent remodelling complexes (Krogan et al., 2003), is necessary for the
assembly of H2A.Z into nucleosomes and is able to mediate replacement of H2A/H2B with
H2A.Z/H2B dimers in vitro (Mizuguchi et al., 2004). The composition of nucleosomes also
affects their stability. In particular H2A.Z increases the instability of H3.3-containing
nucleosomes, which are already less stable than H3.1-containing ones (Jin and Felsenfeld, 2007).
H2AX differs from the canonical H2A by the presence of a four amino-acids C-terminal
domain. The serine inside this domain becomes phosphorylated at sites of DNA double strand
breaks. Spreading of H2AX phosphorylation along the chromosome is an important event for
the recruitment of the break-repair machinery (Rogakou et al., 1998). MacroH2A is a
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vertebrate-specific H2A variant and has an additional globular domain. It is found enriched at
the inactive X chromosome, where it is a hallmark of X inactivation, although is not necessary
for its maintenance (Costanzi and Pehrson, 1998). In female embryonic stem cells (before X
inactivation) MacroH2A is localised at centromeres and relocates to the inactive X upon
differentiation, when one of the X chromosome is silenced (Mermoud et al., 1999). The
remaining H2A variant is also vertebrate-specific but is excluded from the inactive X
chromosome, hence its name H2ABbd (Barr-body deficient). H2ABbd colocalise with
nucleosomes containing acetylated H4K12, a mark of active chromatin (Chadwick and Willard,
2001). Its presence reduce nucleosomal stability, compared to canonical H2A (Gautier et al.,
2004).
1.1.3  Chromatin remodeling
As discussed in the previous sections, a specific chromatin status can be achieved via
covalent modification of several histone residues or through the targeted incorporation of
specific histone variants into a subset of nucleosomes. Further chromatin regulation, achieved
in many cases in combination with the above mentioned mechanisms, is obtained by physical
changes in the chromatin structure mediated by multi-protein complexes that use energy in the
form of ATP (Figure 1.1.5). One of the primary roles of the remodeling complexes is to regulate
access of DNA-binding proteins to nucleosomal DNA, which is normally impeded by the
presence of histones (Logie and Peterson, 1997; Polach and Widom, 1995).
There are three major families of chromatin remodelling complexes, named according to
the respective ATPase subunit: ISWI (imitation-swi) SWI/SNF (switch/sucrose fermentation)
and CHD (chromo-helicase/ATPase DNA binding). The subunits containing the ATPase
domains are able to remodel chromatin without the support of their partners (Kingston and
Narlikar, 1999; Langst and Becker, 2001; Wang and Zhang, 2001). Therefore the additional
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subunits contribute to the functional specificity by mediating interactions with nucleosomes or
other factors. The complexes that contain chromatin remodeling ATPases generally also
include histone modifying enzymes (see Section 1.1.2) and/or methyl-CpG-binding proteins
(see Section 1.1.4) linking together all of these functions.
Some transcription factors have been reported to be able to bind compacted chromatin
regions and initiate their opening. Members of the Forkhead (Fox) family of transcription
factors act in this way to activate the albumin gene during liver development (Cirillo et al.,
2002) and the thyroperoxidase gene during thyroid cells differentiation (Cuesta et al., 2007).
The ability of Fox proteins to bind to compacted chromatin seem to depend on their structure,
which contains a domain resembling the linker histone variant H5 (Clark et al., 1993).
Figure 1.1.5 Consequences of ATP-dependent chromatin remodeling. The central panel shows the starting
chromatin region, with linker DNA is indicated in yellow and nucleosomal DNA in red. (A) Movement of a
nucleosome along the DNA (sliding) can expose a previously nucleosomal DNA region (red). (B) Exchange of a
canonical histone with a variant. (C) Eviction of a nucleosome to expose a large DNA region; mostly in
cooperation with other proteins, such as histone chaperones and DNA-binding factors. (D) Creation of a loop on
the nucleosome surface as a mechanism for exposing nucleosomal DNA without nucleosome sliding. Reproduced,
with permission, from Kingston and Tamkun, 2007. © 2007 by Cold Spring Harbour Laboratory Press
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1.1.4  DNA methylation
Cytosine methylation, which occurs predominantly at CpG (cytosine-phosphate-
guanosine) dinucleotides in mammalian cells was the first epigenetic mechanism that was
shown to regulate transcription (Razin and Riggs, 1980). Methylation occurs on both DNA
strands, a characteristic that suggested that such patterns could be copied during DNA
replication in a semi-conservative fashion, like DNA itself. This would allows the methylation
pattern to be reproduced on the newly synthesised strand (Holliday and Pugh, 1975; Riggs,
1975). The enzyme Dnmt1 (DNA methyltransferase-1), isolated a few years after the discovery
of DNA methylation, confirmed the validity of this hypothesis (Bestor and Ingram, 1983).
Early experiments with gene transfection in somatic cells showed that the unmethylated
transgenes maintained their state, whereas DNA introduced in the pre-implantation embryo or
in embryonic stem cells underwent active methylation (Jahner et al., 1982; Stewart et al., 1982).
These results suggested the presence of two distinct processes: de novo methylation, mediated
by Dnmt3a and Dnmt3b (Okano et al., 1998), and maintenance methylation, mediated by
Dnmt1 (Figure 1.1.6).
Different DNA methylation analyses showed that highly methylated sequences include
satellite DNA, repetitive elements and non repetitive intergenic DNA. CpG islands are an
exception to this general principle.  These sequences are long GC-rich regions found close to
many gene transcription start sites (McKeon et al., 1982) that are consistently hypomethylated
(Bird et al., 1985) and have been shown to be involved in transcription initiation (see Section
1.1.5.1).
A major effect of DNA methylation is gene silencing. This was first demonstrated by using
differentially methylated transgenes injected into frog oocyte nuclei (Vardimon et al., 1982) or
mammalian cells (Stein et al., 1982). Methyl-CpG-binding (MDB) proteins have been shown
to bind to methylated CpG and have been implicated in methylation-dependent repression of
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transcription. Each MDB targets distinct DNA regions independently and shows high levels of
sequence specificity (Klose et al., 2005). A mechanism of repression is the interaction of MDB
family members with other transcription-repressor complexes. For example MeCP2 associates
with Sin3 (see Section 1.1.2.2) and depends on the Sin3 deacetylation activity to mediate
repression (Jones et al., 1998; Nan et al., 1998). This system demonstrates that DNA
methylation can be read as a signal to alter chromatin structure.
1.1.5  DNA regulatory elements
In the 1960s, studies in bacteria identified the interaction of trans-acting transcription
factors with cis-acting regulatory DNA sequences as a key step in the regulation of gene
expression (Jacob and Monod, 1961; Ullmann et al., 1967). Eukaryotes have been shown to
have more complex mechanisms for fine tuning of gene expression, although the interaction of
DNA-binding proteins with DNA is the first step for the regulation of all these processes. Over
the years in vitro and in vivo studies have identified distinct DNA elements that control
activation or silencing of individual genes. Cooperation between these elements is critical for
Figure 1.1.6 and maintenance methylation of DNA. CpG dinucleotides are represented as vertical
strokes on a segment of genomic DNA. Unmethylated DNA (top) becomes methylated by Dnmt3a and Dnmt3b
to give symmetrical methylation at certain CpG pairs (middle). Upon DNA replication the parental strand
maintains its methylation pattern, while the newly synthesised strand is unmethylated (bottom). The maintenance
methyltransferase Dnmt1 then restores the symmetry. Reproduced, with permission, from Li and Bird, 2007. ©
2007 by Cold Spring Harbour Laboratory Press
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the correct expression, in term of levels of transcripts and tissue-specificity. In particular,
transgenic studies have shown that for the control of a gene, independently of the position of
integration, large genomic regions (called domains) are necessary (Greaves et al., 1989;
Grosveld et al., 1987; Sabbattini et al., 1999). These experiments prove that the DNA
sequences that regulate a gene not only cooperate but have dominant effects over the chromatin
location if all the factors that bind them are present. DNA regulatory sequences have been
divided into different categories according to their function and position relative to the
transcription start site (TSS). The main properties of each regulatory element will be discussed
below.
The core promoter is composed of the sequences that recruit the basal transcription factor
machinery. These factors are the minimal set of proteins necessary for transcription in vitro
from a core promoter. They include PolII, the enzyme responsible for gene transcription, and
general transcription factors (GTFs). Together GTFs and PolII bound at the core promoter form
the pre-initiation complex (PIC).
The TATA box was the first identified sequence that is specific for the core promoter. It is
normally present 25-30bp upstream of the TSS (Goldberg, 1979). TBP (TATA-binding
protein) was discovered as a factor directly involved in recognising the TATA sequence
(Buratowski et al., 1988) and is part of a multi-protein complex called TFIID (transcription
factor IID) (Matsui et al., 1980; Parker and Topol, 1984; Sawadogo and Roeder, 1985). TFIID
is composed of TBP and TBP-associated proteins (TAFs). The various TAFs are involved in
different functions, such as histone modifications, core promoter recognition and interaction
with activators and the Mediator complex.
A second sequence characterising core promoters is the Initiator (Inr). Analysis of the
sequences of many efficiently transcribed genes showed the presence of an adenosine at +1
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(relative to the TSS), a cytosine at -1 and a few pyrimidines surrounding them (Corden et al.,
1980). When the Inr sequence is present in combination with a TATA box it dictates the precise
location of transcription initiation, since its deletion alters the start site (Concino et al., 1984;
Dierks et al., 1983). The presence of a TATA box is not necessary for the initiation of
Inr-containing core promoters (Smale and Baltimore, 1989), although in vitro when both are
present the levels of transcription are higher (Smale et al., 1990). In vitro binding assays
showed that TFIID binds Inr sequences, as well as TATA boxes (Emami et al., 1997;
Oelgeschlager et al., 1996), but in TATA-less promoters, the binding of TBP is dispensable
(Martinez et al., 1995).
The Downstream promoter element (DPE) was identified as a sequence necessary for
TFIID binding in TATA-less promoters (Burke and Kadonaga, 1996), where it functions in
combination with the Inr. The core sequence of the DPE is located at precisely +28 to +32
relative to the A+1 nucleotide in the Inr motif. Mutation of either the Inr or the DPE from core
promoters severely reduces the binding of TFIID and transcription (Kutach and Kadonaga, 2000).
The TFIIB recognition sequence (BRE) is an additional element that works in conjunction
with several core promoters that contain a TATA box (Lagrange et al., 1998). Its function in
transcription is contradictory, since different in vitro analyses found that it either promote
transcription (Lagrange et al., 1998) or has a negative transcriptional effect (Evans et al., 2001).
CpG island are a different type of core promoter. They are long GC rich regions that are
generally hypo-methylated (see Section 1.1.4) and usually lack both TATA boxes and DPEs.
The GC sequences function as binding sites for the transcription factor Sp1 (Brandeis et al.,
1994; Macleod et al., 1994). Initiation from CpG islands is not as precise as initiation that is
regulated by TATA boxes or DPEs, since leaky transcription is observed from many sites. Sp1,
or related factors, bound to CpG island are involved in maintaining the hypo-methylated state
of these regions (Brandeis et al., 1994; Macleod et al., 1994) and mediating recruitment of
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GTFs to initiate transcription, in many instances in collaboration with Inr elements (Emami et
al., 1995).
Other types of core promoters exist, although these are less frequent and in some cases they
are specific to single genes (reviewed in Smale and Kadonaga, 2003). Such variety of core
promoters and the combinatory effects when more than one is present, suggest that they are not
only recruiting PolII and its cofactors, but that they are actively involved in regulating gene
expression in combination with the other elements.
The proximal promoter, normally located between -30 and -200bp from the TSS, includes
the sequences that recruit sequence-specific transcription factors, either activators or repressors.
Binding of these factors induces recruitment of many activities, which change the chromatin
structure, modify the histones and ultimately allow the assembly of the PIC. The recruitment of
activators to these elements, in cooperation with the core promoter, causes an increase in
transcription and activation from these elements is highly dependent on their distance from the
TSS (Guarente and Hoar, 1984).
These sequences are much more heterogeneous than core promoters, with basically every
gene having a particular set of elements for the targeting of specific transcription factors. The
identification of functional elements is an additional problem, due to the degenerative nature of
protein-DNA binding. One strategy for addressing this issue involves the analysis of the
sequence upstream the TSS to recognise elements known to be bound by a transcription factor
(Knuppel et al., 1994; Wingender, 1994). An evolution of this approach, called phylogenetic
footprinting, involves comparison of the upstream sequences of genes that have been conserved
in different species, to isolate conserved elements that are likely to have evolved to regulate
transcription (Gumucio et al., 1996). Although this approach has been proven to work in many
instances, the recently published ENCODE (encyclopaedia of DNA elements) pilot project
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shows that the regulatory regions of half of the human genes lack sequence conservation
(Birney et al., 2007). Therefore, in many instances, molecular analysis of factor binding will be
necessary for the ultimate understanding of the regulation of a gene.
Enhancers are sequences that increase transcription independently from their distance from
the TSS and their relative orientation; in addition, they can be located upstream as well as
downstream from the linked promoter. Some distal sequences, called silencers, have a
repressive rather than an activating effect on transcription. The first demonstration of the
enhancer function arose from the use in transient transfection assays of vectors containing viral
sequences, which significatively increased expression of the transgenes (Banerji et al., 1981).
The location of enhancers within the genome can be determined by analysing chromatin
susceptibility to enzymatic digestion (e.g. to DNase I). Regions bound by transcription factors
have a more open chromatin structure that favour digestion, creating the so called
hypersensitive sites (HS) (McGhee et al., 1981). An alternative method is the analysis of the
histone modification pattern of the gene domain of interest. As whole genome histone
modification analyses showed, most active regulatory elements are marked with H3K4me1 and
H3K4me2, so this signature can be used to locate these regions (Heintzman et al., 2007). The
identification of the individual elements within an enhancer can be performed in the same way
as for proximal promoters, since the binding of transcription factors is based on the same
principle of DNA-sequence recognition.
As proximal promoters, enhancers are composed of a series of elements that recruit
sequence-specific transcription factors. The cooperation between multiple DNA sites and the
binding of different transcription factors to them create a functional DNA-protein complex
termed the enhanceosome (Thanos and Maniatis, 1995), which is able to interact with the
complexes formed on other regulatory elements to activate transcription (see Section 1.1.5.5).
39
The best characterised enhanceosome controls the virus-inducible gene Interferon- . The
enhancer of this gene is composed by a series of cis-acting sequences, each having enhancer
activity in reporter assay. Unlike the endogenous Interferon-  these reporters can be activated
by different stimuli, other than viral infection; only the entire Interferon-  enhancer is capable
to correctly regulate the expression of the gene. The interaction of multiple transcription factors
to their binding sites on a wild-type enhancer create a stable complex, the enhanceosome, which
is able to induce regulated expression of a gene (reviewed in Merika and Thanos, 2001).
Locus control regions (LCR) are particular distal activating sequences that have the ability
to give efficient expression of a linked gene in transgenic mice, independently from the site of
integration of the transgene (Greaves et al., 1989; Grosveld et al., 1987). The -globin LCR,
the first to be described, consists of a cluster of DNase I HS (HS1­5) at the 5′ end of the locus
(Forrester et al., 1986; Tuan et al., 1985). Due to the effect of the LCR in activating transgenes
independently of the site of integration, it was initially thought that these elements would
directly act to modify the chromatin structure, to allow its opening and the transcription of the
transgene. It has been then found that these elements are not involved in determining chromatin
conformation, since deletions of portions of the endogenous -globin LCR (HS1-4 or HS5)
affect only the levels of transcription but do not alter the chromatin accessibility or the activity
of other HSs in erythroid cells (Reik et al., 1998). A possible explanation for this discrepancy
is that LCRs remodel the chromatin of a locus during differentiation prior to gene activation,
whereas in the cells where the gene is active LCRs retain only the enhancer function.
Insulators have been described as inter-domain boundaries. Some of these elements prevent
activation from enhancers of a different gene (enhancer-blocking elements) (Chung et al.,
1993), other protect from heterochromatic-mediated silencing (barrier insulators) (Sun and
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Elgin, 1999). Enhancer blocking elements only work when placed between an enhancer and a
promoter. The first factor that was found to be associated with these sequences is CTCF
(CCCTC-binding factor), a ubiquitously expressed zinc-finger transcription factor (Bell et al.,
1999). It has been proposed that CTCF acts by forming clusters with other DNA-bound CTCF
molecules, therefore generating closed loop domains (Yusufzai et al., 2004) that would prevent
enhancer-promoter interaction by steric impediment (Gaszner and Felsenfeld, 2006).
Barrier insulators protect against spreading of heterochromatin (see Section 1.1.1) and gene
silencing induced by this process. The barrier function is achieved by histone acetylation,
nucleosome remodelling or eviction that counteracts the H3K9me-induced, HP1-depentent
chromatin compaction (see section 1.1.2.1) (Bi et al., 2004; Oki et al., 2004).
The existence of either type of insulator, particularly enhancer-blocking elements, as
distinct regulatory elements is controversial. Most of the described insulators are part of
regulatory elements that also have promoter, enhancer or LCR function; CTCF itself can
function as a conventional transcription factor (Kuzmin et al., 2005). The insulator effects can
therefore be a consequence of the regulatory function of these elements. The presence of
specific transcription factors in a particular cell, which can bind to their cis-acting sequences,
is likely to be the limiting factor for the activation or silencing of a gene or for the remodelling
of a chromatin domain (Dillon and Sabbattini, 2000).
All of the regulatory elements described above cooperate to regulate the transcription of
each gene and together they form the transcriptional domain. One link between the complexes
formed on distal elements (LCRs, enhancers and silencers), proximal promoter and the core
promoter has been found in the Mediator (Kim et al., 1994). This multi-protein complex does
not posses any enzymatic activity but is able to bind transcription factors and subunit of the PIC,
forming a physical connection between regulatory elements. The Mediator is directly involved
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in the assembly of TFIID on the core promoter (Johnson et al., 2002; Wu et al., 2003). Binding
of activators has been shown to increase the stability of the Mediator-TFIID complex (Johnson
and Carey, 2003).
Recent data indicate that PolII and GTFs are also bound at distal elements, for example at
the androgen-responsive prostate-specific antigen (Shang et al., 2002) and at the T cell
receptor- (Spicuglia et al., 2002). Additionally, assembly of different subunits of the PIC has
been shown on different distal elements in early stages of development, before the linked genes
are activated. Examples of this phenomenon are the -globin LCR (Vieira et al., 2004), the HS2
Figure 1.1.7 Interaction modes between regulatory elements. Two possible pathways can induce the formation
of the pre-initiation complex (PIC) at the core promoter to initiate transcription. (A) Binding at regulatory elements
of transcription activators (step 1) induces the recruitment of complexes with different activities (e.g. chromatin
remodelling, histone modification – step 2). The changes in the local chromatin structure allow the binding of
general transcription factors (GTFs) to the core promoter (step 3), which recruit RNA polymerase II (PolII), with
the help of the factors bound to distal elements through the Mediator complex. The physical interaction between
the proteins bound on different elements creates a loop on the DNA (step 4). (B) On some enhancer GTFs and
PolII can be recruited along with activators, and induce intergenic transcription (step 3). Modification at the
chromatin around core promoter (step 4) would allow binding of the PIC through DNA looping (step 5) to initiate
transcription. Reproduced, with permission, from Szutorisz et al., 2005b. © 2005 by Elsevier
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of HoxD4 (Rastegar et al., 2004) and the ETCM of the 5-VpreB1 locus (Szutorisz et al.,
2005a) (see Section 1.2.3). The presence of components of the PIC induces intergenic
transcription from these regions. Other examples of transcription from cis-acting elements have
been reported (Gribnau et al., 2000; Masternak et al., 2003; Plant et al., 2001; Rogan et al.,
2004). A possible function can be inferred by the discovery of transcription factories. These are
nuclear foci enriched for PolII where it has been proposed that potentiated genes migrate to be
transcribed (Osborne et al., 2004). Their existence raises the possibility that the DNA, at least
in some instances, migrate to the transcription machinery, rather than the other way round as
had been traditionally thought to happen. The presence of PolII at intergenic sites can therefore
be a method for recruiting a gene domain to a factory (Gaszner and Felsenfeld, 2006).
The existence of the Mediator and the possibility that some enhancers directly recruit the
PIC, suggests that the different elements involved in the regulation of a gene can physically
interact in the nucleus, for example by chromatin looping (Figure 1.1.7). This hypothesis was
confirmed experimentally by two different approaches (chromatin conformation capture - 3C -
and tagging and recovering of associated proteins – RNA TRAP) that showed the association
of distal elements with other regulatory elements (Carter et al., 2002; Tolhuis et al., 2002). The
demonstration of DNA looping confirms the physical plasticity of chromatin as an essential
step in gene regulation.
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1.2  Embryonic stem cells
Embryonic stem (ES) cell research has become one of the most debated biological fields,
not only scientifically but also ethically and politically, due to the proposed benefit of stem
cell-derived regenerative medicine and the potential risks of human cloning. The first evidence
for the existence of pluripotent cells derived from the analysis of teratomas and
teratocarcinomas. The histological analysis of these tumours showed that different cells within
them had characteristic of different adult tissues (Stevens and Little, 1954). It was also found
that a single cell from foetal-derived germinal tumours was able to produce all of the cell types
of a teratocarcinoma when injected intraperitoneally into an adult mouse (Kleinsmith and
Pierce, 1964). It was only about 20 years later that the non-transformed mouse embryonic
pluripotent cells were isolated and grown in vitro from the inner cell mass (ICM) of blastocyst-
stage embryos (Evans and Kaufman, 1981; Martin, 1981). These cells were called embryonic
stem (ES) cells and the ultimate proof of their pluripotency arose when it was demonstrated
these cells have the ability of to form germline chimaeras, following injection into host
blastocysts (Bradley et al., 1984; Nagy et al., 1993).
ES cells have two key properties: self-renewal and pluripotency. This means that they can
be expanded as pure population of undifferentiated cells, maintaining a normal karyotype, but
upon specific stimuli they can differentiate into cells of all three germ layers (Figure 1.2.1).
Over the years much attention has been devoted to understanding the combination of molecules
and signals that confer these features. The control of expression, via extracellular signals and
specific transcription factors networks, and the epigenetic regulation of differentiation potential
have been found to be fundamental for giving ES cells these unique properties.  The most
important features of these mechanisms will be discussed below.
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1.2.1  Extracellular signals
The LIF-gp130-STAT3 was the first identified signalling pathway controlling self-renewal
of ES cells (Matsuda et al., 1999; Niwa et al., 1998; Smith et al., 1988; Williams et al., 1988).
LIF (leukaemia inhibitory factor) is a cytokine secreted by the feeders cells used to sustain ES
cell growth. It binds to its membrane receptor (LIFR), which is present as a dimer with gp130
(glycoprotein-130). The binding induces activation of STAT3 (signal transducer and activator
of transcription-3) that translocate to the nucleus where it functions as a transcription factor,
sustaining for example the transcription of c-myc (Cartwright et al., 2005). Although LIF is
necessary for maintaining mouse ES cell cultures in undifferentiated state, this pathway is not
universal, since human ES cells do not need LIF signalling (Thomson et al., 1998) and gp130
null mouse embryos survive until a stage subsequent to ES cell derivation (Nichols et al., 2001).
Figure 1.2.1 Early mouse development and embryonic stem cell derivation and differentiation. The
fertilisation of an oocyte by a sperm cell crates the zygote, the totipotent precursor cell. The zygote undergoes a
series of cleavage divisions that increase the cell number, while maintaining totipotency. The blastocyst is the
structure where the first clear lineage choice has been made. This embryonic stage is composed of an outer layer
of trophectoderm cells, which will form the extra-embryonic tissues, and an inner cell mass (ICM) containing the
cells that will form the embryo and the adult organism. Embryonic stem (ES) cells are derived from the ICM and
are able to proliferate in vitro in an undifferentiated state (self-renewal) or differentiate into cell of all three
germ-layers, under the appropriate stimuli (pluripotency).
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In addition, LIF alone is not able to maintain the undifferentiated state of ES cells, which also
require serum for growth and self-renewal.
Bone morphogenic protein-4 (BMP4) is a second molecule that, as with LIF, sustains ES
cell self-renewal and pluripotency. Its presence induces transcription of SMAD4 (similar to
mothers against decapentaplegic homologue-4), which activates expression of members of the
ID (inhibitors of differentiation) family (Ying et al., 2003). As with LIF, BMP4 alone can not
keep ES cells undifferentiated but, in the presence of LIF, can substitute for serum in culture.
The canonical Wnt signalling is another pathway that has been shown to play a role in ES cell
biology, being able to maintain an undifferentiated state, even without LIF, by inducing
expression, among others, of Oct4 and Nanog, two key ES cells transcription factors (see
below) (Sato et al., 2004).
1.2.2  Transcriptional regulation
As mentioned above, the extracellular signalling necessary for ES cell self-renewal and
pluripotency all regulate the expression of transcription factors, which then regulate the
transcription of their target genes. Oct4 is the best known transcription factor involved in ES
cell regulation and is used as a marker for stemness for both mouse and human ES cells. It is a
member of the POU-domain family and is encoded by Pou5f1. Oct4 expression is fundamental
for early development since knock-out embryos form blastocysts composed only of
trophectoderm cells (the outer layer of the blastocyst, which will differentiate into the placenta)
(Nichols et al., 1998). Experiments using inducible Pou5f1 have demonstrated that the level of
Oct4 is fundamental for keeping ES cells self-renewing. Oct4 over-expression induces
differentiation towards the primitive endoderm lineage, while its downregulation favours
differentiation into trophectoderm cells (Niwa et al., 2000). One of the proposed functions of
Oct4 is to induce self-renewal by inhibiting expression of differentiation factors. A clear
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example is the interaction with Cdx2, a trophectoderm inducing factor; Oct4 directly down-
regulates the expression of Cdx2, thus preventing ES cell differentiation. Conversely Cdx2
negatively regulates Pou5f1 by interacting physically with Oct4, which is a Pou5f1 activator
(Niwa et al., 2005).
Nanog is a NK2-class homeobox transcription factor, which, unlike Oct4, is able to
maintain ES cell self-renewal and pluripotency without LIF or upon differentiation stimuli
(Chambers et al., 2003). As with Oct4, Nanog is thought to inhibit differentiation by repressing
differentiation-inducing factors, for example Gata6, which induces differentiation into
endoderm-like cells (Mitsui et al., 2003).
Sox2 is a member of the high-mobility group (HMG) family of transcription factors. Sox2,
along with Oct4 and Nanog, is one of the major regulators of ES cell transcription. Sox2
knock-out showed that it is necessary in the early stages of development but, since Sox2 null
embryos die just after implantation (E6.5), these embryos are able to form a blastocyst, unlike
Oct4 -/- mice. The effect is thought to be caused by the persistence in the developing embryo
of the maternal protein, because ES cells from the ICM of these blastocysts could not be
established (Avilion et al., 2003). Several studies have demonstrated a cooperative effect of
Sox2 and Oct4 on the regulation of many genes, including Fgf4 (Yuan et al., 1995) Nanog
(Kuroda et al., 2005; Rodda et al., 2005) as well as Pou5f1 and Sox2 themselves (Chew et al.,
2005; Okumura-Nakanishi et al., 2005; Tomioka et al., 2002), by binding adjacent Oct4/Sox2
binding sites. Other Sox factors (Sox15 and Sox11) are expressed in ES cells, although is still
not clear if they have redundant or distinctive functions (Maruyama et al., 2005; Masui et al.,
2007).
Using ChIP-on-Chip it has been shown that Nanog, Oct4 and Sox2 are present at many
genomic regions in mouse or human ES cells, which indicates that the three factors can act
together to regulate transcription. The elements bound by these transcription factors are found
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at both transcribed and non-transcribed genes. These studies therefore suggested that Oct4,
Nanog and Sox2 form a feedback circuit that maintains pluripotency by positively regulating
Pou5f1, Sox2 and Nanog as well as other genes important for ES cell self-renewal, while they
repress potential differentiation-inducing genes (Boyer et al., 2005; Loh et al., 2006). Since the
fine tuning of expression of Oct4 and Nanog is crucial for keeping ES cells undifferentiated, it
is also likely that there is a direct or indirect negative feedback loop that regulates these genes
(Niwa, 2007a).
Other transcription factors are important for ES cell self-renewal and/or pluripotency. One
of these proteins is Foxd3, a member of the Forkhead (Fox) family of transcription factors.
Knock-out studies showed that the ICM is formed in Foxd3 null embryos, but these died at E6.5,
before gastrulation. Although the ICM was normal, it was not possible to establish ES cell lines
from these embryos (Hanna et al., 2002). Foxd3 has been shown to negatively regulate the
expression of Nanog and Pou5f1 and is regulated by them; this system could create a negative
feedback loop that could be fundamental for maintaining a steady level of expression of these
three factors (Pan et al., 2006). REST (RE1 silencing transcription factor) was first identified
as a repressor of neuronal genes in non-neuronal tissues (Chong et al., 1995; Schoenherr and
Anderson, 1995). More recently it has been shown that it is already expressed in ES cells where
it binds many neuronal genes and actively silences them (Ballas et al., 2005). In addition,
lowering the levels of REST in ES cells reduces proliferation and induces differentiation, thus
affecting self-renewal and pluripotency (Singh et al., 2008). Sall4 is a member of the
homologues of the Drosophila Spalt homeotic protein. Sall4 -/- embryos are the only knock-out
of the Sall family that die at early stages of development (E6.5). The blastocyst of these
embryos has a reduced ICM but ES cells could be established, although their growth was
reduced compared to wild-type cells. These cells showed no alteration in the expression of
pluripotent markers (Oct4 and Nanog). Therefore it was proposed that the primary function of
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Sall4 in ES cells is to sustain proliferation (Sakaki-Yumoto et al., 2006). Klf4 is a Krüppel-like
factor that, like Sall4, is involved in ES cell proliferation (Sakaki-Yumoto et al., 2006) but also
plays an indirect function in pluripotency by participating in the positive regulation of Nanog
(Jiang et al., 2008). Eras and Utf1 are also involved in stimulating proliferation. Eras is an
oncogene of the Ras family of GTPases that activates PI3K (phosphoinositide-3-kinase)
(Takahashi et al., 2005), while Utf1 (undifferentiated embryonic cell transcription factor-1) was
identified as an ES cell specific transcription cofactor (Okuda et al., 1998) whose loss reduces
proliferation (Nishimoto et al., 2005).
The importance of the transcriptional networks that regulate self-renewal and pluripotency
of ES cells has been further highlighted by several recent landmark studies. Using retroviral
transfection of constructs coding for four transcription factors (Oct4, Sox2, Klf4 and c-myc) it
was shown that differentiated cells (embryonic or adult fibroblast) were transformed into cells,
called iPS (induced pluripotent stem), that were very similar to ES cells and had most of the ES
cell properties (Maherali et al., 2007; Okita et al., 2007; Takahashi and Yamanaka, 2006;
Wernig et al., 2007). These studies showed that the transcription factor networks of ES cells
have a dominant transcriptional effect, because they are able to alter the homeostasis of a cell
and to reprogram it to an undifferentiated state. Since both c-myc and Klf4 are dispensable for
the reprogramming, although they increase the speed and efficiency of the process (Nakagawa
et al., 2008a; Wernig et al., 2008; Yu et al., 2007), it was confirmed that Oct4 and Sox2 are the
key player that give ES cells their distinctive properties, along with the endogenous Nanog that
they activate.
An important issue in stem cell biology is how differentiation is triggered. The general
concept has been that extracellular signals activate pathways that silence self-renewing and
pluripotency-inducing genes and activate differentiating ones. Recently it was shown that the
transcription networks in ES cells are also controlling the differentiation via the activation of
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Fgf4 (Fibroblast growth factor-4), one of the first genes that was shown to be regulated by the
Sox2/Oct4 element. Ffg4 is secreted from ES cells and acts in an autocrine fashion to activate
the Ras-Erk signalling pathway, which reduces self-renewal and induces acquisition of
competence for germ layer segregation. Although this pathway does not specify differentiation
in a particular lineage, when it is defective ES cells are refractory to differentiation upon
stimulation (Kunath et al., 2007). Thus the transcription factor circuitries in ES cells not only
maintain self-renewal and pluripotency, but also predispose the cells to differentiation.
1.2.3  Epigenetic features
Embryonic stem cells have been found to have peculiar epigenetic features. These cells
seem to have generally higher level of active histone modification marks (like H3K4
methylation and H3 and H4 acetylation), which decrease upon differentiation, while the levels
of inactive marks (e.g. H3K9 methylation) increase (Keohane et al., 1996; Kimura et al., 2004;
Lee et al., 2004). Global studies of chromatin architecture have shown that the genome ES cells
is largely euchromatic and heterochromatic foci also increase upon differentiation. In addition,
several non-histonic nuclear proteins, for example HP1, have been shown to bind more loosely
to ES cell chromatin than to chromatin of differentiated cells (Meshorer et al., 2006), although
the mechanisms behind these observations are still unclear.
Until recently the more open structure of ES cell chromatin was considered to be one of the
features of pluripotency, which would allow the activation of differentiation programs due to
the permissive nature of ES cell chromatin. The use of chromatin-immunoprecipitation (ChIP)
for the analysis of histone modifications on individual loci or, coupling ChIP to microarrays
(ChIP-on-Chip), for genome-wide studies, revealed a more complex picture.
The pro/pre-B cell-specific 5-VpreB1 locus showed a discrete region of H3K4me2 and
H3K9 acetylation, both active marks, at an intergenic enhancer in ES cells, although the two
50
genes are not expressed at this stage. The same region was also bound by several GTFs, as well
as PolII. The presence of PolII correlates with transcription of intergenic non-coding DNA from
the area (Szutorisz et al., 2005a). It was hypothesised that the element, and the histone marks
characterising it, is a hallmark for the activation of the genes upon the induction of the correct
stimuli. This would confer transcriptional potential on the locus in ES cells, which would be
fulfilled if the B lymphocyte pathway is activated. To describe these characteristics the element
was named the Early-Transcription Competence Mark (ETCM) (Szutorisz et al., 2005a;
Szutorisz and Dillon, 2005). Other loci have been found having similar properties, including
the HS2 within the -globin locus LCR (Vieira et al., 2004) and the HoxB9 promoter
(Chambeyron and Bickmore, 2004). A novel epigenetic player in ES cells was identified in the
proteasome, which has been shown to prevent incorrect transcriptional initiation and restrict
permissive transcriptional activity on regulatory regions that, like the 5-VpreB1 ETCM, keep
the controlled genes in a poised state (Szutorisz et al., 2006).
A second class of epigenetic marks, in addition to ETCMs, was discovered when the histone
modification pattern was analysed at genes that are master regulators of differentiation and at
highly-conserved non-coding elements (Azuara et al., 2006; Bernstein et al., 2006). Many of
these regions were found to be characterised by an unexpected histone combination, which was
called a bivalent domain. These elements, which often correspond to the promoters of the
controlled genes, had histone modification (H3K4me2, H3K4me3 and H3K27me3) that were
previously thought to be mutually exclusive (Strahl and Allis, 2000). H3K4me2 and H3K4me3
are normally found at actively transcribed regions, while H3K27me3 is present at silent genes.
On bivalent regions the two histone marks overlap. Similar to ETCMs, bivalent domains are
thought to poise genes for activation but, in addition, the PRC complexes, recruited by the
H3K27 mark, prevent spurious transcription of genes that might induce unregulated
differentiation. Subsequent studies have indeed shown that most genes marked by H3K4me3
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at their promoters are transcribed but, due to a block on elongation, no processed mRNA is
produced (Guenther et al., 2007).
The discovery of ETCMs and bivalent domains opened the way to the idea that local histone
modifications, rather than global chromatin rearrangement, are the key epigenetic features that
characterise ES cell pluripotency. The real significance of these marks and the consequences of
their existence is still unknown since, for example, the lack of PRC2 members, which abolishes
the H3K27 methylation mark on bivalent domains, does not alter the morphology, the
expression of markers, the self-renewal or the rate of spontaneous differentiation of ES cells
(Azuara et al., 2006; Bernstein et al., 2006; Lee et al., 2006), although their complete
differentiation potential was not assessed. Therefore it was proposed that these epigenetic
marks are not necessary for giving pluripotent features to ES cells, but are rather important for
the correct execution of different differentiation programs (Niwa, 2007a; Szutorisz and Dillon,
2005). Another open issue is the identification of the mechanisms that establish and maintain
these epigenetic marks in self-renewing ES cells, particularly since they are localised to precise
genomic regions. The most likely possibility is that transcription factors recognise specific
DNA sequences and recruit the machinery that modifies the histones on the nearby
nucleosomes. Since many areas that are marked by bivalent domains in mouse ES cells coincide
with elements bound by OCT4, SOX2 and NANOG in human ES cells (Boyer et al., 2005) it
has been inferred that these factors may be involved in the epigenetic marking (Bernstein et al.,
2006). Further support for this possibility can be inferred from the reprogramming of adult cells
into iPS by the expression of Oct4 and Sox2 (see Section 1.2.2).
It is also becoming clear that the newly identified histone lysine demethylases (see Section
1.1.2.1) have a role in regulating self-renewal and pluripotency. Recently two of such enzymes
(Jmjd1a and KDM4C) have been shown to be regulated by Oct4 in ES cells. Both target
H3K9me2 and H3K9me3, signatures of silent chromatin. Their knock-down induces
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differentiation along with reduced expression of ES cells markers (Loh et al., 2007),
highlighting how epigenetic and non-epigenetic mechanism are important for keeping ES cells
self-renewing and pluripotent. These lysine demethylases are also the first example of genes
that are involved in epigenetic regulation whose expression is directly regulated by one of the
member of the ES cell transcriptional network. Such direct control further confirms the
fundamental and dominant function played by Oct4, Sox2 and Nanog in determining the
properties of ES cells (Niwa, 2007b).
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1.3  B cell development
B lymphocytes form part of the hematopoietic system, which also includes erythroid,
myeloid and other lymphoid cells (T lymphocytes, natural killers and dendritic cells). The
maturation of these cells is a step-wise process that starts from the multipotent hematopoietic
stem cells (HSC) in the foetal liver or in the post-natal bone marrow. The different stages of B
cell development are characterised by expression of specific surface markers and by the
recombination status of the immunoglobulin genes (Figure 1.3.1).
Figure 1.3.1 B cell development from early hematopoietic progenitors to immature B cells. The different
developmental stages together with some characteristic markers and the rearrangement states of the
immunoglobulin genes are indicated. Alternative differentiation pathways of multipotent precursors are also
shown. HSC (hematopoietic stem cell); MPP (multipotent precursor); CMP (common myeloid precursors); ELP
(early lymphoid precursor); ETP (early T lineage progenitor); CLP (common lymphoid precursors); NK (natural
killer); DC (dendritic cell); Flt3 (Fms-like tyrosine kinase receptor-3); IL-7R (Interleukin 7 receptor); DH-JH
(immunoglobulin heavy chain – IgH – D to J rearrangement); VH-DJH  (IgH V to DJ rearrangement); SLC
(surrogate light chain); pre-BCR (pre-B cell receptor); VL-JL  (IgL V to J rearrangement); BCR (B cell receptor).
Continuous arrows indicate actual differentiation; dashed arrows represent in vitro differentiation potential.
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HSC have self-renewal potential and give rise to multipotent precursors with more
restricted differentiation capacity. One of the earliest precursors are the multipotent progenitors
(MPP), which are unable to self-renew. MPPs can commit either to the myeloid lineage, giving
rise to common myeloid precursors (CMP) (Akashi et al., 2000), or to the lymphoid lineage
through early lymphoid precursors (ELP) (Medina et al., 2001). ELPs can differentiate into
early T-lineage precursors (ETP) in the thymus (Allman et al., 2003) or into common lymphoid
precursors (CLP) in the bone marrow (Kondo et al., 1997). CLPs are able to develop further
into four distinct cell types: B, T, natural killer and dendritic cells (Kondo et al., 1997; Traver
et al., 2000), although in vivo they do not efficiently generate T lymphocytes (Allman et al.,
2003). The onset of expression of the B cell marker B220 in a subset of CLPs coincides with
entry into the B cell differentiation pathway, with pro-B cells constituting the first stage of this
process (Gounari et al., 2002; Li et al., 1996; Martin et al., 2003; Tudor et al., 2000).
A key event of B cell development is the recombination of the immunoglobulin loci. This
process generates the diversity of immunoglobulins (Ig), which is the fundamental
characteristic of the adaptive immune response system. An Ig molecule is composed of two
chains, one heavy (IgH) and one light (IgL), which are encoded by distinct large multi-gene loci.
In mice, the IgH locus consists of approximately 150 variable (V), 12 diversity (D), 4 joining
(J) and 8 constant region (C) genes (Chevillard et al., 2002). The IgL can be encoded by two
distinct loci,  and , each composed by several V, J and C regions (Thiebe et al., 1999).
The IgH locus is the first to recombine, a process that starts in pro-B cells. The
recombination is mediated by the recombination-activating genes 1 and 2 (RAG1 and RAG2).
These enzymes generate DNA double-strand breaks at recombination signal sequences (RSS)
flanking the Ig genes (reviewed in Oettinger, 1999). The first event is a D to J recombination,
which take place on both IgH alleles. This is followed by an asynchronous recombination of a
V gene to the previously formed DJ segment. If this rearrangement is in a correct reading frame
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the second allele is prevented from undergoing V to DJ recombination, a process called allelic
exclusion. If the first V to DJ rearrangement is non-productive the second allele undergoes
recombination (reviewed in Schlissel, 2002). The newly synthesised IgH is expressed on the
cell surface together with the surrogate light chain (SLC), which is composed of the VpreB and
l5 polypeptides, to form the pre-B cell receptor (pre-BCR) (Karasuyama et al., 1990; ten
Boekel et al., 1998; Tsubata and Reth, 1990). The pre-BCR acts as an important checkpoint to
control the transition from the large pre-B-I to the large pre-B-II cell stage. It also induces cell
survival and proliferation of the large pre-B-II cells (Rolink et al., 2000) as well as down-
regulation of the RAG genes, which plays an important role in allelic exclusion (Grawunder et
al., 1995). The signals mediated by the pre-BCR also down-regulate expression of VpreB genes
and of 5, so that the cells become depleted of pre-BCR and stop proliferating (see Section 1.4).
The IgL-  locus then start to rearrange in small pre-B cells, due to the re-expression of RAG1
and 2. The rearrangement of the IgL-  locus is too asymmetric and, if the first recombination
is productive, the expression of the B cell receptor (BCR) prevents rearrangement of the second
allele in immature B cells. The immature B cells then migrate form the bone marrow to the
secondary lymphoid organs where they further differentiate to eventually become mature B
cells (Loder et al., 1999). These are the cells that, upon encounter with their antigen, terminally
differentiate into antibody-producing plasma cells.
Successful recombination events are essential for B cell maturation, although different
signal pathways have been found to be necessary for B lymphocyte differentiation. The
receptor molecule c-kit is predominantly expressed in HSC (Spangrude et al., 1991), but it is
found also in early B cells up to the pro-B stage. A second early signal is mediated by the
Fms-like tyrosine kinase receptor-3 (Flt3), whose expression characterises the transition from
HSC to MPP cells and continues to be expressed up to the pro-B cell stage (Ballas et al., 2005).
Within MPPs an increase in Flt3 expression commits the cells to the lymphoid rather than to the
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myeloid lineage (Adolfsson et al., 2005). The first lymphocyte-specific markers are B220 and
the Interleukin-7 receptor (IL-7R). In particular, the signals mediated by IL-7R are essential for
sustaining the early steps of B lymphocyte differentiation and their proliferation (Miller et al.,
2002). All of the signals mediated by these receptors originate from the niche of stromal cells
where the differentiation process take place; in addition cell-cell interactions between the
external environment and the maturing hematopoietic cells are  crucial for progression of the
developmental programs (Borghesi et al., 1997; Egawa et al., 2001; Tokoyoda et al., 2004).
1.3.1  Transcriptional regulation
The expression of specific genes at each stage of B lymphocyte development is precisely
regulated by a complex network of transcription factors, which activate lineage-specific gene
expression programmes and restrict the differentiation potential from HSC to committed cells.
One of the earliest transcription factors regulating lymphoid specification is PU.1. PU.1
knock-out mice die during embryogenesis and lack both T and B cells, suggesting a role for this
protein in the early progenitor cells that give rise to both cell types, the MPPs (Scott et al., 1994).
It was initially thought that the levels of PU.1 in MPPs would determine the lineage choice of
the cell, since higher levels of ectopic expression of PU.1 in null foetal liver precursors
generated macrophages, while a lower dose induced B cell differentiation (DeKoter and Singh,
2000). Recently the levels of PU.1 transcription in bone marrow derived CLPs and CMPs were
found to be similar (Back et al., 2005) and it was shown that only at later stages of
differentiation that the differences in PU.1 expression became significant (Nutt et al., 2005).
The ability of CLPs from conditional PU.1 knock-out mice to differentiate into B cells
confirmed the primary role of this transcription factor in the specification of early lymphoid
cells, without its requirement for the subsequent steps (Iwasaki et al., 2005). One of the
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functions of PU.1 in lymphocyte determination has be shown to be the regulation of IL-7R
expression (DeKoter et al., 2002).
A second transcription factor that is important in early B lymphocyte differentiation is
Ikaros. This protein can function as an activator or a repressor, depending on the genetic context
(Harker et al., 2002; Trinh et al., 2001). MPP cells can be isolated from Ikaros null mice, but
they do not express Ftl3 and both B and T cell development is impaired, due to the reduced
transcription of IL-7R and RAG1. Therefore Ikaros is required in the early stages of lymphocyte
specification and, along with PU.1, regulates IL-7R (Yoshida et al., 2006). The related
transcription factor Aiolos has been found to silence some of the genes activated by Ikaros
(including Flt3, RAG1, 5 and IL-7R) at later stages of B cell development, when they are no
longer required to sustain B lymphopoiesis (Thompson et al., 2007). This indicates that a DNA
element can be used either to sustain expression or to silence genes, depending on the
developmental stage and predominance of specific transcriptional regulators.
The basic helix-loop-helix (bHLH) factors E12 and E47, which are produced by differential
splicing of E2A, are required for proper formation of CLPs, while they are dispensable for MPP
generation (Bain et al., 1997; Borghesi et al., 2005). E12 and E47 continue to be expressed
during later stages of B differentiation and have been shown to be involved in regulating several
genes, including the EBF1, Pax5, RAG1, 5 and MB-1 (Ikawa et al., 2004), which are all key
players of B cell maturation.
EBF1 (early B cell factor-1), in the hematopoietic system, is exclusively expressed in the
B lineage. Ectopic overexpression of EBF1 in HSC is sufficient to direct their differentiation to
the B pathway, demonstrating the potent instructive ability of EBF1 (Zhang et al., 2003).
Knock-out of the protein allows the generation of ELPs, but these are then restricted to the
generation of T cells, due to the absence of immunoglobulin recombination and a block in
expression of essential B cell-specific genes (Lin and Grosschedl, 1995). In addition, EBF1 is
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able to rescue the B cell development of progenitors with null mutations of several genes,
including PU.1, E2A or IL7-R, although in most cases the proliferation rate of the cells is
sub-normal (Bain et al., 1994; Dias et al., 2005; Kikuchi et al., 2005; Medina et al., 2004; Seet
et al., 2004). Analysis of EBF1 regulation revealed two alternative promoters, each regulated
by different sets of factors, including E2A, STAT5 (a protein activated by IL7-R signalling),
PU.1, Pax5 and EBF1 itself (Roessler et al., 2007). Thus, during B cell development
progression of the maturation program is controlled by a complex network of transcription
regulators, forming feedback and trans-regulatory loops.
Pax5 (Paired box-5) is a B lineage specific transcription factor. The function of Pax5 seems
to be downstream of E2A proteins and EBF1, since Pax5 null mutation blocks B cell
differentiation at a later stage of development, when IgH rearrangement has already been
initiated (Urbanek et al., 1994). Pax5 is necessary for commitment and maintenance of the B
cell differentiation pathway. In the absence of this factor pro-B cells show a high degree of
plasticity and are able to differentiate in vitro into other lymphoid cells (Nutt et al., 1999). The
importance of Pax5 in determining the commitment to the B cell lineage was highlighted by the
identification of some of the genes regulated by it. Pax5 directly sustains the expression of
genes involved in B cell-specific signalling pathways (e.g. CD19, Ig  and Blnk) (Horcher et al.,
2001), but it is also involved in silencing of genes that are implicated in the maturation of other
lymphoid lineages such as Notch-1, whose expression is one of the determinant of T cell
development (Souabni et al., 2002). Therefore, Pax5 seems to control B-lineage commitment
by repressing inappropriate signalling systems and by simultaneously facilitating signal
transduction from the pre-BCR, via Iga and Blnk, and from the BCR, via CD19.
Other transcription factors have been shown to be implicated in the regulation of early B
lymphocyte differentiation. Sox4, a member of the High Mobility Group (HMG)-box family,
was shown to be involved in B cell development, in particular at the transition from pro-B to
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pre-B cells. Sox4-/- foetal liver cells were not able to reconstitute the hematopoietic system of
irradiated mice and the pro-B cells recovered from these animals had reduced proliferative
capacity upon IL-7 stimulation (Schilham et al., 1996). To date no Sox4 targets in the B cell
lineage have been identified. Therefore remains still to be determined how it interacts with the
B cell transcriptional networks. A more recent player that has been identified in B cell
development is Foxp1, a forkhead transcription factor, whose absence also results in the block
of the transition from pro-B to pre-B cells (Hu et al., 2006).
Following recombination of both of the Ig chain loci and expression of the BCR the newly
formed immature B cells migrate to the secondary lymphoid organs, where they further
differentiate and, upon exposure to antigen, proliferate and terminally differentiate into plasma
cells. During these processes several transcription factors have been found to be important for
regulating specific gene expression programs. Oct2 and Obf1, two octamer binding proteins,
are crucial for the final stages of B cell maturation, as shown by a reduced number of circulating
and peripheral B cells in mice that lacked the genes for either protein (Corcoran et al., 1993;
Hess et al., 2001). Defects in mature B cell proliferation upon antigen stimulation, were
observed in mouse models with null NF-kB (nuclear factor – kB) mutations (Sha et al., 1995).
The last step of differentiation, from B cells to plasma cells, is regulated by a specific set of
transcription factors. The main inducers of these differentiation steps are Blimp1 (B
lymphocyte-induced maturation protein-1) and XBP1 (X-box binding protein-1). In B cells
Pax5 and Bcl-6 (B-cell lymphoma-6) repress both Blimp1 and XBP1, whose expression in turn
represses proliferative signals (e.g. Myc) and some of the transcription factors that determine
B cell identity, such as Pax5 (reviewed in Shapiro-Shelef and Calame, 2005).
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1.4  The  locus
l5 and VpreB are the components of the surrogate light chain (SLC), which through its
association with the VDJ-rearranged IgH chain forms part of the pre-BCR (see Section 1.3). In
mice one 5 and three VpreB genes have been identified. 5, VpreB1 and VpreB2 are located
on chromosome 16 (Kudo et al., 1987), whereas VpreB3 is present on chromosome 10 (Rosnet
et al., 1999). Humans have one 5 (called 14.1) and two VpreB genes, all of which are located
on chromosome 22 (Bauer et al., 1993; Frippiat et al., 1995).
The 3′ end of 5 shows high similarities with the IgL-  gene, while the 3′ end of the VpreBs
is highly similar to the variable region of the  IgL-  (Kudo and Melchers, 1987; Sakaguchi and
Melchers, 1986). Their expression can be detected from the pro-B cell (prior V to DJ
rearrangement) to the large pre-B-II cell stage. No other cell or tissue has been reported to
express these genes (reviewed in Sabbattini and Dillon, 2005). The gene organisation of 5 and
VpreB1 in mice is of particular interest since they are separated only by 4.6kb (Figure 1.4.1),
while VpreB2 is located around 1Mb away and VpreB3 is on a different chromosome. The close
genomic localisation of 5  and VpreB1 is specific for mice and this region does not shows any
conservation in other mammals.
Figure 1.4.1 The  locus. Schematic representation of the genomic region containing the 5 and VpreB1
genes. A ubiquitously expressed housekeeping gene, Topoisomerase 3  (Topo3 ), is located immediately
upstream from VpreB1. Coloured boxes indicate gene exons; white boxes show gene introns. Horizontal arrows
indicate the direction of transcription. Vertical arrows show the position of the identified DNase I hypersensitive
sites (HS).
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The l5 and VpreB proteins have been shown to associate non-covalently with each other to
form the SLC (Kerr et al., 1989). In pro-B cells, prior to the complete rearrangement of the IgH
loci, the SLC interacts on the membrane surface with the BILL (B lineage-, intestine-, liver-
and leukocyte-expressed)-cadherin complex (Karasuyama et al., 1993; Ohnishi et al., 2000;
Winkler et al., 1995), although the signals that are generated by this association are still
unknown. After productive IgH rearrangement, in large pre-B-I cells, the SLC binds IgH by
disulphide bonds between l5 and IgH, to form the pre-BCR (Pillai and Baltimore, 1987).
The importance of the SLC in B cell differentiation has been extensively analysed in several
knock-out models (reviewed in Melchers, 2005). Such analyses have demonstrated that the
SLC, via the pre-BCR, is necessary for the proliferation of the large pre-B-II cells and the
selection of productive IgH rearrangements. While the mutations of individual genes coding for
the SLC do not completely block the B lymphocyte maturation, the ablation of all of the genes
severely impaired cell differentiation at the large pre-B-II cell stage. Importantly, allelic
exclusion is not affected by loss of pre-BCR signalling in the analysed systems. Nevertheless,
in l5-VpreB1-VpreB2 negative pre-B-II cells IgH was detected on the cell surface and its
interaction with other membrane components, such as VpreB3 or BILL-cadherin, could
activate the signal pathway involved in allelic exclusion.
Pre-BCR signalling is mediated by two associated proteins, Iga and Igb (Reth, 1989; Rolli
et al., 2002). Activation of the pre-BCR induces Iga and b phosphorylation, which function as
a binding platform for BTK (Bruton’s tyrosine kinase), PLC-g2 (phospholipase C-g2) and Blnk.
Knock-out of BTK and Blnk have shown that these modulators are the upstream component of
the pre-BCR-activated pathways, due to a block on large pre-B-II cell proliferation and
downregulation of the SLC genes (Jumaa et al., 2003; Jumaa et al., 1999; Khan et al., 1995;
Middendorp et al., 2002; Pappu et al., 1999).
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1.4.1  Transcriptional regulation of the  locus
The mechanisms that regulate expression of the mouse 5-VpreB1 locus have been
extensively investigated. Transgenic studies, with different portions of the mouse genomic
region containing the genes, have identified a 19kb fragment as a domain that includes all of
the sequences that are necessary for correct levels of expression and tissue-specificity
(Sabbattini et al., 1999). This region contains the two genes and the 5′ end of the ubiquitinously
expressed gene Topoisomerase 3  (Topo3 ) (Minaee et al., 2005; Szutorisz et al., 2005a).
Fine mapping of the DNase I HS sites in the 5-VpreB1 locus identified 12 potential
regulatory regions (Minaee et al., 2005) (see Figure 1.4.1); two of these HS sites are
constitutive (HS1 and HS11), while the others are pro/pre-B cell specific. HS11 coincide with
the Topo3  promoter and therefore it might be not involved in the regulation of the other two
genes. Of particular interest are the five HS at the 3′ end of the locus, which have been shown
to function as the LCR for the locus, driving efficient and stage-specific expression of
transgenes, independently of the site of integration (Sabbattini et al., 1999). Other elements in
the locus might participate in the LCR activity. Potential candidates are two intergenic
hypersensitive sites (HS7 and 8), which are the first of the pro/pre-B cell specific HS to appear
during B cell differentiation (Szutorisz et al., 2005a). A fragment containing HS7 and 8 has
been shown to have enhancer activity in transgenic mice (Minaee et al., 2005).
Several early studies focused on the sequences upstream of the two genes to identify the
regulatory elements and trans-acting factors that are involved in controlling the expression of
5 and VpreB1. Sequence analyses showed that the promoters of both genes are regulated by
Inr elements (see Section 1.1.5.1) and contain multiple transcription starting sites (Kudo et al.,
1989; Okabe et al., 1992a). Reporter experiments and EMSAs (electrophoretic-mobility shift
assay) were used to identify regulatory sequences and specific cis-acting elements.
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The first factors that was shown to bind to regulatory elements in the locus was called
EBB-1 (early B lymphocyte-specific DNA binding protein) (Okabe et al., 1992b), later found
to be Pax5 (Tian et al., 1997). Although these reports demonstrated the binding of Pax5 to the
promoters of 5 and VpreB1 and showed that mutation of the recognition site impaired the
transcription of reporter constructs, mice carrying a null mutation for Pax5 did not had any
downregulation of 5-VpreB1 transcripts (Nutt et al., 1997).
EBF1 and E47 were also shown to bind to sites in the locus promoters and ectopic
expression of these factors was able to induce high level of 5 transcription particularly when
coexpressed, demonstrating a synergistic effect (Martensson and Martensson, 1997;
Sigvardsson et al., 1997). The role of EBF1 and E47 in the regulation of the 5-VpreB1 locus
is supported by analysis of knock-out mice lacking EBF1 or E2A, which showed reduced
transcription of 5 and VpreB1 (see Section 1.3.1).
Silencing of the genes that encode the components of the surrogate light chain is an
important developmental step, since it reduces the pre-BCR signalling, inducing an halt in
proliferation of small pre-B cells that allows rearrangement of the IgL loci. There is evidence
that part of the silencing mechanism involves competition with activating factors, which
continue to be expressed even after the locus has stopped to be transcribed.  Members of the
Ikaros family of transcription factors were the first candidates for this involvement in 5-
VpreB1 downregulation. Two Ikaros binding sites are present in the 5 promoter, one of which
overlaps with an essential EBF1 binding element (Lo et al., 1991). Mutation of one of the
binding sites for Ikaros impaired the silencing of the promoter in mature B cells in a transgenic
assay, highlighting the fundamental role of members of the Ikaros family of transcription
factors in 5-VpreB1 downregulation. Since Ikaros is expressed all the way through B cell
development, as are EBF1 and E2A, the question of how the competition between the factors
is developmentally regulated remains unanswered . A solution was recently discovered when it
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was demonstrated that Aiolos, a member of the Ikaros family, is responsible for the silencing
of 5, rather than Ikaros (Thompson et al., 2007). Since the expression of Aiolos starts at a later
stages compared to Ikaros in B cell development (mediated by the pre-BCR via Blnk), the
stage-specific activation and silencing of 5 and VpreB1 could be explained by differences in
the affinity of the transcription factors (Aiolos>EBF1>Ikaros). The interferon regulatory
factors IRF4 and IRF8 have also been implicated in 5-VpreB1 silencing, since double null
mice failed to downregulate the SLC genes (Lu et al., 2003), although it is still not known if
IRF4/8-mediated silencing is direct.
1.4.2  Epigenetic regulation
The important role played by epigenetic mechanisms in the control of gene expression and
silencing has already been discussed in Section 1.1. A detailed analysis of active histone
modifications within the 5-VpreB1 locus indicated the presence of specific epigenetic features
at early stages of B cell development, prior to the expression of the two genes (Figure 1.4.2)
(Szutorisz et al., 2005a). In ES cells, representing the pluripotent precursors of all of the cell
types of an organism, the region of the locus corresponding to HS7 and 8 showed high levels
of the activating histone marks H3K4me2 and H3K9ac, together with binding of PolII and
GTFs (see Section 1.2.3). In Ba/F3 cells, which correspond to early pro-B cells where 5 and
VpreB1 are not yet expressed, the active histone modifications are still restricted in the
intergenic region around the HS7 and 8, but the marked area has widened compared to ES cells.
A second marked area appears in these cells at the 3′ of the locus, in a region corresponding to
the HS1. In pre-B cells, which express the genes, H3K4 methylation extends across the entire
locus, in agreement with the fully active state of the region. Mature B cells, where the locus is
silenced, and adult liver cells, which derive from a non-lymphoid differentiation program, show
no enrichment for the analysed active histone marks.
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Figure 1.4.2 Pattern of active histone modifications across the -  locus at different stages of during
B cell differentiation. ChIP results (fold enrichment over input) were obtained using antibodies against acetylated
H4 (blue), acetylated H3 (red) or H3K4 dimethylation (green) in the indicated cell types or tissue. The black bar
indicates the regions of the locus that are marked by these histone modifications. A locus map in shown below the
plots; amplicon positions are indicated by vertical lines. Reproduced, with permission, from Szutorisz et al., 2005a.
© 2005 by American Society for Microbiology.
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Interestingly, in all the analysed cell types these histone modifications were found on the
Topo3   promoter  and  5′  end,  confirming  its  ubiquitous  transcriptionally­active  state.  The
independent pattern of histone modification of 5 and VpreB1 compared to Topo3  suggest that
the latter has a distinct regulation, which is not affected and does not influence the rest of the
locus, even though they are so closely linked.
The pattern of active histone modifications around 5 and VpreB1 suggested that at
different stages of B differentiation, prior to transcriptional activation of the gene, a series of
sequence-specific transcription factors bind key regulatory elements of the locus to maintain it
in a poised state. Since these modifications are restricted to the same region in different cell
types, factors recognising the same elements could be involved in this process. The expansion
of the ETCM region during commitment to the B cell lineage could be due to differences in the
complexes recruited by these proteins. In pre-B cells the open chromatin conformation would
facilitate transcription of the genes. At later stages of B lymphopoiesis, when the genes have
been silenced, the active marks are lost.
1.5  Aim of the project
ES cells are an important tool in modern biology since they represent one of the earliest
stages of mammalian development and for their potential to differentiate into any adult cell type.
These cells possess peculiar epigenetic features at non-transcribed genes, which could be
involved in determining the pluripotency of ES cells. The primary focus of this project was to
identify the cis-acting sequences and the trans-acting factors involved in establishing the
histone modifications that characterise these epigenetic marks in ES cells. The 5-VpreB1 locus
was used as a model system for this analysis, since it contains a precisely localised epigenetic
mark in ES cells, the ETCM, and because the expression of 5 and VpreB1 during development
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is known in details. These features would allow one to study potential correlations between the
establishment of epigenetic marks in pluripotent precursors and the regulation of transcription
during differentiation.
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2  Materials and methods
2.1  Cell cultures
2.1.1  Embryonic stem cells
E14 ES cells were grown at 37°C – 10% CO2 in Dulbecco’s minimal essential medium
(DMEM) supplemented with 15% foetal calf serum (FCS), 2mM L-glutamine, 1% sodium
pyruvate, 1% nonessential amino acid solution, 50mM b-mercaptoethanol and 2400U/ml of
leukaemia inhibitory factor (LIF). Cells were plated in 0.1% gelatine-coated tissue culture
flasks on a feeder layer of stromal g-irradiated ST2 cells.
2.1.2  Pro-B cells
Abelson transformed proB cells that were originally derived from foetal livers of RAG2-
deficient mice (Alt et al., 1992) were cultured at 37°C – 5% CO2 in DMEM supplemented with
15% FCS, 2mM L-glutamine and 50mM b-mercaptoethanol.
2.2  Protein lysates
2.2.1  Nuclear cell extracts
Approximately 2.0-3.0x107 cells were harvested and washed once with phosphate buffered
saline (PBS). The pellet was resuspended in Buffer A (10mM Hepes pH7,9; 10mM KCl;
0,1mM EDTA; 0,1mM EGTA; 1mM DTT; 1X protease inhibitor cocktail - Roche) and the cells
were allowed to swell for 15min at 4°C before adding 0.6% final of Nonident P-40. The nuclei
were precipitated and the supernatant discarded. The nuclei were resuspended in Buffer C
(20mM Hepes pH7,9; 400mM NaCl; 1mM EDTA; 1mM EGTA; 1mM DTT; 1X protease
inhibitor cocktail) and were vigorously shaken for 15min at 4°C. The membranes were
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recovered by centrifugation and the supernatant, containing nuclear proteins, was collected and
stored at -70°C.
2.2.2  Whole cell extracts
Cells were harvested and washed once with PBS. Cell pellet was resuspended in Lysis
Buffer (50mM Hepes pH7,9; 50mM NaF; 5mM sodium pyrophosphate; 1mM EDTA; 10%
glycerol; 1mM DTT; 1% Triton X100; 1X protease inhibitor cocktail) and allowed to swell for
15min at 4°C. The homogenate was precipitated and the supernatant, containing the protein
extract, was recovered and stored at -70°C.
2.2.3  Whole tissue extracts
Thymus and brain were obtained from an adult mouse and frozen in liquid nitrogen. The
frozen tissue was pulverized and resuspended in RIPA buffer (50mM TrisHCl pH8; 150mM
NaCl; 1% NP-40; 0.5% sodium deoxycholate; 0,1% SDS; 1X protease inhibitor cocktail). The
lysate was sonicated for 5min in a Diagenode Bioruptor sonicator, to reduce viscosity. The
homogenate was precipitated and the supernatant, containing the protein extract, was recovered
and stored at -70°C.
2.3  DMS  footprinting
DMS in vivo footprinting was carried out using the method described by Tagoh and
colleagues (Tagoh et al., 2006) with minor modifications (see below).
2.3.1  Genomic DNA preparation
3.0x107 cells were harvested and washed once in PBS. DNA was purified using established
methods (proteinase-K digestion, RNA degradation, phenol:chloroform extraction and ethanol
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precipitation) and resuspended in 1X TE buffer (10mM TrisHCl pH 7.5, 1mM EDTA pH8) to
a final concentration of 4-20mg/ml. Aliquots of 20-100mg of DNA were then treated for 3min at
room temperature with different concentrations (from 0.25 to 0.75% v/v) of dimethyl sulphate
(DMS) in 200ml final volume of DMS Buffer (50mM sodium cacodilate, 1mM EDTA). The
reaction was stopped by adding 50ml of DMS Stop Buffer (1.5M sodium acetate pH7, 1mM
EDTA). The methylated DNA was then precipitated with 100% ethanol and resuspended in
99ml of TE buffer. The DNA was cleaved by adding 1ml of 10M piperidine and incubating for
10' at 90°C. The DNA was recovered by lyophilisation and dissolved in 10mM TrisHCl pH 8.0
to a final concentration of 1mg/ml.
2.3.2  DMS  treatment
Approximately 3.0x107 cells were harvested and washed twice in PBS. The cell pellet was
resuspended in 1ml of PBS containing 0.2% of DMS and treated for 5min at room temperature.
The reaction was stopped by adding ten volumes of ice-cold PBS and harvesting the cells. The
pellet was washed twice with ice-cold PBS and the DNA was then purified with conventional
methods and resuspended in 1X TE buffer. 1ml of 10M piperidine was then added to 99ml of
DNA and the reaction was incubated for 10min at 90°C. The DNA was recovered by
lyophilisation and resuspended in 10mM TrisHCl pH8 to a final concentration of 1mg/ml.
2.3.3  Ligation-mediated PCR
All of the primers were designed using the Oligo 6.8.1 software (MBI) with the following
parameters: length between 21 and 25bp, total Na+ equivalents 208.9mM, nucleic acids
concentration 250pM. To perform a ligation-mediated (LM)-PCR a total of three nested
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primers are needed. The melting temperature of the primers should increase in the order
1st<2nd<3rd.
Cleaved DNA (2mg), from genomic DNA or DMS treated cells, was extended on a single
strand with a biotinylated primer specific for the region of interest. The reaction mix contains
2mg of cleaved DNA (1mg/ml), 1X ThermoPol Buffer (New England Biolabs), 0.25mM dNTPs,
1pmol first primer, 2.5% DMSO and 2U Vent Exo- DNA polymerase (New England Biolabs).
The suspension was incubated in a thermo-cycler with the following program: 10min-95°C,
15min-1st primer annealing temperature, and 20min-72°C.
First strand extension products were ligated to a double stranded DNA oligonucleotide
linker LP21/25 (LP21: GAA TTC AGA TCT CCC GGG TCA; LP25: GCG GTG ACC CGG
CAG ATC TGA ATT C). To the first strand extension reaction mixture were added 10ml of
ligation mix containing 1X T4 ligase buffer (New England Biolabs), 10% polyethylene glycol
6000, 40pmol LP21/25 linker and 3U of ligase (New England Biolabs). The ligation reaction
was performed over night at 16°C.
The products were then isolated and purified using magnetic streptavidin-coated beads
(Invitrogen). Beads (150mg) in 15ml of 2X binding and washing buffer (10mM TrisHCl pH 7.5,
SOXA 1st 5' GGA GGT CTG GAA ACT TAC TGT 3' 49
SOXA 2nd 5' CTG TGG AAG TAG CTG AGG AAG TC 3' 56
SOXA 3rd 5' GCT GAG GAA GTC TAG AAA CTG CTG C 3' 61
SOXB/Fox 1st 5' TTT CCA TTT GTT ATT GAC TT 3' 48
SOXB/Fox 2nd 5' TGC TTG TGC TTG CCT GGA CT 3' 60
SOXB/Fox 3rd 5' CTT GCC CAT TTT TAA GCC TAG TCT CC 3' 63
LM-PCR primer sequences.
Table 2.1
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1mM EDTA, 2M NaCl) were added to the ligation reaction and incubated with shaking for 4
hours at room temperature. The samples tubes were then transferred into a magnetic plate for
the purification of the DNA bound to the beads. The DNA was washed once with 2X binding
washing buffer and once with 1X TE, then resuspended in 10ml of 0.1X TE. Finally, the
purified DNA was released from the beads by heating the suspension at 95°C for 10min.
Purified DNA was amplified by PCR using a second sequence specific nested primer and
the LP25 oligonucleotide. The PCR reaction was performed in 50ml final volume with the
following components: 1X PFU buffer (Stratagene), 1.4M betaine, 250mM dNTPs, 10pmol 2nd
sequence specific primer, 10pmol LP25 oligonucleotide and 2.5U PFU Turbo Taq DNA
Polymerase (Stratagene). The cycler programme was: 5min-95°C, 22 cycles of 45s-95°C –
3min-2nd primer annealing temperature – 5min-72°C, 10min-72°C.
A 40pmol aliquot of the third primer was labelled for one hour at 37°C in 1X kinase buffer
(New England Biolabs) with 10U of T4 polynucleotide kinase (New England Biolabs) using
60mCi of g32P-ATP. The labelled primer was purified from the unincorporated nucleotides by
gel filtration using sephadex spin-columns (GE Healthcare).
The labelled third primer was used to extend the PCR products. To 5ml of the PCR reaction
was added 5ml of labelling mix containing 0.5X PFU buffer, 0.7M Betaine, 250mM dNTPs,
1pmol 3rd sequence specific primer – 32P labelled, 1.25U PFU Turbo Taq DNA Polymerase. For
the labelling reaction was used the following thermal cycle is: 5min-95°C, 7 cycles of 45s-95°C
– 3min-3rd primer annealing temperature – 5min-72°C, 10min 72°C. The samples were then
denaturated by adding 10ml of Loading buffer (80% formamide, 10mM NaOH, 1mM EDTA,
xylene cyanol, bromophenol blue) and heating for 5min at 95°C.
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2.3.4  Denaturing polyacrylamide gel electrophoresis
DNA products from the labelling reaction were separated on a 6% polyacrylamide (19:1
acrylamide:bisacrylamide), 7M urea gel in 1X TBE (89mM Tris-borate, 2mM EDTA). The gel
was pre-run for at least one hour to warm it up before loading the samples. The electrophoresis
was performed at 1650V constant (65W maximum).
2.4  Electrophoretic-mobility shift assay
2.4.1  Probe labelling
Double stranded probes (3.5pmol) of were end-labelled for 30min at 37°C in 1X Kinase
buffer (New England Biolabs) with 5U of T4 Polynucleotide kinase (New England Biolabs)
using 60mCi of g32P-ATP. Labelled probes were purified from the unincorporated nucleotides
by gel filtration using sephadex spin-columns (GE Healthcare).
2.4.2  DNA binding reaction
Aliquots of 10mg of nuclear extracts were incubated for 15min at 17°C in 1X binding buffer
(4% glycerol; 1mM MgCl2; 0.5mM EDTA; 0.5mM DTT; 50mM NaCl; 10mM Tris-HCl pH
7.5; 50mg/ml poly(dI-dC).poly(dI-dC)). For the supershift assays 10mg of each of the following
antibodies were added to the binding reaction: anti-Sox2 (Santa Cruz Biotechnology); anti-
Foxd3 (Millipore); anti-Sox15 (Santa Cruz Biotechnology); anti-Sox4; anti-Foxp1 (Abcam);
normal IgG (Santa Cruz Biotechnology).  For competition assays, 100 fold excess of cold
probes were added to the binding reaction. Labelled probe (20000-50000cpm) was then added
to the binding reaction mixture and incubated for 20min at 17°C. The reaction was stopped with
1X Gel loading buffer (25mM Tris-HCl pH7.5; 4% glycerol; bromophenol blue).
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2.4.3  Electrophoresis of DNA-protein complexes
The binding products were separated on an 8%  non-denaturing polyacrylamide (29:1
acrylamide:bisacrylamide) gel in 1X TBE (89mM Tris-borate, 2mM EDTA). The
electrophoresis was performed at a constant voltage (250V) with cooling.
2.5  Chromatin immunoprecipitation
2.5.1  Chromatin preparation
Approximately 1.0-3.0x108 cells were harvested and resuspended in 100ml of culture
medium. The cells were fixed in a final concentration of 1% of formaldehyde (w/v). After
10min at 37°C, the reaction was stopped by adding glycine to a final concentration of 0.125M;
the cells were incubated at room temperature for 5min and then washed 3 times with ice-cold
PBS. Fixed cells were resuspended in 10ml of Swelling buffer (25mM Hepes pH 7.9; 1.5mM
MgCl2; 10mM KCl; 0.1% NP-40, 1X protease inhibitor cocktail), chilled on ice for 10min and
homogenized in a dounce homogenizer. The nuclei were recovered by centrifugation and
resuspended in Sonication buffer (50mM Hepes pH 7.9; 140mM NaCl; 1mM EDTA; 1% Triton
SOXA
FW   5' CCC CAT TGT CCT TGC CTC ACC CCA TTG TCC TTG CCT CA 3'
REV 5' TGA GGC AAG GTC AAT GGG GTG AGG CAA GGA CAA TGG GG 3'
SOXA M
FW   5' CCT CGT CGC CTT CGT CTC ACC TCG TCG CCT TCG TCT CA 3'
REV 5' TGA GAC GAA GGC GAC GAG GTG AGA CGA AGG CGA CGA GG 3'
SOXB/Fox
FW   5' TGT CCT GGA ATT GGC CCA GTT TTC TCA GTA CTT TGT TAT TAT ACA T 3'
REV 5' ATG TAT AAT AAC AAA GTA CTG AGA AAA CTG GGC CAA TTC CAG GAC A 3'
SOXB/Fox M
FW   5' TGT CCT GGG ACT AGC CTA GTT TTC TCA GTA TTT TAT TAC TAT ACA T 3'
REV 5' ATG TAT AGT AAT AAA ATA CTG AGA AAA CTA GGC TAG TCC CAG GAC A 3'
SOXB/Fox SOX M
FW   5' TGT CCT GGG ACT AGC CTA GTT TTC TCA GTA CTT TGT TAT TAT ACA T 3'
REV 5' ATG TAT AAT AAC AAA GTA CTG AGA AAA CTA GGC TAG TCC CAG GAC A 3'
SOXB/Fox Fox M
FW   5' TGT CCT GGA ATT GGC CCA GTT TTC TCA GTA TTT TAT TAC TAT ACA T 3'
REV 5' ATG TAT AGT AAT AAA ATA CTG AGA AAA CTG GGC CAA TTC CAG GAC A 3'
Probes used in EMSA. FW=forward oligonucleotide; REV=reverse oligonucleotide; M=mutated oligonucleotide.
Red letters highlight oligonucleotides mutated.
Table 2.2
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X-100; 0.1% Na-deoxycholate; 0.1% SDS; 1X protease inhibitor cocktail). Nuclei were
sonicated to obtain chromatin fragments of approximately 0.5-1.0kb, using a Diagenode
Bioruptor sonicator. The samples were centrifuged at 12000xg for 15min at 4°C and the
supernatant, containing the sheared chromatin, was recovered. Chromatin concentration was
determined by measuring the optical density at 260nm.
2.5.2  Immunoprecipitation
Aliquots of 500mg of chromatin per immunoprecipitaion (IP) was pre-cleared with protein
G-sepharose (Applied Biosystems) and one tenth of the reaction was kept aside as input
material. The immuno-reaction was carried out overnight at 4°C in sonication buffer, adjusted
with 1% bovine serum albumin, using the following amount of antibodies for each IP: 20mg
anti-H3K4me2 (Abcam); 20mg antiH3K27me3 (Millipore); 35mg anti-Sox2 (Santa Cruz
Biotechnology); 35mg anti-Foxd3 (Millipore); 35mg anti-Sox15 (Santa Cruz Biotechnology);
35mg anti-Sox4; 35mg anti-Foxp1 (Abcam); 35mg normal IgG (Santa Cruz Biotechnology).
100ml of protein G-sepharose were added to the reactions and the immunoprecipitation was
performed at 4°C for 3 hours. The immunoprecipitated material was washed twice with
Sonication buffer, twice with Wash buffer A (50mM Hepes pH 7.9; 140mM NaCl; 1mM
EDTA; 1% Triton X-100; 0.1% Na-deoxycholate; 0.1% SDS; 500mM NaCl), twice with Wash
buffer B (20mM Tris-HCl pH 8.0; 1mM EDTA; 250mM LiCl; 0.5% NP-40; 0.5% Na-
deoxycholate) and twice with TE buffer (10mM Tris-HCl pH8.0; 1mM EDTA). Chromatin was
then eluted twice with 250ml of Elution buffer (50mM Tris-HCl pH8.0; 1mM EDTA; 1% SDS)
and the two eluates were combined. The crosslinking of the chromatin was reversed by
incubating at 65°C overnight in the presence of 16mM final of NaCl and 20mg of DNase-free
RNase-A. Immunoprecipitated and input material was digested with 50mg of proteinase-K and
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the DNA recovered by phenol-chloroform extraction and ethanol precipitation. The amount of
recovered DNA was determined using the Quant-iT PicoGreen dsDNA Assay kit (Invitrogen).
2.6  Q2ChIP
The Q2ChIP was performed as described by Dahl and Collas (Dahl and Collas, 2007) with
minor modifications. Dynabeads protein G paramagnetic beads (Invitrogen) were pre-
incubated for 2 hours at 4°C with the following amount of antibodies for each IP: 5mg
anti-H3K4me2 (Abcam); 5mg anti-H3K27me3 (Millipore); 10mg anti-Suz12 (Santa Cruz
Biotechnology); 10mg normal IgG (Santa Cruz Biotechnology). Chromatin was prepared as
described  above (Section 2.5.1), starting from 107 cells. Aliquots of 100mg of chromatin were
immunoprecipitated overnight at 4°C, with the antibody previously bound to the beads. The
immunoprecipitated material was recovered using a magnet and subsequently washed as
described above (Section 2.5.2). At each washing step the samples were recovered using a
magnet. Subsequently the final wash with TE buffer and the samples were transferred to a new
test tube, to avoid carrying over of chromatin non-specifically bound to the plastic.
Chromatin was then eluted and the crosslinking was reversed in a single step using 150ml
of Elution buffer (50mM Tris pH8.0; 50mM NaCl; 1mM EDTA; 1% SDS; 3ug DNase-free
RNase-A). The samples were incubated at 68°C overnight in a thermomixer at full speed. An
additional elution step was performed with 150ml of Elution buffer at 68°C for 1 hour in a
thermomixer at full speed. DNA was recovered by proteinase-K digestion, phenol:chloroform
extraction and ethanol precipitation. The amount of recovered DNA was determined using the
Quant-iT PicoGreen dsDNA Assay kit (Invitrogen).
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2.7  ChIP-on-Chip
ChIP was performed as described above (Section 2.5). The recovered DNA was amplified
using the GenomePlex Whole Genome Amplification (WGA) system (Sigma-Aldrich) with
modification, as described by O'Geen and colleagues (O'Geen et al., 2006). To the ChIP
material were added 2ml of 1X Library preparation buffer and 1ml of Library stabilisation
solution; the samples were denatured at 95°C for 2min before adding 1ml of Library preparation
enzyme. The samples were transferred to a thermocycler with the following program: 20min-
16°C, 20min-24°C, 20min-37°C, 5min-75°C. The ChIP DNA was then amplified by adding
60ml of master mix (7.5ml 10X Amplification master mix; 47.5ml water; 5ml WGA DNA
polymerase) and incubating in a thermocycler as follow: 3min-95°C; 14 cycles of 15s-94°C,
5min-65°C. The amplified DNA was purified using the QIAquick PCR cleanup columns
(Qiagen) and the amount of recovered DNA was determined as optical density at 260nm.
The amplified input and pull-down DNA were labelled with Cy3 and Cy5 by random
priming and hybridised to the microarray by NimbleGen Systems. The microarray was
prepared by tiling 50mer oligonucleotides probes, with a 100bp resolution, covering 210 mouse
genomic regions. High-frequency repeats were excluded from the array and each probe was
represented in duplicate. Input and pull-down signal intensities, scaled log2 ratios and
enrichment peaks were provided by NimbleGen. Enrichment peaks were calculated by
NimbleGen Systems using a permutation-based algorithm. This estimates the false discovery
rate (FDR) for each peak, which is equal to the probability of finding a peak of comparable
significance by chance. Significant peaks are characterised by low FDRs and correspond to four
or more probes within a 500-bp sliding window with signals above the cut-off value (cut-off
values are a percentage ranging from 90 to 15% of a hypothetical log2 ratio maximum, which
is the mean+6standard deviation).
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2.8  Reporter assay
The basal 5 promoter- -globin construct contains a 410bp fragment which includes the
promoter of the 5 gene cloned into a pUC18 plasmid vector (Sabbattini et al., 1999). To
generate the enhancer-containing construct, a 1379bp SphI-BamHI fragment including the
ETCM region was inserted upstream of the 5 promoter (Szutorisz et al., 2006). Mutation to
the SoxA, SoxB and Fox sites were produced by site-directed mutagenesis using the
QuikChange II XL Site-Directed Mutagenesis kit (Stratagene). The procedure relies upon the
linear amplification of the template DNA, using high-fidelity DNA polymerases. Template
DNA (10ng) was incubated with 125ng of mutated oligonucleotides (forward and reverse), 3ml
of QuikSolution, 1ml of dNTPs mix and 2.5U of PfuUltra HF DNA polymerase in a final
volume of 50ml. The reaction was then incubated in thermocycler with the following
programme: 1min-95°C; 18 cycles of 50s-95°C, 50s-60°C 10min-68°C; 7min-68°C. The
reaction was then incubated for 1 hour at 37°C with 10U DpnI, a nuclease that digests only
methylated DNA. Since newly synthesised DNA is unmethylated, only the template DNA,
which is methylated during bacterial culturing, is digested by DpnI. A 2ml aliquot of the mixture
was then used to transform bacteria, using conventional methods. The mutation of the desired
nucleotides was confirmed by direct sequencing of the purified plasmids.
Plasmid DNA (4mg) of containing the different reporters, plus 1mg of a plasmid coding for
eGFP (enhanced-green fluorescent protein) were diluted in 250ml of Opti-MEM reduced serum
medium (Invitrogen). In a separate tube, 5ml of Lipofectamine 2000 (Invitrogen) was diluted in
250ml of Opti-MEM. After 15min of incubation at room temperature, the two suspensions were
combined and left for an additional 15min at room temperature to allow Lipofectamine-DNA
complex formation. Six-well tissue culture plates were coated with 0.1% gelatine. 6.5x105
freshly harvested ES cells were added to the mixture and plated on individual well in a final
volume of 2ml. 24 hours after transfection the media was changed and the cells were collected
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after additional 24 hours in culture. Approximately 104 cells were tested for GFP expression
using FACS analysis, to determine the transfection efficiency for each individual sample,
which was between 87 to 98% in each sample. Each GFP-positive cell was considered to have
been transfected also with the reporter vector, due to the random nature of Lipofectamine-DNA
complex formation.
Total RNA was extracted using the SV Total RNA Isolation system (Promega). 500ng of
total RNA were retrotranscribed into cDNA with 200U Superscript II RT (Invitrogen) and
100ng random primers in a final volume of 20ml containing 1X First Strand buffer, 10pmol
dNTPs, 200pmol DTT. The mixture was first denatured at 65°C for 5', followed by 10'
annealing at 25°C and 50min reverse-transcription at 42°C.
2.9  Real-time PCR
Real-time quantitative PCR (qPCR) reaction were performed on the DNA Engine Opticon
system (MJ Research) using the SYBR Green JumpStart Taq ReadyMix (Sigma-Aldrich). Each
reaction was performed in duplicate in a final volume of 25ml. The following thermal cycle was
Name Sequence
SOXA mut.
FW     5' GCC TAG TCT CCT TAA CTG CAA TTT GAA GTC TGT CCT AGG ACT AGT CTA ATT
               TTC TCA GTA CTT TGT TAT TAT ACA TTC TGC TTT C 3'
REV  5' GAA AGC AGA ATG TAT AAT AAC AAA GTA CTG AGA AAA TTA GAC TAG TCC
              TAG  GAC AGA CTT CAA ATT GCA GTT AAG GAG ACT AGG C 3'
SOXB mut.
FW     5' CCT TAA CTG CAA TTT GAA GTC TGT CCT GGG ACT AGC CTA GTT TTC TCA GTA
               CTT TGT TAT TAT CAC T 3'
REV  5' AGT GAT AAT AAC AAA GTA CTG AGA AAA CTA GGC TAG TCC CAG GAC AGA
              CTT CAA ATT GCA GTT AAG G 3'
Fox mut.
FW    5' CTG GAA TTG GCC CAG TTT TCT CAG TAT TTT ATT ACT ATA CAT TCT GCT TTC
              CAA GTC TGT G 3'
REV  5' CAC AGA CTT GGA AAG CAG AAT GTA TAG TAA TAA AAT ACT GAG AAA ACT
              GGG CCA ATT CCA G 3'
Primers used for site-directed mutagenesis.
Table 2.3
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used for all the samples: 10min-95°C; 40 cycles of 15s-95°C, 15s-primers specific annealing
temperature, 15s-72°C. For each experiment, the threshold was set to cross a point at which
real-time PCR amplification was linear (0.02 to 0.05 relative fluorescent units for the majority
of the experiments). Previously unpublished primer pairs were tested for amplification
efficiency, carrying out reaction with serial dilutions of sheared genomic DNA. Calibration
curves were generated by plotting the cycle number at which the PCR signal rose above the
background (Ct value) against the dilution of the template. The slope of the so generated curve
was used to determine the efficiency of the PCR (Svanvik et al., 2000), which was between 90
and 110% with all primer pairs.
For the analysis of ChIP experiments, 0.5ng of input and immunoprecipitated material were
analysed in every qPCR. The enrichment of a given target sequence precipitated by an antibody
was determined as the fold difference between the amount of target sequence in the
immunoprecipitated fraction and the amount of target sequence in the input DNA using the
following formula: fold enrichment=2[C(t)input–C(t)IP]. Average fold enrichment and standard
deviation was calculated from at least three independent immunoprecipitations and PCR
duplicates for each immunoprecipitation.
For the analysis of reporter transcription were used 2ml of cDNA per reaction. For each
sample the transcript levels of the reporter gene and the of the endogenous MLN-51 were
measured. The expression of MLN-51, a housekeeping gene (Szutorisz et al., 2005a), was used
as internal control to normalise differences in the efficiency of the reverse transcription reaction.
The expression levels of each reporter were measured as fold relative to MLN-51, according to
the following formula: 2[C(t)MLN-51–C(t)reporter]. To correct for differences in the transfection
efficiency, the relative expression levels of each reporter construct were normalised according
to the transfection efficiency measured as eGFP positive cells.
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Name Sequence Ta °C
Topo3 promoter (1) FW   5' TTT ATT TTT ATT TGA TAT GCA TTG GT 3'REV 5' ATA TGG CAG CTC ACA ACT ATC CC 3' 60
VpreB1 ex1 (1) FW   5' CAA ACC CAG AGC CAC AAA G 3'REV 5' GGG GAG AGG GTC ACT GC 3' 60
VpreB1 3' (1) FW   5' CAA GTG ACA GGT GTG GAG CAA GTT 3'REV 5' GGA GAG CAC ACC CCA GTA GGA TTA 3' 60
HS9 (1) FW   5' GTG ACA GAC CCG TTA CCA A 3'REV 5' AGA AAG AGA AGG GGA AAA AGA G 3' 52
ETCM1 (1) FW   5' TCC CCA TTG CCA GAT AGA GAC ACA 3'REV 5' TGG GCC CAA CAG ATT AAC ACA GAG 3' 60
ETCM2 FW   5' GAT GGG GGA GGT CTG GAA ACT 3'REV 5' ATG GAA TGT CCC AGC CAC T 3' 60
ETCM3 (1) FW   5' TGA CTT GCT TGT GCT TGC CTG GAC 3'REV 5' ATA ATA ACA AAG TAC TGA GAA AAC 3' 57
HS7 (1) FW   5' TGG ATA ACT GCA GGA AGC TGT 3'REV 5' GCA GTG CCA GAT CTC CAG AC 3' 60
L5 promoter (1) FW   5' ATG GGT GAT ACT TAC AAA ATT TGG G 3'REV 5' TCA GGA AAA ATG ATT AAA ATG GTG TTT 3' 60
L5 3' (1) FW   5' GGC TGC ACC TGG AAA ACC TTA 3'REV 5' ATC AAA ATC TTC CCC TCA ATC TGT 3' 57
HS5 (1) FW   5' AGG AGA CCA GAA GGG GCA GTT 3'REV 5' GGT TCA ATG TTT AAG AGC AAG TTT 3' 52
HS2 (1) FW   5' ACC CAG TAA GCA AGT TTT CA 3'REV 5' ATA AGC TCT CCT CCC TCA AG 3' 57
HS1 (1) FW   5' TGG AGT ATG AGG CAG TGA TTG TTA 3'REV 5' AGA GTT TTG ACG GCT TCC AGA 3' 52
PTMS FW   5' GAC CGA GAC CCC TCC CTT AC 3'REV 5' CAA GGA CAA TCG GAA AGA GTT G 3' 60
TEK FW   5' CTG GTC CTC ATC GCA TAC CA 3'REV 5' AAC TGG ATT GTG GGG CAG AG 3' 60
RAG1/TRAF6 FW   5' TTG CCT CAG CTA AGC CAT GA 3'REV 5' AAG GCA AAC CTG CCA ACT TC 3' 60
BLIMP1 ETCM FW   5' CAA AGC CAC AGA CCA TCA CC 3'REV 5' CTT GCC CAG GCT CCT GTA GT 3' 60
SLP65/Dntt FW   5' CAC ACC CGA CTA CAC CTC CA 3'REV 5' GCC CTG GGT TTT  CTT CTG TG 3' 60
EBF intr FW   5' CTG CCT TGC TCT GTG TTT GG 3'REV 5' CGG CAG AGT GCA AGC TAA GA 3' 60
EBF promoter FW   5' CCG TGC TCA GAC CAA GAC TG 3'REV 5' CGA TGT CCA CGA TGT CCA CT 3' 60
PAX5 (2) FW   5' ATGGGAGTTTGTTTTCCTGTGT 3'REV 5' AGTGATGTTTGGCCTAATCCTG 3' 60
IRX2 (2) FW   5' TAACACGGCCTGAAATCTTCTC 3'REV 5' GCATCCCACTTCTACAGTCCTC 3' 60
TCF4 (2) FW   5' CGGATGTGAATGGATTACAATG 3'REV 5' ATTGTTCTTCGGTCTTGTTGGT 3' 60
Primers used for quantification of ChIP DNA. (1) Szutorisz et al., 2005a (2) Bernstein et al, 2006. FW=forward
oligonucleotide; REV=reverse oligonucleotide.
Table 2.4
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2.10  RNA interference
siRNA (125pmol) was diluted in 250ml of Opti-MEM reduced serum medium (Invitrogen).
In a separate tube 5ml of Lipofectamine 2000 (Invitrogen) was diluted in 250ml of Opti-MEM.
After 15min of incubation at room temperature, the two suspensions were combined and left for
an additional 15min at room temperature to allow Lipofectamine-DNA complex formation.
Six-well tissue culture plates were coated with 0.1% gelatine and 5x104 g-irradiated ST2 cells
were added to each well. 6.5x105 freshly harvested ES cells were added to the Lipofectamine-
DNA mixture and plated on individual well in a final volume of 2ml. The media was changed
every 24 hours, until the cells were collected at the different time points. Parallel experiments
using fluorescein-labelled dsRNA (125pmol -  Invitrogen) were carried out to asses the
transfection efficiency. The cells used for the Q2ChIP experiments were cultured in 25cm2
flasks, adjusting the amount of siRNA, media volumes and cell number according to the
different surface area. Each knock-down experiment was tested for SOX2 downregulation with
western blot analysis; FACS (fluorescence-activated cell sorting) analysis of Oct4 and SSEA-1
was also performed to asses the expression of ES cell markers, as described below.
2.10.1  FACS analysis of ES cell markers
Approximately 106 cells were fixed with 2% paraformaldehyde (w/v) for 30min at room
temperature. Cells were washed twice with PBS and resuspended in HBSS (Hank’s balanced
Name Sequence Ta °C
b-Globin (1)
FW   5' AGG TTA CAA GAC AGG TTT AAG GAG ACC 3'
REV 5' CCT AAG GGT GGG AAA ATA GAC CA 3' 60
MLN-51 (2)
FW   5' ACA GCC GGA AAT GCA CCT T 3'
REV 5' GGG ACA TGG ACA CTG GTG GT 3' 60
Primers used for quantification of reporter expression. (1) Szutorisz et al., 2006 (2) Szutorisz et al., 2005a.
FW=forward oligonucleotide; REV=reverse oligonucleotide.
Table 2.5
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salt solution) supplemented with 1% w/v BSA (bovine serum albumine) and 0.05% w/v of
saponin, which was used as permeabilizing agent. After 10min the cells were washed with PBS
and incubated in 200ml of PBS supplemented with 1% BSA and 0.05% saponin with the
following antibodies: 0.5mg FICT-conjugated goat anti-mouse IgG (SouthernBiotech), 0.5mg
anti-Oct4 (BD Biosciences), 50ng PE-conjugated anti-SSEA-1 (R&D Systems). The cells were
incubated for 20min and then washed twice with PBS supplemented with 1% BSA. The cells
previously incubated with with the anti-Oct4 antibody were resuspended in 200ml of PBS
supplemented with 1% BSA and 0.05% saponin and incubated with 0.5mg FICT-conjugated
goat anti-mouse IgG (SouthernBiotech) for 20min at room temperature and washed twice with
PBS supplemented with 1% BSA. The cells were resuspended in 200ml of PBS supplemented
with 1% BSA and analysed on a FACScan (BD Biosciences).
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3  Binding of transcription factors to the  locus Early-
Transcriptional Competence Mark in ES cells
Epigenetic regulation of chromatin plays a fundamental role in controlling the
transcriptional status of genes. The epigenetic modifications that have been most studied in
recent years are the covalent modifications to the N-termini of histones and the different
combinations of these. The “histone code” hypothesis (Strahl and Allis, 2000) was formulated
to explain the effects of these epigenetic signatures on the higher-order structure of chromatin
and on the recruitment of effectors molecules to the DNA. Based on this theory it may also be
possible to predict if a gene is actively transcribed or is silent by analysing the histone
modifications present on and around its transcriptional unit.
Embryonic stem (ES) cells have the unique ability to self-renew and to differentiate into all
of the somatic lineages in the body. These cells have been extensively studied for their
epigenetic characteristics on both individual genes and genome wide. Some of these studies
have identified novel and unusual combinations of histone marks. For example it has been
shown that histone modifications associated with activation (histone H3K4 methylation) and
silencing (histone H3K27 methylation) co-exist on regulatory regions of many non transcribed
genes with developmental function (Azuara et al., 2006; Bernstein et al., 2006). Due to the dual
nature of this mark, the combination of these histone modifications has been called “bivalent
domain” and it has been suggested that its function is to keep a gene poised for activation, while
repressing its expression.
A second type of mark emerged from an analysis of the epigenetic profile of the pro/pre-B
cell specific 5-VpreB1 locus at different stages of B cell development (Szutorisz et al., 2005a).
In ES cells a localised peak of active marks (H3K4 methylation and H3K9 acetylation) was
found on a intergenic enhancer in the locus, which is active in pro- and pre-B cells. General
transcription factors (GTFs) and RNA polymerase II (PolII) were also found to bind to the
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region, although the two genes are not expressed in ES cells. The -globin locus control region
(LCR) (Vieira et al., 2004) and the Hoxb9 promoter (Chambeyron and Bickmore, 2004), have
been shown to have similar epigenetic modifications in ES cells, even though they are too not
expressed in these cells. The combination of active epigenetic modifications and the presence
of GTFs and PolII has been termed an Early-Transcription Competence Mark (ETCM) and it
was hypothesised that it helps to prime enhancers and other regulatory elements in ES cells for
the activation of a gene at later stages of development (Szutorisz and Dillon, 2005).
The fact that bivalent domains and ETCMs are both localised in defined DNA regions
suggests that they are regulated by binding of sequence-specific factors. The identification of
these proteins is one of the main objectives of this work.
3.1  Sox and Fox recognition sites within the  ETCM are
occupied in ES cells
The aim of this study was to identify proteins bound to the 5-VpreB1 locus ETCM in vivo
without pre-selecting them. Therefore DMS in vivo footprinting was chosen as the assay for
finding transcription factors binding sites occupied in ES cells (Garrity and Wold, 1992;
Mueller et al., 1988; Mueller and Wold, 1989). The method has the advantage that it allows
identifying DNA sequences that are bound by proteins in vivo at single nucleotide resolution
(Figure 3.1). DMS (dimethyl sulphate) is a small lipophilic molecule that can enter into the
nuclei of living cell where it methylates guanosine on N-7 and, less efficiently, adenosine on
N-3. The presence of a protein on the DNA can interfere with this reaction by masking
nucleotides (protection) or by bending the DNA and overexposing neighbouring nucleotides
(hyper-reactivity).  The DNA is subsequently isolated and single strand breaks are generated at
the sites of the modified nucleotides by heating in the presence of piperidine. Piperidine
treatment induces opening of the methylated purine ring by increasing the pH and by catalysing
the -elimination of both phosphate from the sugar (Maxam and Gilbert, 1980).
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Figure 3.1 Schematic outline of DMS  footprinting. Cells (not drawn) are treated with dimethyl-sulphate
(DMS). This results in the methylation (M) of guanosine residues on the DNA. The presence of a protein bound
(B) changes the DNA reactivity to DMS, compared to the same region with no factor bound (A). Genomic DNA
is then isolated from the cells and heated in the presence of piperidine; this produces single strand breaks where
the nucleotides have been methylated. Ligation-mediated (LM)-PCR is subsequently used to amplify and label the
target genomic region. The products are then separated for visualisation on a denaturing acrylamide gel where each
band corresponds to a methylated guanosine of the analysed sequence. In this example the loss of bands in (B)
reflects protection from methylation by a protein bound to that DNA region.
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To map the location of these lesions, the DNA region of interest is amplified and labelled
using ligation-mediated (LM)-PCR in order to obtain a sufficient amount of material for
visualisation on a denaturing acrylamide gel. By comparing the position and frequency of DNA
modifications carried out in different cell types, it is possible to obtain a map of the elements
bound by proteins in a particular cell. The analysis of a footprinted sequence can give
information on the identity of the protein directly binding to that region by comparison with
known consensus elements.
DMS in vivo footprinting experiments were carried out on ES cells and on NIH-3T3
fibroblasts, which were used as a negative control. Figure 3.2a shows the DMS in vivo
footprinting results obtained using a set of primers that covers an area of the 5-VpreB1 locus
from -2406bp to approximately -2270bp, relative to the 5 transcription start site (TSS). This
region, of around 140bp, corresponds to the 5′ end of the ETCM. The cleavage pattern obtained
from the fibroblasts is similar to the pattern obtained for DMS-treated genomic DNA, which
was used as a reference sequence. This result confirms that no protein is binding to the analysed
region in 3T3 cells and it can therefore be used as a genuine negative control for the
identification of cell-specific footprints. The pattern of bands obtained from the DMS treatment
of ES cells revealed a protected region of around 15bp (from -2406 to -2391) (Figure 3.2a). The
nucleotide sequence corresponding to this region was analysed using P-Mach, a bioinformatics
software that compares user defined sequences with the TRANSFAC database of consensus
binding elements (Chekmenev et al., 2005). The bioinformatics analysis of the footprinted
sequence indicated that it corresponds to a binding site for SRY related (Sox) proteins
(thereafter called SoxA site) (Figure 3.2b).
A second experiment was performed using a set of primers covering the region between
-2286bp -2140bp, relative to 5 TSS, which is located in the middle of the ETCM. The pattern
of bands corresponding to this region showed that an area of around 40bp was protected from
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Figure 3.2 A Sox element within the  locus ETCM is occupied in ES cells. (A) DMS in vivo
footprinting on ES cells and on NIH-3T3 cells (3T3). DMS treated genomic DNA (G) was used as sequence
reference. In the magnified view of the gel open circles show the position of the footprinted nucleotides. Analysis
of the sequence of the protected region identified it as a Sox consensus binding site. (B) Map of the 5-VpreB1
locus and location of the ETCM; the sequence shows the region analysed in the experiment and the position of the
footprinted element. The number refers to nucleotides positions relative to 5 transcription start site. The figures
shows one representative film of two independent in vivo footprinting experiments.
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Figure 3.3 Sox and Fox elements within the  locus ETCM are occupied in ES cells. (A) DMS in
vivo footprinting on ES cells and on NIH-3T3 cells (3T3). DMS treated genomic DNA (G) was used as sequence
reference. In the magnified view of the gel open circles show the position of the footprinted nucleotides. Analysis
of the sequence of the protected regions identified them as a Sox and a Fox consensus binding sites. (B) Map of
the 5-VpreB1 locus and location of the ETCM; the sequence shows the region analysed in the experiment and the
positions of the footprinted elements. The numbers refers to nucleotides positions relative to 5 transcription start
site. The figures shows one representative film of two independent in vivo footprinting experiments.
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DMS methylation in ES cells, compared to the 3T3 fibroblasts (Figure 3.3a). Considering that
the average length of DNA binding elements is around 10-15bp, the size of the footprinted
region suggested that more than one factor binds to this region. P-Mach was again used for the
analysis of this protected sequence and indicated the presence of one Sox and one Fox
(Forkhead box) elements (SoxB and Fox sites) (Figure 3.3b). The presence of protected
nucleotide between the two sites raises the possibility that binding of Sox and Fox proteins to
their respective recognition sequences results the formation of a multimeric protein complex at
the ETCM.
These results suggest that at least three different DNA elements in the 5-VpreB1 ETCM
region are bound by transcription factors in ES cells. The Sox and Fox families contain a large
number of transcription factors and ES cells have been shown to express members of both
families. Sox2 is the main SRY-related protein expressed in ES cells and plays an essential role
in early development (Avilion et al., 2003). Along with Oct4 and Nanog, Sox2 is a major
regulator of gene transcription in ES cells, with the three factors forming a complex regulatory
network (Boyer et al., 2005). Sox2 is also one of the four factors that have been shown to be
able to reprogramme somatic cells into pluripotent precursors (Okita et al., 2007; Takahashi
and Yamanaka, 2006; Wernig et al., 2007). Sox15 is a second SRY-related protein expressed
in ES cells (Maruyama et al., 2005). Knock-out experiments showed that it is not essential
during embryogenesis and null mice do not show abnormalities. In embryonic stem cells Sox2
and Sox15 bind to different Sox sites, although they recognise the same binding element,
suggesting that they play a complementary transcriptional role in these cells (Maruyama et al.,
2005). More recently it has been shown that Sox15 can binds to Sox sites that were thought to
be Sox2 specific and, as a consequence, can maintain Sox activity even in the absence of Sox2
(Masui et al., 2007).
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Foxd3 is the only Forkhead box protein known to be expressed in ES cells. Knock-out
studies showed that it too plays a role in early development and ES cells maintenance (Hanna
et al., 2002). Foxd3 was first described as a transcription repressor using reporter assays (Sutton
et al., 1996) but a more recent study has shown that it can also function as an activator,
specifically for the expression of Nanog and Oct4, and that it creates a negative feedback loop
with these factors to maintain a steady expression on Foxd3, Nanog and Oct4 in pluripotent
cells (Pan et al., 2006).
3.2  Sox2 and Foxd3 bind to consensus sequences in the  locus
ETCM
DMS in vivo footprinting experiments show that a DNA region is bound by a protein, but
give no proof of its identity. Electrophoretic-mobility shift assays (EMSA) were therefore
performed to identify the ES cell proteins that bind to the footprinted sequences.
A radiolabelled probe, corresponding to the SoxA site, was incubated with nuclear extracts
from ES cells to analyse for the formation of DNA-protein complexes. As shown in Figure 3.4a,
one major complex is formed between this sequence and proteins from ES cells nuclear extracts.
To confirm that the complex forming on the probe reflects a genuine sequence specific
DNA-protein binding, a 100x molar excess of unlabelled wild-type probe or an unlabelled
probe containing mutations that disrupt the binding site, was added to the EMSA reaction. Only
the unlabelled wild-type probe was able to compete for the formation of the complex, thus
confirming its specificity.
Addition to the EMSA of an antibody that is specific for a particular factor alters the
mobility of complexes that contain that protein (supershift). This allows identifying a protein
bound to a specific DNA region. Antibodies against Sox2 or Sox15 were used to test whether
any of the SRY proteins that are known to be expressed in ES cells were present in this complex.
The addition of the anti-Sox2 antibody induced the formation of a lower-mobility complex,
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indicating that the antibody reacted with its target creating a higher molecular weight complex,
which run slower on the acrylamide gel. No changes in the band pattern were observed when
Figure 3.4 Binding of Sox2 to consensus site in the  locus ETCM. Electrophoretic-mobility shift
assays with probes for the SoxA site (A) or for the SoxB/Fox sites (B). White arrows indicate the position of the
complexes formed with ES cells nuclear extracts. Supershifted complexes (black arrows) were detectable when
the anti-Sox2 antibody was added to the reactions. No supershifts were observed when using an antibody that
recognise a different Sox family member (Sox15) or with non-specific IgG. Full competition was observed when
100x molar excess of unlabelled probe was added to the reaction, while no competition occurred when the same
molar excess of a mutated (mut.) probe was used, confirming the sequence specificity of the binding. The figure
shows representative gels of 3 independent experiments.
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the Sox15 specific antibody was added to the reaction, suggesting that Sox15 is not part of the
proteins forming the complex on the probe (Figure 3.4a).
A second EMSA experiment was performed to analyse the proteins binding to the additional
Sox and Fox consensus binding sites identified in the in vivo footprinting. Incubation of a probe
corresponding to this region with nuclear extract from ES cells gave three complexes (Figure
3.4b). The presence of multiples bands indicates that distinct complexes can bind the DNA
sequence, thus confirming that this element contains more than one recognition site.
Competition assays using excess unlabelled wild-type or mutated probes, confirmed that the
complexes forming with this probe are sequence specific. Antibody against Sox2, Sox15 and
Foxd3 were used to supershift the complexes to test the presence of these factors. The
SoxB/Fox element was supershifted when the anti-Sox2 antibody was added to the reaction,
while no changes in the complex mobility were observed when the anti-Sox15 antibody was
used. No differences either were observed when an antibody specific for Foxd3 was added to
the EMSA reaction.
3.3  Chromatin immunoprecipitation analysis confirms the binding of Sox2
and Foxd3 to the  locus ETCM in ES cells
To confirm the binding of Sox2 and to determine whether Foxd3 binds to the ETCM,
chromatin immunoprecipitation (ChIP) analysis of the 5-VpreB1 locus was performed in ES
cells. The ChIP protocol involves fixing the cells with formaldehyde in order to stabilise the
DNA-protein binding.  The fixed chromatin is then sheared by sonication into fragments of
200-1000 bps that are subsequently immunoprecipitated with antibodies specific for the protein
of interest.
The antibody bound fragments are then separated from the unbound fraction using
sepharose beads coated with proteins that specifically bind with immunoglobulins. The
recovered material is then heated to reverse the fixation and the DNA is purified. The amount
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Figure 3.5 Sox2 and Foxd3 bind the  locus on the ETCM region in ES cells. (A) Scheme of the
5-VpreB1 locus. Red lines show the positions of the primer sets used for the quantitative PCR. (B-C) qPCR
results of ChIP experiments using Sox2 (B) or Foxd3 (C) specific antibodies. Immunoprecipitation with normal
IgG was used as a control for the specificity of the pull-down. Results are express as fold enrichment over input
chromatin material. Error bars show the standard deviations of 3 independent ChIP experiments. * P<0,01 (paired
Student’s t-test; specific antibody vs. IgG).
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of recovered material for any specific region is proportional to the number of proteins initially
bound in the analysed cells population. The most common method to quantify the precipitated
material for a specific region is PCR, due to the simplicity and speed of the assay. The use of
real-time PCR systems (quantitative PCR or qPCR) allows direct quantification of the starting
material and detection of small differences between samples. The DNA immunoprecipitated
from ES cells with the different antibodies was quantified via qPCR using primer pairs covering
the entire 5-VpreB1 locus (Figure 3.5a). Immunoprecipitation with non-specific IgG was used
to confirm the specificity of the pull-down material on the different regions.
When ChIP analysis was carried out on ES cells using an antibody specific for Sox2,
significant enrichment for this factor was found only with primers for the ETCM region (Figure
3.5b). The levels that were detected in other regions of the locus were at, or close, to the
background levels obtained with IgG. The presence of non-specific immunoprecipitation can
be caused by a number of factors. These include greater accessibility of some chromatin regions
to immunoglobulin and crosslinking of neighbouring DNA regions induced by the fixation
process.
ChIP was also performed to determine whether Foxd3 binds to the ETCM. An antibody that
recognise Foxd3 showed significant enrichment specifically on the ETCM region of the
5-VpreB1 locus (Figure 3.5c). The results of the ChIP experiment provide evidence that Foxd3
is binding the ETCM in ES cells, even though no supershift was obtained in the EMSA (see
Section 3.2). The failure to see a supershift in the EMSA could be due to the many parameters
that need optimisation in the gel-shift/supershift assay, such as ionic strength, co-factors
presence, incubation time and temperature. If any of these conditions is sub-optimal the 3D
structure of a protein complex bound in vitro to a DNA can be altered, thus inhibiting the
binding of an antibody to its epitope and preventing the supershift of a DNA-protein complex.
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Due to the size of the shared fragment, which is between 200-1000bp, is not possible to
precisely determine the regions actually bound by Sox2 and Foxd3 using ChIP experiments.
The primer pairs used to analyse the ETCM region (ETCM 1, 2 and 3) cover an area of 1.4kb
with approximately 400bp gaps between them, therefore some fragments could have been
amplified by more than one primer pairs. Nevertheless, the DNA precipitated with the anti-
Sox2 antibody was amplified only with the the ETCM1 and ETCM2 primer pairs, indicating
that Sox2 preferentially binds the 5' end of the ETCM. The DNA precipitated with the
anti-Foxd3 antibody was amplified with all the three primer pairs covering the ETCM region
and also with the primer pair covering the HS7, which is located approximately 500bp
downstream of the ETCM. This result indicate that multiple Foxd3 binding sites could be
present within the ETCM region and possibly downstream of it.
3.4  The ETCM Sox and Fox sites have opposite effects on transcription in
ES cells
Previous results have shown that the ETCM of the 5-VpreB1 locus has enhancer activity
in pre-B cells (Minaee et al., 2005) and in ES cells (Szutorisz et al., 2006). To investigate if the
identified Sox and Fox sites have any involvement in this effect of the ETCM in ES cells, a
reporter assay was carried out using a construct in which the ETCM region was placed upstream
from the 5 promoter linked to a promoterless human -globin gene (Szutorisz et al., 2006).
To study the effects of the SoxA, SoxB and Fox sites on the enhancer activity in ES cells,
these sites were individually mutated to prevent Sox2 or Foxd3 binding. The effectiveness of
the mutations was tested in EMSAs using DNA probes that contained these modifications to
compete for complex formation using nuclear extracts from ES cells. The formation of
complexes with the SoxA and SoxB-Fox was unaffected by the presence of  100-fold excess of
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the mutated probes (Figure 3.4). These results confirmed that the mutations inserted in the
sequences prevent the formation of functional complexes.
The different reporter constructs were transfected into ES cells to test the transcriptional
effects of the wild-type or mutated ETCM on transcription. A vector expressing the Green
fluorescent protein (GFP) was co-transfected along with the reporters. The percentage of GFP
positive cells was measured by FACS 48 hours after transfection and was used to correct for
transfection efficiency. Total RNA was extracted from the transfected cells and the levels of
reporter gene RNA were measured using RT-qPCR. The results showed that the presence of the
ETCM induced a five fold expression increase in transcription, confirming the enhancer
activity of this element in ES cells (Figure 3.6b). The loss of either of the Sox sites decreases
the reporter expression and, in particular, the mutation of the SoxB site reduces the transcription
to basal levels. The mutation of both Sox sites not only abolishes the enhancer function of the
ETCM but also repress the reporter expression below its basal levels. The effect of mutating
Figure 3.6 The Sox and Fox sites of the ETCM have opposite effect on transcription. (A) Scheme of the
reporter genes used in the assay. (B) b-globin transcript levels after transfection with the indicated constructs.
Transcripts levels were analysed using RT-qPCR. The values were calculated as ratios relative to the expression
levels of the ubiquitinously expressed MLN-51 gene, which was used as an internal control (Szutorisz et al.,
2005a). The results have been further normalised for the differences in transfection efficiency (percentage of eGFP
positive cells) and are expressed as fold relative to the expression levels of the construct L5-G, which was arbitrary
set to 1. Error bars show the standard deviations of 3 independent experiments.
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both of the Sox sites suggests that they play a synergic role in the enhancer effect of the ETCM
in ES cells.
When the Fox site was mutated, the result that was observed was the opposite to the effects
of mutating the Sox sites. The loss of the Fox site caused an increase in the transcription of the
reporter (Figure 3.6b), an observation in accordance with the reported repressive function of
Foxd3 (Sutton et al., 1996). This result also supports the conclusion that Foxd3 is bound to the
5-VpreB1 locus ETCM on the Fox site, as shown by the ChIP data.
It has been previously shown that intergenic transcript are originated within the ETCM
(Szutorisz et al., 2005a; Szutorisz et al., 2006). In addition, the 5 promoter drives transcription
from multiple sites (see Section 1.4.1). As a consequence, multiple transcription start sites are
activated from the reporter but none is able to drive productive transcription of the gene
(Szutorisz et al., 2006). The results obtained from the mutation of the Sox and Fox sites within
the ETCM suggest that Sox2 sustain transcription controlled by this element, while Foxd3
counterbalance the enhancer function.
3.5  Summary
In vivo footprinting was used to identify the sequences within the 5-VpreB1 ETCM
occupied by transcription factors in ES cells. The advantage of such an approach is that it allows
DNA-protein interactions to be studied in vivo without the use of antibodies and therefore
without the need to pre-select candidate proteins. This make the system less biased, compared
for example to ChIP, and also make it possible to investigate the interactions between
transcription factors and DNA in more detail, since it gives information at single nucleotide
resolution.
The results from the in vivo footprinting experiments provided positive support for the
hypothesis that the ETCM is established by sequence-specific factors by showing that specific
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DNA sequences within the region are occupied by proteins in ES cells. Two distinct elements
were identified. Factor binding to the most 5′ element, relative to the 5 promoter, creates a
footprint of approximately 15bp and bioinformatic comparison with known consensus binding
sites indicated that that sequence is a recognition site for proteins of the Sox family of
transcription factors (SoxA site). The second footprinted region is approximately 40bp long and
is located 65bp downstream of SoxA. Bioinformatic analysis of the 3′ element showed that it
contains two consensus sequences. One of these was another Sox site (SoxB) and the other was
a binding site for Forkhead proteins (Fox site). The presence of distinct binding sites located
close together raises the possibility of physical interaction between the complexes recruited to
the ETCM by these elements, which could play a role in the establishment of the epigenetic
mark. The in vivo  footprinting  results  support  this  hypothesis,  since  the  3′  element  is
characterised by a continuous footprint that covers both the SoxB and Fox sites, suggesting that
the protection is caused by a complex that interacts with both binding sites.
Sox2 and Sox15 are the main Sox proteins expressed in ES cells, while Foxd3 is the only
Fox member known to be expressed in these cells. EMSA and ChIP experiments were used to
demonstrate that only Sox2 is able to bind to the ETCM on the SoxA and SoxB sites. ChIP
analysis also showed that Foxd3 binds to the ETCM. The identification of specific transcription
factors that interact with the footprinted sites indicates that these could be indeed functional
sites. Since the 5-VpreB1 ETCM has enhancer activity in ES cells (Szutorisz et al., 2006), the
identified Sox and Fox sites were mutated in reporter assays to test whether they are functional.
The results obtained from the reporter experiments confirmed that the three sites regulate the
enhancer activity of the ETCM in ES cells and, in particular, that the Sox elements are positive
regulator of transcription, while the Fox binding site is a repressive element. The results
obtained from the reporter assays further support the idea that the two footprinted regions
cooperate, since the mutation of both Sox sites completely abolishes the reporter activity,
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suggesting that they have a synergic function. When these results are considered together with
the footprinting data, which suggest the formation of a single multimeric complex interacting
on the SoxB/Fox element, it can be inferred that all three of the identified sites act together to
regulate the ETCM enhancer activity in ES cells. The repressive function of the Fox site
suggests that Foxd3 negatively modulate the transcriptional activity of Sox2. The presence of
an activator and a repressor mimic bivalent domains, where positive and negative epigenetic
signals are simultaneously present. At bivalent regions PRCs alter the chromatin environment
to repress transcription, whereas on the 5-VpreB1 ETCM, where no histone modifications
linked to silencing have been found, transcription is repressed by Foxd3 without the
introduction of any negative epigenetic signals.
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4  Sox2 and Foxd3 bind to epigenetically marked regions at a
number of tissue-specific genes in ES cells
The results described in Chapter 3 show that Sox2 and Foxd3 bind the ETCM region of the
5-VpreB1 locus in ES cells. In order to determine whether this combination of active histone
modifications and Sox2 and Foxd3 binding is present at other genes, a ChIP-on-chip assay was
carried out to analyse factor binding and histone modification profile at 210 gene loci. Sox2 has
also been proposed to be involved in the regulation of bivalent domains (Bernstein et al., 2006)
although its binding to these regions was not proven experimentally. Therefore, known bivalent
domain marked genes were included in the array to test this hypothesis and to determine
whether Foxd3 is also involved in regulating bivalent domains.
The analysis was carried out using a custom tiling array generated by NimbleGen Systems.
The array covered a total area of 20Mbp of genomic DNA and was composed of 50mer
oligonucleotide probes. The genomic sequences covered by the probes were spaced by 100bp
long gaps. To avoid ambiguous hybridisations, repetitive DNA elements were excluded from
the design. Each probe was represented in duplicate to control for non-specific hybridisation
and to allow normalisation of the enrichment levels. Each selected locus contained one or more
genes, not known to be expressed in ES cells. For most of the analysed loci, the probes covered
a region that extent from to -20kb to +10kb relative to the transcription start site (TSS) of the
target gene.  Recently a detailed characterisation of the transcriptional status of more than
13000 genes in ES cells was published (Mikkelsen et al., 2007). Most of the genes included in
our array are present in this dataset and this was used to confirm that they are silent in ES cells.
Based on data available on public databases (NCBI-Entrez Gene and Jackson Laboratory-
Mouse Genome Informatics) the expression of most of the selected genes was found to be
tissue-specific or tissue-restricted; in addition, the selected genes are distributed across all
mouse chromosomes (Figure 4.1).
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4.1  The majority of tissue-specific genes are epigenetically marked in ES
cells
The main characteristic of the 5-VpreB1 locus Early-Transcription Competence Mark is a
localised peak of histone H3K4me2 (Szutorisz et al., 2005a). This was therefore used as the
major criteria to identify regions with ETCM-like properties. Bivalent domains are instead
characterised by co-localisation of H3K4 methylation (both di- and tri-) and H3K27me3 peaks
(Azuara et al., 2006; Bernstein et al., 2006). DNA immunoprecipitated with antibody against
H3K4me2 or H3K27me3 was therefore used to search for ETCMs and bivalent domains within
the gene loci included in the array. The DNA was amplified using the Whole Genome
Amplification kit (Sigma-Aldrich) in order to have sufficient material for hybridization. This
method was chosen since it has been shown to linearly amplify DNA with reduced bias and
lower signal to noise ratio compared to conventional ligation-mediated PCR, the alternative
amplification system (O'Geen et al., 2006).
Figure 4.1 Distribution and specificity of the gene loci included in the ChIP-on-chip array. Distribution of
the loci included in the ChIP-on-chip array according to their tissue-specificity across the mouse genome.
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The analysis of the pattern of enrichment of H3K4me2 and H3K27me3 on the selected
genes indicated the presence of different classes of epigenetic signatures. Enrichment peaks for
these modification were detected using the SignalMap software from NimbleGen Systems.
Bivalent domains were characterised by overlapping peaking regions of both histone
modification; an example of gene marked by a bivalent domain is BDNF (Brain-derived
neurothophic factor), a neurotrophin expressed in the central nervous system. In ES cells its
promoter region, TSS and 5′ end were found marked by both H3K4 and H3K27 methylation
(Figure 4.2a). The localisation of the bivalent domain around these element is typical of most
bivalent domain, as previously reported (Azuara et al., 2006; Bernstein et al., 2006).
CD86 is a B lymphocyte-specific gene, expressed from the early stages of B cell
differentiation. Figure 4.2b shows the profile of the two histone modifications around its
genomic region in ES cells. No H3K27 signal was detectable on any analysed region, while two
distinct peaks of H3K4me2 were found. One of the marked region is located at -7kb from the
TSS and is 3kb long; the second mark is intragenic, located in a introns and extend for around
4kb. Compared to bivalent domains the location of ETCMs is more variable, being present
upstream or downstream to the TSSs of the linked genes at different distances; none of the
analysed genes showed ETCM-like peaks at the TSS.
Some genes were found marked both by a bivalent domain and an ETCM, like St8sia1 (ST8
alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase-1), a gene highly expressed in the
brain, particularly in glial cells. The histone modification profile (Figure 4.2c) showed the
presence of  the bivalent domain around  the TSS, with  the highest peak at  the 5′ of  the first
introns; the ETCM was found 15kb upstream of the gene and extended for 2kb. The presence
of more than one type of signatures suggest that more than one pathway could be involved in
marking these genes. A possible consequence of this more complex regulation is that these
genes may require multiple signals to activate their expression.
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Figure 4.2 Examples of genes marked with different epigenetic signatures in ES cells. Log2 ratio profiles
(IP/Input) of DNA immunoprecipitated with antibodies specific for H3K4me2 (red) or H3K27me3 (blue).
Magenta lines highlight the location of bivalent domains, cyan of ETCMs and green of H3K27me3 alone. Arrows
show the position of the TSS and the direction of transcription. (A) Gene marked by a bivalent domain around its
TSS. (B) Gene marked by two distinct ETCMs, one upstream of the TSS and one intronic. (C) Gene marked by a
bivalent domain at its 5′ end and by an ETCM upstream of the TSS. (D) Gene marked by H3K27me3 alone. (E)
Gene not presenting any of the analysed histone modification.
p63, a transcription factor of the p53 family involved in epithelial differentiation, presented
only a mark for H3K27me3 within the first introns (Figure 4.2d), suggesting that it was actively
silenced but it was not been poised for later activation, since it lacked the H3K4 methylation
mark that characterise bivalent domains. The gene encoding for the skeletal muscle receptor
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tyrosine kinase (Musk) is an example of the genes found not marked by any of the analysed
histone modifications (Figure 4.2e).
Figure 4.3 summarise the results obtained for all of the 210 analysed loci, according to the
different type of epigenetic signatures found. Bivalent domains characterise the majority of the
analysed genes, with approximately 59% of the loci marked by this signature. A histone
modification profile similar to the 5-VpreB1 locus ETCM was found on 30 loci (14,3% of the
sample), corresponding to 33 genes. Approximately 20% of the gene loci did have any of the
analysed histone modifications. A total of nine gene loci (4,3% of the total) had both bivalent
domains and ETCMs, while only few genes were marked by H3K27 methylation alone. Almost
20% of the analysed genes showed no enrichment for any of the histone modifications that were
measured in this analysis.
In order to determine whether the different marks reflected functional differences, the genes
were catalogued in clusters using the NIAID-NIH David Bioinformatics Database web-based
software (Dennis et al., 2003) (Table 4.1). Transcriptional regulators are the largest functional
group, representing almost 37% of the analysed genes. Additional clusters include signal
transducers (22,7%) enzymes (14,8%) and structural molecules (5,9%). When the analysis was
Figure 4.3 Most tissue-specific genes
are epigenetically marked in ES cells.
Percentage of genes marked in
embryonic stem cells with the different
epigenetic signatures.
Bivalent domains: colocalised peaks of
H3K4me2 and H3K27me3.
ETCMs: peak of H3K4me2.
Bivalent + ETCM: loci marked by both
bivalent regions and ETCMs.
H3K27me: peaks of H3K27me3.
No marks: loci not marked by any of
the histone modification analysed.
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performed only on the genes marked by bivalent domains, transcription regulators became the
absolute majority of the genes (50,9% of the population), while all the other categories were
underrepresented. Since many of these transcription factors have a developmental function,
these results are in accordance with published data reporting that bivalent domains are involved
in regulating genes that have a role in controlling differentiation programs.
The opposite results was obtained when the analysis was restricted to the ETCM marked
genes. Only 22,4% of the genes in this group are transcription regulators but no category
become predominant, although the percentage of signal transducer (27,3%) and enzymes
(18,2%) is increased compared to the total sample. Interestingly no genes with structural
function has an ETCM-like mark, but this could be explained by the relatively small number of
genes that were analysed in this category. The fact that no functional cluster is predominant
between the ETCM marked genes could mean that it is a general marker of regulatory elements
of tissue-restricted genes with a variety of different functions.
Among the genes that did not show any of the analysed histone marks, transcriptional
regulators were under-represented (12,2%). Within the unmarked genes there was a significant
increase of signal transducers (34,1%), enzymes (24,4%) and structural molecules (7,3%). No
clustering was possible for the loci marked by both bivalent domains and ETCMs or for the
genes marked by K27 trimethylation alone, due to the small number of genes present in these
groups.
Transcription regulators 75 - 38,5% 59 - 50,9% 8 - 24,2% 5 - 12,5%
Signal transducers 46 - 22,7% 20 - 17,2% 9 - 27,3% 14 - 34,1%
Enzyme 30 - 14,8% 10 - 8,6% 6 - 18,2% 10 - 24,4%
Structural molecules 12 - 5,9% 7 - 6,0% 0 3 - 7,3%
Genes with different functions show preferential epigenetic marks in ES cells. Number of genes with different
functional annotation divided according to their epigenetic profile. The percentage is calculated relative to the total
number of genes included in each epigenetic category.
Table 4.1
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4.2  RNA polymerase II binds to ETCM elements in ES cells
Binding of RNA polymerase II (PolII) is another feature that characterise the 5-VpreB1
locus ETCM (Szutorisz et al., 2005a). Recently it was shown that associated to some bivalent
domains there is a particular form of PolII, the serine-5 phosphorylated (Stock et al., 2007),
which is normally associated with inducible promoters prior their activation (Boehm et al.,
2003; Espinosa et al., 2003; Spilianakis et al., 2003).
The antibody used in the present study to immunoprecipitate chromatin bound to PolII
(Covance clone 8WG16) was not previously tested for its phospho-specificity and was recently
found to recognise with low efficiency phosphorylated PolII (Stock et al., 2007). The ChIP-on-
Chip results obtained with this antibody showed that PolII is significantly enriched at more that
a third of the identified ETCMs (Table 4.2). The others ETCM-marked elements could be
bound by specific form of PolII, not detected by the antibody used here, or there could be a
genuine distinction between PolII-bound or unbound ETCMs. Since the presence of PolII at the
5-VpreB1 ETCM is associated to intergenic transcription (Szutorisz et al., 2005a), a possible
difference could be the expression of non-coding transcripts at specific loci.
Less than one in ten bivalent regions were found associated with PolII, while none of the
unmarked genes were enriched for this enzyme (Table 4.2). As mentioned above the presence
of specific post-translational modification could have affected the affinity of the antibody,
therefore reducing the chromatin pull-down at some loci marked by bivalent domain.
Since several regions marked by either ETCMs or bivalent domains were found enriched
for PolII, it raise the possibility that the different phosphorylation states at different loci could
Bivalent domain 11/123
ETCM 11/30
H3K27me3 0
Unmarked 0
Association of PolII to marked regions in ES cells. Number
of loci bound by PolII in the different epigenetic categories.
Most of the bivalent domains do not present this protein in the
marked region, while it is bound to several ETCMs. Region
characterised by other histone modification profiles were never
found to be bound by PolII.
Table 4.2
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be the consequence of specific signals or the presence of factors that induce PolII
phosphorylation.
4.3  ETCMs and bivalent domains can be bound by Sox2 and Foxd3
In addition to the histone modification profiles of the selected gene loci, the location of
Sox2 and Foxd3 binding was analysed and compared with the position of the different
epigenetic marks. DNA precipitated with antibodies specific for Sox2 and Foxd3 was treated
as described above (section 4.1) and enriched peak were identified using SignalMap.
Pax5 (Paired box gene-5), a gene expressed in the B lineage, presents in ES cells around
its TSS a bivalent domain bound by Sox2, Foxd3 and PolII. This particular bivalent domain is
characterised by a large genomic area marked by H3K27me3 with a narrower peak of H3K4
methylation, which correspond to the element bound by the analysed transcription factors
(Figure 4.4a). An example of colocalisation between an ETCM and Sox2, Foxd3 and PolII is
the Ptms (Parathymosin)-Lag3 (Lymphocyte-activation gene-3) locus. Ptms is expressed in
different adult tissues, while Lag3 is only expressed in activated natural killer and T cells. The
histone modification profile in ES cells showed different peaks of H3K4me2; the H3K4
methylation peak upstream of Ptms TSS is bound by all of the three analysed transcription
factors (Figure 4.4b). Blimp1 (B-lymphocyte-induced maturation protein 1) is a transcription
regulator expressed in primordial germ cells, during plasmacells maturation and in the late
stages of T cell differentiation. The epigenetic analysis in ES cells showed that it is marked by
a bivalent domain around the TSS and by an upstream ETCM. The Blimp1 ETCM is also
characterised by binding of Sox2, while no enrichment was found for Foxd3 of PolII (Figure
4.4c).
Table 4.3 shows the distribution of all of the Sox2 and Foxd3 peaks that were detected in
the analysis. A total of 38 elements, with the characteristic of either bivalent domain or ETCM
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colocalised with a Sox2 peak, whereas no region in any of the unmarked genes showed any
enrichment for transcription factor. Interestingly, approximately 20% of the total number of
loci in each of epigenetic categories is bound by Sox2. Foxd3 showed significant peaks on
fewer elements compared to Sox2 and, similarly to Sox2, no binding of this factor was observed
on regions that did not have histone modifications. Foxd3 also did not showed a preference for
Figure 4.4 Examples of transcription factor binding to loci marked by different epigenetic marks. Log2 ratio
profiles (IP/Input) of DNA immunoprecipitated with antibodies specific for H3K4me2 (red), H3K27
trimethylation (blue), RNA polymerase II (green), Sox2 (purple) or Foxd3 (brown). Magenta and cyan lines
highlight the location of bivalent domains or ETCMs respectively. Horizontal arrows show the direction of
transcription. Orange arrows show the position of the transcription factor peaks. Some genes have been found to
be bound by all three transcription factors on elements characterised by bivalent domains (A) or ETCMs (B). (C)
Gene marked by a bivalent domain and an ETCM. A Sox2 peak characterise the ETCM of this locus.
Bivalent 28/123 (22.8%) 18/123 (14.6%)
ETCM 7/30 (23.3%) 4/30 (13.3%)
Bivalent + ETCM 2/9 (22.2%) 0
H3K27me3 1/7 (14.3%) 1/7 (14.3%)
Unmarked 0 0
Sox2 and Foxd3 colocalise to all types of
epigenetic marks. Number of loci bound by
Sox2 or Foxd3 in each category. The lower
number of loci showing both bivalent domains
and ETCMs or being marked by H3K27me3
alone means that is not possible to say whether
the apparent reduction in binding frequency of
Sox2 and Foxd3 to these loci is significant
Table 4.3
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a particular epigenetic mark, being present on approximately 15% of the genes in each group.
These results suggest that Sox2 and Foxd3 are indeed involved in the regulation and function
of bivalent domains and ETCMs. Since Sox2 and Foxd3 are bound to all types of epigenetic
mark it suggest that their presence is gene specific. This would imply that it is the recognition
sequences located at specific regulatory elements (promoter and enhancer) that are the main
elements determining the recruitment of these transcription factors. The fact that many
elements have been found  not bound by either of these factors, indicates that other ES cells
factors are also involved in the formation of epigenetic marks.
One of the questions that the ChIP-on-chip experiment was designed to answer was
whether Sox2 and Foxd3 colocalise on ETCMs and eventually on bivalent domains (Figure 4.5).
Of the marked loci that were analysed, 15 out of 170 showed peaks of both Sox2 and Foxd3.
Most of the Foxd3 bound elements are also bound by Sox2 and, in particular, all of the ETCMs
that have Foxd3 peaks are bound by Sox2. Since the Sox2 bound elements outnumber the
Foxd3 ones, most of the Sox2 peaks within bivalent domains did not bind Foxd3, while more
Figure 4.5 Colocalisation profile of Sox2, Foxd3 and PolII on bivalent domains and ETCMs. Number of gene
loci marked by bivalent domains (A) or ETCMs (B) that show binding of Sox2, Foxd3 and PolII.
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than half of the ETCMs bound by Sox2 also have Foxd3. The analysis of the colocalisation of
PolII with Sox2 and Foxd3 showed that most of the PolII bound bivalent domains also show
peaks for Sox2 or Foxd3, while the opposite was observed on ETCMs with peaks for PolII.
Among the identified loci marked by both ETCMs and bivalent domains only two showed
binding for Sox2, while no element was found to be enriched for Foxd3. As mentioned above,
none of these loci showed any enrichment for PolII, although the limitations of the antibody
used in this study to detect PolII mean that different isoforms of this enzyme may be present at
these elements but were not detected by this analysis.
4.4  Summary
A ChIP-on-Chip array was used to investigate whether Sox2 and Foxd3 binding correlate
with epigenetic marks at other tissue-specific genes. A total of 210 gene loci were selected for
the analysis, each containing one or more genes that are not expressed in ES cells. The levels
of histone H3K4me2 and histone H3K27me3 were analysed along with the binding of Sox2 and
Foxd3, to locate the bivalent domains and potential ETCMs within the selected gene loci. Most
of the analysed genomic regions showed at least one epigenetic mark. Among the marked genes
the largest group was characterised by bivalent domains, demonstrating that this mark is
widespread at tissue-specific genes in ES cells. Clustering analysis according to gene function
showed that most of the genes that are marked by bivalent domains are transcription factors, as
previously reported (Azuara et al., 2006; Bernstein et al., 2006). An ETCM-like histone
modification profile was found on fewer genes, compared to bivalent domains. Clustering
analysis showed that ETCMs mark genes of any functional group, without the preference
showed by bivalent domains. Moreover ETCMs characterise gene that are expressed in
different tissues. Thus this type of mark is not a specific feature of any class of genes. A small
number of genes were marked by H3K27me3 alone, suggesting that these genes are actively
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repressed in ES cells, but are not poised for activation. Around 20% of the analysed genes did
not present any of the epigenetic marks that were analysed in this study. These genes could
indeed lack any epigenetic signature or, alternatively, they might be marked by other histone
modifications. If the first scenario is the correct one, it raises the question of why some genes
need additional level of regulation to control for their transcriptional potential, while others
have a simple on/off state. The lack of methylated histones could also be caused by the activity
of histone demethylases specifically recruited to these genomic regions.
An interestingly difference between bivalent domains and ETCMs is their location relative
to genes. While bivalent domains are present mostly around promoters and at  the 5′ end of
genes, ETCMs are located mostly upstream of the linked gene or within intronic regions. The
location of ETCMs suggests that, similar to the 5-VpreB1 ETCM, the marked regions could
be distal regulatory elements (e.g. tissue-specific enhancers). The presence of the bivalent mark
at promoters supports the hypothesis that one of its main functions is to prevent unregulated
gene transcription. Since most of the genes marked by bivalent domains are transcription
factors, spurious transcription from these genes would compromise ES cell homeostasis,
affecting self-renewal and pluripotency. Interestingly, a number of gene loci were characterised
by a bivalent domain, around the 5′ end of the gene, and an ETCM on a distal element. This
type of configuration suggests than an additional level of regulation might be necessary for the
poising of these genes.
Once the histone modification profile of the selected genes was known, the location of
bivalent domains and ETCMs was analysed in relation to peaks of Sox2 and Foxd3 binding.
Both transcription factors were found to bind at a number of bivalent domains and ETCMs.
Therefore neither of these two factors has a specific correlation with a particular epigenetic
signature. Sox2 and Foxd3 do not always colocalise on marked elements as they do on the
5-VpreB1 ETCM, so it is clear that they can function independently of each other. Most
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regulatory elements are formed by a combination of a number of factor binding sites. Studies
on the interferon-  enhancer have shown that the presence and binding of all of the interacting
partners is necessary for the correct activity of a regulatory element (Thanos and Maniatis,
1995). It is therefore likely that, where not present together, Sox2 and Foxd3 cooperate with
other transcription factors at the element where histone marks have to be introduced. Oct4 and
Nanog are two major candidate for a role in epigenetic marking in ES cells and for interaction
with Sox2, since it is known that Sox2 co-localises in human ES cells with Oct4 and/or Nanog
on several non-expressed genes (Boyer et al., 2005). Since neither Sox2 nor Foxd3 are present
on all of the epigenetic marks that were identified in this study, they are not the only factors that
are involved in establishing the active histone modifications that characterise ETCMs and
bivalent domains. Ultimately, analysis of the binding sites occupancy within each individual
marked element will be required to determine which transcription factors are important for
establishing the epigenetic profile of a specific gene.
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5  Involvement of Sox2 in establishing epigenetic marks at
tissue-specific genes in ES cells
The experiments described in the previous chapters demonstrate an association between
binding of two transcription factors expressed in ES cells, Sox2 and Foxd3, and histone
modifications that characterise epigenetic marks on regulatory elements at many tissue-specific
genes. In particular, the ChIP-on-Chip data showed that Sox2 is bound to approximately 20%
of all of the sequences that showed peaks of enrichment for methylated histone H3K4 and
H3K27. One approach to investigating the function of a protein in a biological process is to
mutate its gene in order to abolish its expression, a technique called gene knock-out (Mansour
et al., 1988). However, knock-out mice have to be bred over several generations in order to
obtain homo- or heterozygous animals in a pure background. These animals can then be studied
to identify malfunctions and it is also possible to derive embryonic stem cells to be used in vitro.
Analysis of Sox2 knock-out mice showed that this transcription factor is essential during early
development with no progression over E7.5 and also that is not possible to establish Sox2 null
ES cells (Avilion et al., 2003).
An alternative method for studying the function of a protein uses specific double-stranded
RNA oligonucleotides (small interfering RNA - siRNA) to block the translation of a specific
gene in a process called RNA interference (RNAi) (Brummelkamp et al., 2002; Elbashir et al.,
2001). Since the effects are generally transients and protein production is not completely
blocked, this system is also known as gene knock-down. Because exogenous nucleotides can
be transfected relatively easily into many cell types, RNAi has become a widely used method
for investigating the function of proteins in cultured cells.
A siRNA specific for Sox2 was used to determine whether this protein plays a direct role in
establishing ETCMs and bivalent domains in ES cells. The analysis focused in particular on the
effects of Sox2 knock-down on the levels of histone modifications that form these epigenetic
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marks, H3K4me2 and H3K27me3. The latter modification is known to be generated, in the
context of bivalent domains, by polycomb repressive complexes (PRCs) and member of PRC2
were found directly bound to these elements (Azuara et al., 2006; Boyer et al., 2006). Therefore
the presence of Suz12, a polycomb factor, was analysed to investigate a possible link between
the binding of Sox2 and PRC2 recruitment.
5.1  Selection of an effective siRNA for Sox2 in ES cells
Many parameters influence the efficiency of RNA interference. This is consequence of the
events that follow the natural production or the transfection of a siRNA. At least four major
steps have to occur to induce knock-down. These are: 1) siRNA recognition by a multi-protein
complex called pre-RISC (RNA-induced silencing complex); 2) ATP-dependent RISC
activation; 3) target recognition and 4) target cleavage (Nykanen et al., 2001). Thus
thermodynamic and sequence-specific properties are crucial to the design of RNAs that form
functional duplexes, in addition to sequence comparison analyses to minimise off-target effects
(Jackson et al., 2003; Khvorova et al., 2003; Reynolds et al., 2004). Many web-based and
commercial tools are available to automatically design siRNA specific for the target mRNA.
Moreover several companies provide pre-designed oligonucleotides for specific proteins.
Because of the complexity of the RNA interference processes, it is necessary to test
multiple siRNAs to identify a duplex that gives the desired level of knock-down in the cells of
interest. A further parameter that was taken into consideration was the duration of the RNAi
effect. True epigenetic modifications are defined as hereditable through cell divisions.
Therefore it is desirable that the cell go through several cell cycles following knock-down of
the protein. The average duration of a cell cycle for embryonic stem cells is 16 hours, thus 72
hours (4 to 5 cell divisions) after siRNA transfection was chosen as a suitable time to test the
effects of Sox2 knock-down on the histone modifications of marked regions.
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Three pre-designed siRNAs (Applied Biosystems) were tested for significant and consistent
Sox2 knock-down over 3 days. To confirm the specificity of the siRNAs, parallel experiments
were performed using a mock siRNA or a GAPDH (Glyceraldehyde 3-phosphate
dehydrogenase) specific siRNA. The duplexes were transfected using a liposome based
Figure 5.1 Analysis of siRNA transfection efficiency. ES cells transfected with a green-fluorescent labelled
siRNA analysed 24 hours after transfection. Most of the cells show a positive green signals (B), confirming that
they have incorporated the RNA duplex.
Figure 5.2 Different Sox2-specific siRNAs have varying knock-down efficiencies. Western blotting analysis of
Sox2 and GAPDH expression at three time points after transfection. Sox2 siRNA-1 and -2 demonstrated a high
level of knock-down soon after transfection compared to Sox2 siRNA-3. Sox2 siRNA-2 showed the longest
interference effect and was therefore chosen for the subsequent experiments. Mock siRNA or GAPDH-specific
siRNA showed no effect on Sox2 expression levels at any of the analysed time points.
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approach. A green-fluorescent labelled siRNA was used to test for the transfection efficiency
and, as shown in Figure 5.1, after 24 hours most of the cells had incorporated the labelled
duplex, confirming that the conditions used give high transfection efficiency. The level of Sox2
knock-down was analysed at different time points via western blotting (Figure 5.2). Each
siRNA showed a specific kinetics and a different extent of knock-down. In particular, Sox2
siRNA-1 and -2 gave a quicker and more efficient knock-down than Sox2 siRNA-3. The
second Sox2 siRNA was chosen to be used in the subsequent experiments since it showed the
longest knock-down activity. Western blotting analysis of ES cells treated with mock or
GAPDH specific siRNAs confirmed the specificity of the knock-down by the Sox2 siRNAs.
Since Sox2 has a fundamental role in the biology of ES cells, its knock-down could
potentially compromise their viability or induce differentiation. Morphological analysis
Untreated 87,5 ±3,7 86,5 ±3,0
Mock siRNA 86,8 ±3,8 83,9 ±3,9
GAPDH siRNA 87,7 ±3,7 78,0 ±6,3
Sox2 siRNA 76,6 ±8,9 70,5 ±9,9
Sox2 siRNA does not induce ES cells
differentiation. Percentage of cells positive for
Oct4 or SSEA1, as measured by FACS, after 72
hours of treatment. Sox2 siRNA induces some cells
to loose the markers, although most of the cells are
still in an undifferentiated state.
Figure 5.3 Sox2 specific siRNA does not alter ES cells morphology or viability. Phase-contrast images of
untreated ES cells or ES cells transfected with mock or Sox2 specific siRNA at the indicated time points after
transfection. The treatment does not affect the morphology or the viability of the cells.
Table 5.1
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Figure 5.4 Effects of Sox2 siRNA on ES cell markers. FACS analysis of Oct4 and SSEA1 after 72 hours of
transfection with the indicated siRNA. Most of the cells treated with Sox2 siRNA were still positive for both
markers, with only a minimal reduction in the average signal intensity.
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showed no differences between cells treated with siRNAs (both Sox2 specific and control) and
untreated cells (Figure 5.3). FACS was used to analyse ES cell markers in more details to
confirm the morphological data. Two common markers of embryonic stem cells are the
transcription factor Oct4 and the surface molecule SSEA1 (stage-specific embryonic antigen-1)
(Figure 5.4). FACS analysis showed that after treatment with Sox2 siRNA the number of cells
positive for each marker is only slightly lower compared to untreated cells or cells that were
treated with mock or GAPDH specific siRNAs (Table 5.1). The main difference in the Sox2
siRNA treated cells is reduced average signal intensity for both markers (Figure 5.4). This was
expected since Sox2 directly control the expression of many ES cells genes, in particular Oct4
(Okumura-Nakanishi et al., 2005). The FACS data, in combination with the morphological
analysis, confirmed that, while Sox2 expression was reduced, most cells maintained ES
properties and did not differentiate during the time frame of the analysis. Therefore it can be
concluded that the epigenetic effects after Sox2 knock-down are due to the reduced abundance
of the protein, rather than a secondary effect caused by differentiation or cell death. The
maintenance of ES properties after Sox2 knock-down can be the consequence of the non-
absolute removal of the protein, intrinsic to the siRNA approach, particularly after several cell
divisions, when Sox2 can be again detected via western blotting (Figure 5.2).
5.2  Q2ChIP – quick and quantitative chromatin immunoprecipitation
assay
Traditional chromatin immunoprecipitation requires large amount of cells (around 108 per
immunoprecipitation) as starting material, due to extensive sample handling, which generates
significant loss of material. Obtaining this number of cells would have required a substantial
and costly scale-up of the siRNA experimental conditions. As a consequence alternative ChIP
approaches were investigated to allow the use of fewer cells.
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A recently described ChIP protocol suggests the theoretical possibility of performing
epigenetic analysis on as few as 100 cells (Dahl and Collas, 2007). This protocol uses 100ng of
crosslinked and sonicated chromatin as starting material, instead of the 500ng that is generally
used. The higher efficiency is mainly achieved by using paramagnetic beads in place of
sepharose coated beads. This reduces the loss of material during the different wash steps, since
paramagnetic beads are more compact and do not need a highly viscous suspension to
precipitate. Additional modifications proposed by Dahl and Collas include changing of the
Figure 5.5 Q2ChIP can be used as an alternative protocol to conventional ChIP. (A) Scheme of the 5-VpreB1
locus. Red lines show the regions analysed via quantitative PCR. (B) Enrichment over input levels of H3K4me2
across the 5-VpreB1 locus obtained with conventional ChIP protocol (black bars) or Q2ChIP (red bars). The
profile obtained with the two methods is overlapping, with one peak on the Topoisomerase III-beta promoter a
second enriched area over the ETCM region. Error bars show the standard deviations of 3 independent ChIP
experiments
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tubes after the last wash step, before the elution of the purified DNA. This should reduce the
background levels by eliminating the chromatin non-specifically bound to the tube plastic.
The improvements to the ChIP procedure suggested by Dahl and Collas were applied to the
standard protocol optimised for ES cells. To test its performance, the modified ChIP protocol
was used to analyse the histone modification profile of the 5-VpreB1 locus, starting from 107
ES cells and using 100ng of chromatin per immunoprecipitation. Optimisation of the protocol
to this level of efficiency would allow the standard transfection conditions to be used, without
the need for scaling-up.
Figure 5.5 shows that the profile of H3K4me2 across the locus obtained using the Q2ChIP
is overlapping to the profile of traditional ChIP, with a peak over the Topoisomerase III beta
promoter and a second peak in the intragenic region between 5 and VpreB1, which
corresponds to the ETCM. Based on these results, it was concluded that substituting the Q2ChIP
for the conventional ChIP protocol would allow a substantial reduction in number of cells
required as starting material.
5.3  Sox2 knock-down reduces the levels of H3K4me2 at tissue-specific
genes that binds Sox2 in ES cells
ES cells were cultured for 72 hours after transfection with mock or Sox2-specific siRNA,
along with untreated cells. The cells were crosslinked with formaldehyde, lysed and sonicated;
the sheared chromatin was then immunoprecipitated using the Q2ChIP protocol described
above. The level of Sox2 knock-down was tested in each experiment using western blotting and
the cells were checked via FACS for expression of Oct4 and SSEA1 and to asses their viability.
The immunoprecipitated DNA was analysed via qPCR on the 5-VpreB1 locus and on other
ETCMs or bivalent domains identified in the ChIP-on-Chip experiment (see Chapter 4).
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The histone modification profile of the 5-VpreB1 locus showed that after Sox2 knock-
down, methylation of H3K4 was significantly reduced only on the ETCM region of the locus,
where Sox2 is bound (Figure 5.6). The extent of the reduction was between 40 to 50% of the
original levels and the effect was specifically caused by the reduced expression of Sox2 since
the mock siRNA did not induce any changes to the H3K4me2 levels. None of the other regions
of the locus showed a change in the H3K4me2 enrichment levels, highlighting the link between
Sox2 and this epigenetic modification on the ETCM.
Figure 5.6 Sox2 knock-down reduces the levels of H3K4me2 on the  locus ETCM. (A) Scheme of
the 5-VpreB1 locus. Red lines show the regions analysed via quantitative PCR. (B) Enrichment over input of
H3K4me2 after 72 hours of transfection with mock or Sox2 specific siRNA. The interference of Sox2 induces a
reduction of methylation specifically over the ETCM region. All the other analysed regions of the locus were not
affected by the knock-down. Error bars show the standard deviations of 3 independent siRNA experiments
*P<0,01 (ANOVA).
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Figure 5.7 Sox2 knock-down reduces the levels of H3K4me2 on ETCMs and bivalent domains bound by
Sox2 in ES cells. The histograms show percentage of H3K4me2 enrichment, relative to untreated cells, 72 hours
after transfection with mock or Sox2 specific siRNA. Error bars show the standard deviations of 3 independent
siRNA experiments. *P<0,01 (ANOVA).
Figure 5.8 Sox2 knock-down does not change the levels of H3K4me2 on regions that are not bound by Sox2.
The histograms show percentage of H3K4me2 enrichment, relative to untreated cells, 72 hours after transfection
with mock or Sox2 specific siRNA. Error bars show the standard deviations of 3 independent siRNA experiments.
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The same analysis was performed on other randomly chosen loci that have ETCMs or
bivalent elements and were found to be enriched for Sox2. Similar to the ETCM of the
5-VpreB1 locus, all of these analysed elements showed a reduction of H3K4 methylation of
between 40 and 60% after Sox2 was knock-down. No significant changes were observed on the
samples treated with mock siRNA, confirming the specificity of the effect induced by Sox2
RNAi (Figure 5.7).
In order to ensure that the reduction in the levels of H3K4 methylation was a direct effect
of Sox2 knock-down, the enrichment of this histone modification was measured on other
marked regions that showed no evidence of Sox2 binding in the ChIP-on-Chip experiment. In
contrast to the elements bound by Sox2, no change in the levels of H3K4me2 was observed on
any of these regions (Figure 5.8), indicating a direct correlation between Sox2 binding and the
methylation of H3K4.
5.4  Sox2 knock-down has no effect on the binding of PRC2 or on
methylation of H3K27
In Drosophila PRCs are recruited to their target genes by binding to polycomb response
elements (PRE) (Chan et al., 1994; Simon et al., 1993). Recognition sites for mammalian PRCs
have not yet been identified and it has been suggested that the recruitment of PRCs to bivalent
regions might be secondary to the binding of other sequence-specific DNA-binding proteins
(Bernstein et al., 2006; Boyer et al., 2006). Sox2 is one of the proposed factors that could have
such a function, along with Oct4 and Nanog, since it binds in human ES cells several sites
(Boyer et al., 2005) that have been subsequently found to be occupied by PRCs (Boyer et al.,
2006) and marked by bivalent domains (Bernstein et al., 2006).
Suz12 is one of the non-catalytic subunits of PRC2 and it is responsible for the binding to
nucleosomes. Previous ChIP-on-Chip studies on ES cells have shown that Suz12 is bound to
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the regions marked by bivalent domains (Bernstein et al., 2006; Boyer et al., 2006).  To test
whether Sox2 has any involvement in the recruitment of this factor to bivalent domains, Suz12
enrichment was measured by Q2ChIP after 72 hours of Sox2 knock-down. No difference in the
level of Suz12 binding was detectable at bivalent domains bound by Sox2 (Figure 5.9a).
Bivalent domains that are not bound by Sox2, also showed too no difference in enrichment of
Suz12 after Sox2 RNAi (Figure 5.9b). These results indicate that Sox2 has no involvement in
PRC binding as previously suggested.
Figure 5.9 Sox2 knock-down has no effect on the binding of the PRC2 subunit Suz12. The histograms show
percentage of enrichment of Suz12, relative to untreated cells, 72 hours after transfection with mock or Sox2-
specific siRNA on bivalent domains that bind Sox2 (A) or not normally bound by Sox2 (B). Error bars show the
standard deviations of 3 independent siRNA experiments.
Figure 5.10 Sox2 knock-down has no effect on the levels of H3K27me3. The histograms show percentage of
enrichment of H3K27me3, relative to untreated cells, 72 hours after transfection with mock or Sox2 specific
siRNA on bivalent domains that bind Sox2 (A) or not normally bound by Sox2 (B). Error bars show the standard
deviations of 3 independent siRNA experiments.
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A further confirmation that Sox2 knock-down has no effect on PRC recruitment came from
the analysis of the H3K27me3 profile on bivalent domains. Similar to Suz12 binding, the levels
of this histone mark were unaltered on bivalent domains after Sox2 knock-down (Figure 5.10).
These results suggest that the histone modifications characterising bivalent domains are
controlled by two distinct pathways: the first would methylates H3K27 via polycomb, while the
second induces methylation of H3K4 via recruitment of histone methyltransferases by
sequence-specific transcription factors.
5.5  Summary
Epigenetic signatures, such as ETCMs and bivalent domains that are found at tissue-
specific genes in ES cells, have gained extensive attention in the past few years because of their
potential involvement in the control of developmental programs. Until now there was little
information on the factors responsible for the regulation of one of the key histone modification
that characterise these marks, H3K4 methylation. Knock-down of Sox2 by siRNA was used to
verify whether Sox2 is directly involved in establishing the histone modifications that
characterise ETCMs and bivalent domains and in recruiting the PRC2 complex to bivalent
marked regions. ChIP analysis of ES cells treated with this siRNA showed that the H3K4me2
mark is specifically reduced at the ETCMs and bivalent domains that were shown to be
occupied by Sox2 in the ChIP-on-Chip assay. The effect of Sox2 is direct and specific, since
the levels of histone modification were not altered at sites not bound by Sox2. The H3K4me2
was not completely lost after Sox2 knock-down; this could be due to the non-absolute removal
of Sox2, intrinsic to the siRNA approach, or can be explained by the cooperative activity of
other transcription factors, which bind to the marked element along with Sox2. This provides
further support for the idea that the cooperative activity of multiple transcription factors is
important for the efficient regulation of epigenetic marks. Of particular interest was the finding
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that, at bivalent domains, the loss of Sox2 does not affect binding of PRC2 subunits, which
explains why the levels of H3K27me3 were not altered. This suggests that the active and
repressive histone modifications could be established independently of each other at bivalent
domains. PRCs complexes are likely to be recruited to their target sites by still uncharacterised
mammalian polycomb response elements, located specifically at genes marked by bivalent
domains, or by factors other than Sox2 at the genes that were analysed in this study.
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6  Embryonic stem cell transcription factors are replaced by
tissue-specific factors during B cell differentiation
As shown in the previous chapters, ETCMs and bivalent domains are present in ES cells at
a number of elements that are involved in regulating of tissue-specific genes. Analysis of
elements within the 5-VpreB1 locus ETCM identified Sox2 and Foxd3 as proteins that interact
with the ETCM in ES cells. The same factors were shown to bind to other DNA regions in ES
cells that were linked to non-transcribed tissue-specific genes and showed enrichment for
activating histone modifications. Sox2 was also found to be involved in maintaining the
methylation of histone H3K4 that characterises these elements, while it is not involved in
recruiting members of the PRC2 complex or in generating histone H3K27 methylation.
To date there is no information on the function of ETCMs and bivalent domains in ES cells.
The general working hypothesis proposes that they are epigenetic signatures that act to maintain
an open chromatin structure on key regulatory elements, such as enhancers and promoters, thus
facilitating activation of the linked genes upon differentiation (Szutorisz and Dillon, 2005). At
the same time, PRC binding and the presence of H3K27me3, which characterise bivalent
domains, have been shown to impede spurious gene transcription of master regulator of
differentiation (Azuara et al., 2006; Bernstein et al., 2006).
To understand the relationship between the factors involved in the establishment and
maintenance of the epigenetic marks in ES cells and the function of these elements when the
linked genes are active, factor binding to the 5-VpreB1 locus ETCM region was analysed in
pro-B cells derived from foetal livers of RAG deficient mice, where these gene are transcribed.
ChIP-on-Chip analysis of factor binding in pro-B cells was also performed to identify more
general functions for these transcription factors.
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6.1  B lymphocyte specific Sox and Fox factors bind to the  locus
in pro-B cells
The region of the 5-VpreB1 locus that corresponds to the ETCM in ES cells, was already
known to be DNase I hypersensitive in an early pro-B cell model (BaF3 cells). These cells do
not express the two genes and lack the other HS sites that have been mapped in the locus in
pre-B cells (Minaee et al., 2005; Szutorisz et al., 2005a). In late pro-B cells and in pre-B cells,
when 5 and VpreB1 are transcribed, eleven HS sites have been characterised. HS7 and 8
correspond to the region marked by H3K4me2 in ES cells. The same region was shown to have
enhancer activity in pre-B cells (Minaee et al., 2005).
Since Sox2 and Foxd3 were found to be involved in the epigenetic marking of the
5-VpreB1 locus in early development, Sox and Fox factors that are known to have functional
effects in B lymphocyte were considered as potential candidate for involvement in regulating
5 and VpreB1 expression. Sox4 and Foxp1 are the only members of these families that are
known to be expressed in B lymphocyte. Interesting phenotypic similarities can be noted from
the mice that have null mutations in the genes encoding for these factors (Hu et al., 2006;
Schilham et al., 1996). Both mutations are embryonic lethal due to cardiac outflow defects.
Rescue of immunodeficient mice from these knock-outs by transplanting lymphocyte
precursors was also defective. In particular, the B lymphocyte progression was blocked at the
pro-B cell stage in both mutants. This is the developmental stage at which 5 and VpreB1 start
to be expressed. l5 and VpreB1 are the components of the surrogate light chains (SLC) that, by
association with IgH, form the pre-B cell receptor (pre-BCR). The pre-BCR is fundamental for
the expansion and further differentiation of pro/pre-B cells leading to the hypothesis that Sox4
and Foxp1 could have a role in the regulation of these genes. If Sox4 and Foxp1 are involved
in regulating 5 and VpreB1 expression, impaired transcription of these two genes can be one
of the mechanisms causing the block on B lymphocyte differentiation of the null mutant mice.
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6.1.1  Generation of a Sox4 specific antibody
No commercially available anti-Sox4 antibody has proven suitable for ChIP analysis.
Therefore a custom rabbit polyclonal antibody was ordered from Eurogentec. The N-terminal
sequence of Sox4 (MVQ QTN NAE NTE ALL) was selected for the rabbit immunisation since
it was the only amino acid sequence that showed high antigenic potential together with high
specificity. The serum collected from the rabbit after immunisation was analysed by western
blotting to verify the specificity of the antibody (Figure 6.1). Northern blotting analyses on
mouse tissues indicated that Sox4 is highly expressed in thymus and it is absent from adult brain
(van de Wetering et al., 1993). These two tissues were therefore used to test the specificity of
the antibody. Nuclear extracts from pro- or pre-B cells were also analysed to further confirm
the expression of Sox4 in these cells. The western blotting experiment confirmed the specificity
of the antibody by showing a band of the expected molecular size, 47kda, in extracts from
thymus, pro- and pre-B cells, while no band was detected in the brain extracts. In addition to
the predicted band, signals with lower molecular weights were detected. These bands could
correspond to different isoforms of the protein or to specific degradation products.
Figure 6.1 Western blotting analysis of Sox4 expression. Whole protein extracts from mouse thymus and brain
and nuclear cell extracts from pro- and pre-B cells were analysed using the anti-Sox4 antibody. Black arrow
indicates the major band which has the expected molecular weight of Sox4. White arrows show the additional
bands detected by the antibody.
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6.1.2  Sox4 and Foxp1 bind to the  locus
To investigate whether there is a link between Sox4, Foxp1 and the transcriptional
regulation of the 5-VpreB1 locus, ChIP analysis was carried out on RAG-deficient pro-B cells
using antibodies against Sox4 or Foxp1. High levels of enrichment for Sox4 were found at the
ETCM/HS7­8 region; an additional area of significant binding was observed at the 3′ end of the
locus, corresponding to HS1 and 2, which are part of the 5-VpreB1 LCR (Figure 6.2b). The
pattern of enrichment obtained using the custom anti-Sox4 antibody further confirmed its
specific reactivity.
The ChIP for Foxp1 showed that it is bound across the  entire 5-VpreB1 locus, with the
exception of the HS1-2 and the Topo3  promoter (Figure 6.2c). The lack of binding of both
factors on the Topo3   promoter, an ubiquitinously expressed gene, confirmed the specificity
of the binding to the other locus elements and further support the idea that Topo3 regulation
is distinct from 5 and VpreB1, even though the three genes are closely linked.
The presence of Sox4 and Foxp1 on the locus provided strong support for the hypothesis
that they are involved in the regulation of 5 and VpreB1. The different binding pattern of the
two transcription factors suggest that Foxp1 has a more broad function in the locus regulation,
whereas Sox4 has mainly an enhancer function. A potential role for Foxp1 could be to open the
chromatin structure across the whole locus, a function that has been reported for other Fox
proteins (Cirillo et al., 2002; Clark et al., 1993; Cuesta et al., 2007).
6.2  The Sox and Fox sites in the  locus ETCM are occupied in
pro-B cells
The fact that factors that belong to the same families as Sox2 and Foxd3 are present on the
5-VpreB1 locus in cell types that express these genes, raised the possibility that B cell factors
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Figure 6.2 Sox4 and Foxp1 bind to the  locus in pro-B cells. (A) Scheme of the 5-VpreB1 locus.
Red lines show the regions analysed by quantitative PCR. (B-C) qPCR results of chromatin immunoprecipitation
experiments using antibodies that recognise Sox4 (B) or Foxp1 (C). Immunoprecipitation with normal IgG was
used as a control for the specificity of the pull-down. Results are express as fold enrichment over input chromatin
material.* P<0,01 (paired Student’s t-test; specific antibody vs. IgG).
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could bind to the same elements as the ES cell factors. To test this hypothesis DMS in vivo
footprinting experiments were carried out in RAG-deficient pro-B cells using the ligation-
mediated (LM)-PCR primer sets that cover the SoxA and SoxB/Fox elements of the ETCM.
LM-PCR using the primer set covering the SoxA site was performed on DNA purified from
DMS-treated pro-B cells and NIH-3T3 fibroblasts, which were used as a negative control. The
band pattern obtained from this experiment demonstrated that the sequence that is bound in ES
cells (see Figure 3.2) also shows footprinting in pro-B cells (Figure 6.3). Since the ChIP
experiment indicated the Sox4 binds to the locus in pro-B cells, it is likely that this is the
transcription factor that binds to the SoxA element in these cells.
In vivo footprinting analysis was also carried out on the SoxB/Fox element in pro-B cells.
Similar to the SoxA site, this element also showed a specific footprint in pro-B cells (Figure 6.4),
suggesting that Sox4 and Foxp1  bind to the sequence. The relative intensity of the bands in the
SoxB/Fox element are different in ES cells compared to pro-B cells, highlighting differences in
the chromatin conformation. This could be due to steric differences between the DNA-protein
complexes, which can affect the reactivity of individual nucleotides to DMS treatment.
These results showed that elements that are bound in ES cells by factors involved in creating
epigenetic marks are also occupied in cells that express the genes linked to these regulatory
regions. This suggest that these DNA sequences could have a pivotal role, in the first steps of
the gene activation.
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Figure 6.3 The Sox  element within the  locus ETCM is occupied in pro-B cells. (A) DMS in vivo
footprinting of pro-B cells and on NIH-3T3 cells (3T3). DMS treated genomic DNA (G) was used as sequence
reference. In the magnified section open circles show the position of the footprinted nucleotides. The protected
nucleotides correspond to the SoxA site. (B) Scheme of the 5-VpreB1 locus and location of the ETCM; the
sequence shows the region analysed in the experiment and the position of the footprinted element. The numbers
refers to the nucleotides positions relative to 5 transcription start site.
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Figure 6.4 The Sox /Fox element within the  locus ETCM is occupied in pro-B cells. (A) DMS in
vivo footprinting of pro-B cells and on NIH-3T3 cells (3T3). DMS treated genomic DNA (G) was used as sequence
reference. In the magnified section open circles show the position of the footprinted nucleotides. The protected
nucleotides correspond to the SoxB and to the Fox site, (B) Scheme of the 5-VpreB1 locus and location of the
ETCM; the sequence shows the region analysed in the experiment and the position of the footprinted elements.
The numbers refers to the nucleotides positions relative to 5 transcription start site.
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6.3  Sox4 and Foxp1 bind to the ETCM Sox and Fox sites
Both the ChIP and the DMS in vivo footprinting results indicated that Sox4 and Foxp1 bind
to the 5-VpreB1 locus and that the SoxA and SoxB/Fox elements are occupied by proteins in
pro-B cells. Electrophoretic-mobility shift assay (EMSA) was used to confirm that the occupied
sites are able to bind Sox4 and Foxp1. The assay was carried out using the probes that were
previously used for studying the binding of Sox2 and Foxd3 in ES cells were used (see Figure
3.4).
Incubation of nuclear extracts from pro-B cells with the radiolabelled SoxA probe resulted
in the formation of one DNA-protein complex. The presence of Sox4 in this complex was
confirmed by supershifting of the band after addition of the anti-Sox4 antibody to the reaction.
The specificity of the formed complexes was also verified by competition with 100-fold molar
excess of either the cold probe or a competitor probe containing a different Sox binding site.
Both of these probes were able to bind Sox4, thus preventing formation of the complex with the
SoxA probe. No competition was observed when 100-fold excess of the mutated SoxA probe
was used, an additional proof of the specificity of the binding between the labelled probe and
Sox4 (Figure 6.5a).
EMSA experiments performed by incubation of the probe containing the SoxB/Fox element
with pro-B cell nuclear extracts gave of two complexes. Supershifted complexes were observed
when either anti-Sox4 or anti-Foxp1 antibodies were added to the reaction, confirming binding
of these factors to the element. Again, the binding specificity was confirmed by competition
with 100-fold excess of cold probe. When binding competition was also tested using 100-fold
excess of probes carrying mutation on the SoxB or Fox sites, only partial competition was
observed (Figure 6.5b). This result suggests that efficient interaction of the protein complexes
with the SoxB/Fox element requires both binding sites, with Sox4 and Foxp1 having to interact
directly or indirectly to form the complexes on this element.
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Figure 6.5 Sox4 and Foxp1 bind to sequences within the  locus ETCM. Electrophoretic-mobility
shift assays with probes for the SoxA site (A) or for the SoxB/Fox sites (B). White arrows indicate the position of
the complexes formed with pro-B cell nuclear extracts. (A) A single supershifted complex (black arrow) was
detected after the anti-Sox2 antibody was added to the reaction. Full competition was observed after 100x molar
excess of unlabelled or competitor probes were added to the reaction, while no competition occurs when using the
same molar excess of a mutated (mut.) probe, confirming the sequence specificity of the binding. (B) Anti-Sox4
and anti-Foxp1 antibodies causes a supershift of the complexes (black arrow). Competition reactions with 100x
molar excess of cold probe or cold probes carrying mutation in either the SoxB or FOX sites confirm the sequence
specificity of the binding.
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6.4  Evidence for binding of Sox4 and Foxp1 in pro-B cells to regulatory
elements that are bound by Sox2 and Foxd3 in ES cells
To investigate whether the switch in binding of ES cell transcription factors to occupancy
by B cell specific factors is a general phenomenon, ChIP-on-Chip was used to investigate was
used to verify the binding pattern of Sox4 and Foxp1 in RAG-deficient pro-B cells. The
analysis was carried out using the microarray that was previously used to investigate the
correlation between ETCMs, bivalent domains and binding of Sox2 and Foxd3 in ES cells. The
results showed that Sox4 and Foxp1 binds to several lymphocyte- or B cell-specific genes
known to be expressed in pro-B cells. One of these genes is Pax5, a transcription factor that is
expressed from the pro-B cell stage and plays a fundamental role in B lymphocyte
differentiation (see Section 1.3.1). The analysis of histone modifications (H3K4 and H3K27
methylation) and of Sox2 and Foxd3 binding in ES cells showed that Pax5 is marked by a
bivalent domain and is bound by both Sox2 and Foxd3 (see Figure 4.5a). Knock-down of Sox2
also showed that binding of Sox2 is essential for the maintaining of the H3K4me2 mark on this
domain (see Figure 5.7). The analysis on the Sox4 and Foxp1 binding in pro-B cells indicated
that these factors bind to the same region as their cognate factors in ES cells. In addition Foxp1,
similar to the 5-VpreB1 locus, was found at several elements within the Pax5 genomic region
(Figure 6.6a).
Another example of the switch from ES to pro-B cell factors is the Blnk/Dntt genomic
region. These genes encode proteins essential for different lymphoid differentiation programs,
including B cell development. In ES cells the intergenic domain is characterised by an ETCM-
like epigenetic mark, which is bound by Sox2, and by additional ETCM-like domains located
close to the Blnk gene. Similar to the Pax5 bivalent domain, the H3K4 methylation that forms
part of the intergenic mark is dependent on the presence of Sox2 (see Figure 5.7). No
enrichment for Foxd3 was detected in this genomic region in ES cells. The analysis of factor
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Figure 6.6 Factor switching at the B cell-specific  and  loci. Log2 ratio profiles (IP/Input) of
DNA immunoprecipitated with antibodies specific for Foxd3 in ES cells (brown), Foxp1 in pro-B cells (green),
Sox2 in ES cells (purple), Sox4 in pro-B cells (pink) and H3K4me2 (red) or H3K27me3 (blue) in ES cells.
Magenta and cyan lines highlight the location of bivalent domains or ETCMs respectively. Horizontal arrows
show the direction of transcription. Orange arrows show the position of the transcription factor peaks.
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Figure 6.7 The T cell-specific  and genes do not undergo factor switching in pro-B cells. Log2
ratio profiles (IP/Input) of DNA immunoprecipitated with antibodies specific for Foxd3 in ES cells (brown),
Foxp1 in pro-B cells (green), Sox2 in ES cells (purple), Sox4 in pro-B cells (pink) and H3K4me2 (red) or
H3K27me3 (blue) in ES cells. Magenta and cyan lines highlight the location of bivalent domains or ETCMs
respectively. Horizontal arrows show the direction of transcription. Orange arrows show the position of the
transcription factor peaks.
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binding in pro-B cells indicated that Sox4 binds in these cells to the same region bound in ES
cells by Sox2. Interestingly, Foxp1 was found to be enriched on the Blnk promoter and on the
intergenic domain. The presence of Foxp1 bound to a genomic region that does not bind Foxd3
in ES cells suggest that the binding switch is restricted to a subset of elements.
The binding profile of the Sox and Fox factors to genes that are not expressed in B cells
confirmed that the switch is lineage-specific. Helios is a transcription factor that belongs to the
same family as Ikaros and Aiolos, but it is only expressed during T cell development. In ES
cells, Helios is marked by a bivalent domain around its promoter and is bound by Sox2. In
pro-B cells the gene is not expressed and no binding of either Sox4 or Foxp1 was detected
(Figure 6.7a). A parallel case is CD44, which is a marker of the T lineage. CD44 is also marked
by a bivalent domain on the promoter in ES cells and the region contains an area that is enriched
for Foxd3. No significant signal for Sox4 or Foxp1 was detected in pro-B cells where CD44 is
not transcribed (Figure 6.7b).
6.5  Summary
Using the same approaches that were employed to identify Sox2 and Foxd3 as the factors
binding to the 5-VpreB1 ETCM – in vivo footprinting, ChIP and EMSA – it was shown that
Sox4 and Foxp1 interact with the same elements in pro-B cells that are bound by Sox2 and
Foxd3 in ES cells. Since the region corresponding to the ETCM is an enhancer in pre-B cells
(Minaee et al., 2005), these results suggest that Sox4 and Foxp1 could be involved in regulating
the enhancer function of this element. A further confirmation of the potential role of Sox4 and
Foxp1 in the regulation of 5 and VpreB1 came from the ChIP results, which showed that these
transcription factors bind to additional regulatory elements within the 5-VpreB1 locus. ChIP-
on-Chip analysis, using the same array that was used in ES cells, demonstrated that a number
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of regulatory elements that are associated with of B lymphocyte-restricted genes and are bound
by Sox2 and/or Foxd3 in ES cells are also occupied by Sox4 and Foxp1 in pro-B cells.
The binding of transcription factors to regulatory elements of genes that are not transcribed
in ES cells has an important impact on the chromatin modification of the region. Many
transcription factors with distinct tissue and cell-type specificity have conserved DNA binding
domains and recognise similar DNA sequences. It has been shown that ES cell specific factors
are replaced by factors that are expressed in B cells at several regulatory elements located close
to genes that are active in the B lineage. The switch in factor binding to regulatory sequences
when a differentiation program is activated suggests that these DNA elements play a key role
in gene regulation.
A switch between transcription factors from the same family has been previously described
for the regulation of genes at different stages of development. In early erythrocyte precursors
the -globin gene cluster, although not expressed at this stage, is marked by H3K4me2 and
bound by GATA2. At later stages of differentiation GATA2 is replaced by GATA1, whose
presence activate transcription (Anguita et al., 2004). This example demonstrate the
establishment of epigenetic marks by binding of factors after lineage commitment has occurred.
Binding of factors to the same element can lead to different outcomes, such as gene poising
or transcription. This is probably due to the expression of additional regulatory proteins that are
essential for creating the network of factors, which regulates the transcription of a particular
differentiation program. The specific transcriptome of a cell ultimately determines whether a
gene is poised, activated or silenced in that cell.
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7  Discussion
Epigenetic control of gene expression has been proposed to be a major determinant of ES
cell pluripotency. Histone modification profiling of ES cells demonstrated that many genes are
marked by unusual epigenetic states, which could determine their transcriptional potential. One
of the first of these epigenetic marks to be identified in ES cells is located at an enhancer of the
pro/pre-B cell specific 5-VpreB1 locus. This element, which was described as an Early-
Transcription Competence Mark (ETCM), is characterised by active histone modifications
(H3K4 methylation and H3K9 acetylation) and binding of general transcription factors and
PolII, even when the two genes are not expressed in ES cells (Szutorisz et al., 2005a). A second
epigenetic modification that is present in ES cells is the bivalent domain, which has been found
around the promoters and transcription start sites (TSS) of many non transcribed genes that are
involved in developmental control. Bivalent domains are characterised by the methylation of
both histone H3K4 and histone H3K27, which were previously found only on active or on silent
genes respectively (Azuara et al., 2006; Bernstein et al., 2006).
Bivalent domains and ETCMs are believed to keep the marked genes poised for
transcription in pluripotent cells until the relevant differentiation pathway is activated. The fact
that ETCMs and bivalent domain are characterised by localised peaks of histone modifications
suggests that they are regulated by the binding of transcription factors to elements within these
domains, since the complexes responsible for histone methylation have to be recruited
specifically to the chromatin regions that have to be modified. The ETCM of the pro/pre-B
cell-specific 5-VpreB1 locus was used as a model system to identify the cis-acting sequences
and the transcription factors bound to them that are responsible for establishing the epigenetic
mark on this locus.
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7.1  Sox2 and Foxd3 regulate the epigenetic status and transcriptional
function of the  ETCM in ES cells
The analysis of factor binding to the 5-VpreB1 locus in ES cells (Chapter 3) identified
Sox2 and Foxd3 as two factor interacting on the ETCM region of this locus. Sox2 and Foxd3
were previously known for their fundamental role in early development, highlighted by the
early embryonic lethality in mice carrying null mutation for either Sox2 or Foxd3 and the fact
that is not possible to derive ES cells from these embryos (Avilion et al., 2003; Hanna et al.,
2002). In particular, Sox2 is considered to be a key player in the ES cells network of
transcription factors. In this thesis it has been shown for the first time that Sox2 binds directly
to a region epigenetically marked in mouse ES cells, the 5-VpreB1 ETCM, a discovery that
support the hypothesis that Sox2 is involved in the epigenetic poising of ES cells (Bernstein et
al., 2006).
While Sox2 was hypothesised to be involved in epigenetic regulation of ES cells and
consequently its presence could have been detected directly by ChIP, the use of in vivo
footprinting as the technique to identify the factors interacting on the 5-VpreB1 locus ETCM
was pivotal to the discovery of Foxd3 as a potential epigenetic regulator. This highlights the
importance of using approaches with low bias for the study of DNA-protein interactions that
may be involved in gene regulation. Foxd3 is not a widely studied transcription factor, but it
has been implicated in both gene activation and repression in ES cells. An interesting feature
of Fox transcription factors is their ability to bind to compacted chromatin to promote local
unfolding, due to a linker histone-like domain common to these proteins (Cirillo et al., 2002;
Clark et al., 1993; Cuesta et al., 2007). Such ability would allow Foxd3 to open the chromatin
on localised elements within repressed genomic regions to allow the formation of complexes
able to modify histone tails.
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One of the feature of the 5-VpreB1 locus ETCM is the presence of intergenic transcripts.
The mutation of the ETCM Sox and Fox sites in reporter constructs demonstrated that these
elements, and the factors bound to them, are involved in regulating the expression of these
transcripts. In particular the Fox elements has a repressive activity that counterbalance the
enhancing function of the Sox sites. The presence of an activator and a repressor keep
transcription to basal levels, while allowing the formation and the maintenance of the
epigenetic mark. It has been previously reported that the proteasome represses intergenic
transcription by blocking unspecific recruitment of PolII (Szutorisz et al., 2006). It can be
hypothesised that one of the mechanism for the Foxd3-mediated repression involves the
recruitment of the proteasome to the 5-VpreB1 locus. Such repressive model could be tested
by interfering with Foxd3 expression and analysing variation in the binding of the proteasome
to the 5-VpreB1 locus. If proven true, the transcription factors-mediated recruitment of the
proteasome to genomic elements marked only by active histone modifications, could be a
system to reduce transcription alternative to the epigenetic repression observed at bivalent
domains.
An important feature that will have to be investigated in the future is the interdependence
of Sox2 and Foxd3 for binding to the 5-VpreB1 locus and the formation of the histone marks
characterising the ETCM. While it has been shown in this thesis that the knock-down of Sox2
reduces the levels of H3K4me2 at the ETCM (Chapter 5), the mark was not completely deleted.
This might be due to the persistence of Foxd3 binding and its recruitment of histone
methyltransferases. The knock-down of Foxd3 would allow to determine whether it is too
involved in the formation of the histone mark, or its presence only represses the transcription
of non-coding RNAs activated by complex binding to the Sox sites. The knock-down of both
Sox2 and Foxd3 will have to be investigated in the future to analyse whether these two proteins
are necessary and sufficient for the formation of the ETCM on the 5-VpreB1 locus.
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7.2  Sox2 and Foxd3 are involved in the epigenetic marking of a subset of
tissue-specific genes in ES cells
The ChIP-on-Chip experiments (Chapter 4) identified a series of elements, linked to
tissue-specific genes not expressed in ES cells, whose epigenetic profile resembles an ETCM.
Due to the physical limits of the platform used for the experiments (40Mbp) only 30 additional
ETCM-like elements have been identified. The employment of genome-wide arrays or the use
of alternative techniques, like ChIP-seq, could bring to the identification of further ETCM, but
already from the data presented in this work it can be concluded that bivalent marks are a more
widespread epigenetic mark of untranscribed genes in ES cells.
Of the newly identified ETCMs only a fraction has been shown to be bound by Sox2 and
Foxd3, which suggest that other transcription factors, or combinations of factors, are involved
in the marking of these elements. Therefore multiple regulatory networks are involved in the
epigenetic control of silent genes in the early stages of embryonic development. As for the
identification of Sox2 and Foxd3, only the detailed analysis of factor binding to individual gene
loci will bring to the identification of other proteins able to alter the epigenetic state of silent
genes. Sox2 and Foxd3 have also been shown for the first time to bind bivalent domains in
mouse ES cells. It was proposed that the binding of transcription factors to bivalent elements
could be pivotal to the recruitment of PRC2 subunits to these regions, triggering the
methylation of lysine 27 at H3 (Bernstein et al., 2006). By knocking-down Sox2 it has been
shown here that the proposed model is not valid, since Sox2 knock-down did not affect either
the binding of Suz12 - a PRC2 subunit - or the levels of H3K27me3 at bivalent regions, while
the same experiments showed that the lack of Sox2 reduces the methylation of H3K4 at
Sox2-bound bivalent domains. A possible model for the recruitment of both activities could
involve first the binding of PRC2, which in turn would allow the interaction of transcription
factors. ES cells knock-out for the PRC2 protein Eed have already been used to demonstrate
that polycomb proteins are involved in the methylation of H3K27 at bivalent regions (Azuara
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et al., 2006). The same cell lines could be used to verify whether the binding of Sox2 and/or
Foxd3 to their target bivalent elements is dependent of PRC2 recruitment and H3K27
methylation. If the loss of PRC2 binding and H3K27 methylation will be shown not to affect
Sox2 or Foxd3 binding, it could be concluded that the activity responsible for the methylation
of H3K4 and H3K27 are recruited independently of each other. If this hypothesis will be
confirmed it could be inferred that the bivalent marks are not always present at the same time
on both alleles, but that histone 3 methylation at K4 and K27 is highly dynamic and cycles of
methylation/demethylation maintained the gene poised while repressed.
In ES cells Sox2 and Foxd3 also bind to the regulatory elements of the genes that are
directly activated or repressed by these factors. What determines the different activities of the
two factors at different genes? At bivalent domains the presence of polycomb repressive
complexes (PRC) is fundamental for the methylation of H3K27 and direct repression of the
marked genes (Azuara et al., 2006; Bernstein et al., 2006). Why the presence of transcription
factors and active histone modifications at ETCMs does not activate transcription of the linked
genes is still unclear. One possibility is the lack in ES cells of specific transcription factors,
whose interaction with promoters or other regulatory elements would trigger gene activation.
In such a scenario the binding of factors to an enhancer would recruit the complexes that are
able to modify chromatin, creating the ETCM, while the absence of other key partners would
inhibit the formation of the complete activation complex. An alternative possibility would be
the recruitment, at different elements, of distinct complexes that would create either an active
enhancer or an ETCM. An example of differential cofactor interaction has been described for
the transcription factor REST. This protein has been found alternatively recruiting to its target
DNA sequences two distinct repressive complexes, Sin3 and CoREST (Andres et al., 1999;
Naruse et al., 1999). While both have histone deacetylase activity, the interaction of REST with
CoREST also recruits chromatin remodelling factors of the SWI-SNF family, the methyl
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DNA-binding protein MeCP2 and the H3K9 methyltransferase G9a (KMT1) (Battaglioli et al.,
2002; Lunyak et al., 2002; Roopra et al., 2004; Shi et al., 2003), thus inducing long range
chromatin silencing (Lunyak et al., 2002). Very little is known about the cofactors that are
recruited by Sox2 or Foxd3 to the region that they bind to. The identification of these partners
could give further insights into the mechanisms that regulate epigenetic marks in ES cells. As
mentioned above, the recruitment of the proteasome to region marked by an ETCM could be
one of the features that distinguish complexes that induce the formation of a poised epigenetic
state from complexes that regulate the activation/repression of a gene.
7.3  A factor relay system for the developmental regulation of tissue-
specific genes
To understand the function of bivalent domains and ETCMs it is important to understand
the function of the marked elements in the cell types that express the linked genes and how
these elements are regulated. The 5-VpreB1 locus was again used as a model system to study
this issue. A clue to the function of the 5-VpreB1 locus ETCM came from the fact that Sox4
and Foxp1, two transcription factors that belongs to the same families as Sox2 and Foxd3, have
been described as important regulators of B lymphocyte development. Both factors have been
shown to be involved in the transition from pro- to pre-B cells (Hu et al., 2006; Schilham et al.,
1996), the stage when 5 and VpreB1 are expressed. The analysis of factor binding in pro-B
cells demonstrated that both Sox4 and Foxp1 bind the 5-VpreB1 locus in these cells (Chapter
6), where Sox2 and Foxd3 are not expressed. Since the same site within the ETCM that have
been shown to be bound in ES cells are also occupied in pro-B cells, the use of reporter
constructs with mutated Sox and Fox sites would give a further confirmation of the importance
of these elements for the regulation of 5 and VpreB1 from early development through B-cell
differentiation.
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If factor switch exists, when does it occurs? The transition from pluripotent stem cells to
multipotent stem cells is a potential candidate for an handover from ES cell transcription factors
to tissue-specific ones. Multipotent stem cells have a more restricted differentiation potential
compared to ES cells and it might be expected that activating epigenetic marks would be
restricted to genes that are due to be expressed in the lineages that are derived from these cells.
Therefore, it can be hypothesised that in hematopoietic stem cells (HSC) Sox4 and Foxp1 could
replace Sox2 and Foxd3 on the 5-VpreB1 ETCM, to maintain the poised state of the locus.
Other hematopoietic genes, which are bound in ES cells by Sox2 or Foxd3, would also be
expected to maintain their epigenetic marks in HSC. The analysis of protein expression in HSC
could indicate whether at this stage a switch in the expression of Sox and Fox factor exists. The
analysis of the histone modifications profile in HSC would also confirms the maintenance of
the epigenetic mark during the differentiation of pluripotent to multipotent cells.
If a gene is not destined to be expressed in a particular lineage one possibility is that loss of
the poised state would be caused by lack of transcription factor binding to any of the sequences
responsible for the maintenance of the epigenetic marks. Support for this hypothesis comes
from the observation that binding of Sox4 and Foxp1 is absent in proB cells at genes that are
unrelated to B lymphocyte differentiation, even though these genes were bound by Sox2 and/or
Foxd3 in ES cells. An alternative mechanism for the disappearance of epigenetic marks during
differentiation could be due to the activity of histone lysine demethylases (KDM). This active
system would erase epigenetic signals that are unnecessary for the developmental program in a
particular cell-type. Similar to other enzymes that modify histones, KDMs are targeted to
specific sequences by interacting with transcription factors. Therefore, at some stage of
development, one or more sites within ETCMs and bivalent domains would be occupied by
factors recruiting KDM-containing complexes. A factor switch could also be involved for such
a scenario with the ES cell factors replaced at the target sites by tissue-specific factors that
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would induce the erasure of the histone marks. Therefore, at each differentiation steps the
combination of binding sites on a regulatory element and the expression of the transcription
factors that are able to bind to them, would determine the maintenance or loss of epigenetic
signatures.
The results described in this thesis provide evidence that factor-relay mechanisms can be
initiated at the earliest stages of development, before there has been any commitment to a
specific lineage. During development, the ES cell factors would be replaced at their DNA
binding sites by tissue-specific factors that share their DNA recognition domains. This model
allows the poised epigenetic state to be maintained during different stages of development by
recruiting enzymes that are able to modify chromatin to the marked elements. These poised
regions would then become the hub for the formation of the activation complex that would
induce transcription when all of the necessary factors are expressed.
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